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Advances in genetic research have allowed us to identify speciﬁc genetic aberrations
associated with behavioral and intellectual developmental disorders. However it is also
becoming increasingly clear that there is not a unilateral relationship between genetic
deviations and their manifestations. Rather, the expression and evolution of these disor-
ders represent a complicated dance between genetic makeup (genotype) and behaviors
and characteristics (phenotype), the environment, and learning over time. The study of
genetically determined syndromes associated with speciﬁc behavioral phenotypes,
including autism and intellectual disability, offers an opportunity to study these interac-
tions. Autism is a disorder that is increasingly recognized as being inﬂuenced not only by
genetic factors, but also by environmental factors (Hallmayer et al., 2011). While most of
the genetic syndromes associated with intellectual disability and a pronounced psychi-
atric dimension are rare, even extremely rare, collectively they represent a signiﬁcant
proportion of severe intellectual disability, where autism is likely under–identiﬁed. The
study of the behavioral and intellectual development aspects of these syndromes can
help us understand better the complex etiology, progression, and classiﬁcation of
autism spectrum disorders. 
Brain–behavior relationships develop as a result of brain programming and func-
tional connectivity within neural circuits and networks, all determined by gene expres-
sion. Gene expression affecting brain programming and function is inﬂuenced by the
interplay between genes, learning behavior and social context. Thus, brain–behavior
relationships are not a static given, individual experiences within environments will over
the lifespan also inﬂuence the brain and may result in alternative developmental trajec-
tories (Oliver et al., 2000; Rutter, 2005; Pennington, 2009; Saemundsen et al., 2010). 
The objective of the research projects in this dissertation was to study autism as
part of phenotypes in selected (ultra) rare genetic syndromes; and to examine autism
within a different sociocultural environment. 
Genotype of behaviorally described neurodevelopmental and psychiatric disorders
An individual’s genetic make–up (as determined by DNA sequence) deﬁnes genotype.
Genetic risk factors may disturb neural development and functioning of speciﬁc brain
regions that serve aspects of cognition and behavior. These disruptions may ultimately
lead to neurodevelopmental phenotypes such as intellectual disability and autism spec-
trum disorder, involving atypical social responsiveness and impaired ﬁltering of stimuli,
and language development, and/or repetitive–restrictive behaviors. Similar phenotypes
that may emerge from distinctly different genetic defects (pathways) are thought to
have been caused by the multidirectional interaction between genetic and environmen-
tal risks and protective factors. Conversely, a given genotype can give rise to different
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phenotypes depending on environmental circumstances. Establishing the genetic
underpinnings of neurodevelopmental disorders is rarely straightforward – complex
behavior rarely maps to a speciﬁc gene. Even when the genes are highly deterministic,
there is a range of severity, the range variations possibly reﬂecting environmental and
other circumstances. 
A well–known example of a highly deterministic disorder that may feature autism
spectrum disorder as part of the behavioral phenotype is Fragile X syndrome. The study
of genetic syndromes in a subset of patients with the same genetic defect/aberration,
such as Fragile X syndrome, has added to our insight into the potential genetic pathways
of autism spectrum disorder, while at the same time highlighting the diversity of possi-
ble outcomes without autism spectrum disorder. It has lead to the understanding that
single deﬁcit models for understanding complex developmental disorders disregard the
pleiotropy of a given genetic cause and the diversity of effects that it may have on behav-
ioral outcomes and cognitive deﬁcits.
Many recent genetic studies have investigated chromosome regions and possible
loci on various chromosomes with regard to their contribution to the cause of autism
spectrum disorder, intellectual disability, and schizophrenia. Several of these studies
have concluded that many of the genomic variants investigated are not disease–speciﬁc,
rather they contribute to the expression of varying clinical symptoms crossing diagnos-
tic boundaries and leading to various phenotypes such as intellectual disability, autism
spectrum disorder and schizophrenia. Similar to intellectual disability, autism spectrum
disorders are considered to be complex multifactorial, heterogeneous syndromes for
which no single causative factor has been identiﬁed. Much research over the past few
decades has focused on characterizing and describing the behaviors that are part of the
core symptomatology. Increasingly, such studies have employed multiple approaches to
advance our understanding. 
Behavioral phenotype
A phenotype may be deﬁned as a group of observable, measurable characteristics that
are the result of interactions between genotype and environment. Many different phe-
notypes can be distinguished in this way, for example molecular, biochemical, physical,
psychiatric, and cognitive phenotypes. Prevailing deterministic models have frequently
focused on a single neurobiological cause to explain phenotypic outcome, disregarding
the complex interactions among a multitude of factors in the social and nurturing envi-
ronments. While genetic defects inﬂuence brain function and may lead to psychiatric
problems in an individual, existing inter–individual variability can make it difﬁcult to arrive
at comparable proﬁles for behavior and cognition within a genetic syndrome. It is neces-
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sary for such problems to be considered within the framework of developmental phase,
family and life events, and social and learning environments, to determine their meaning
and clinical signiﬁcance for that individual. It is clear that behavioral characteristics in any
genetic syndrome are not solely determined by genetics (Harris, 2010) and too strong an
emphasis on the biological determinants of behavior is misleading. 
Research examining cognitive proﬁles together with speciﬁc behavioral patterns has
led to the realization that certain syndromes or chromosomal anomalies may well be
characterized by speciﬁc behaviors or a speciﬁc combination of behaviors (Mazzocco &
Reiss, 1994; Flint, 1995). To consider a combination of behaviors a behavioral phenotype,
two conditions must be met (Flint & Yule, 1994; Turk & Hill, 1995; Dykens et al., 2000).
First, the behavioral phenotype, a deﬁned pattern of speciﬁc behaviors, must be seen in
almost all cases affected with the syndrome, while rarely observed in other syndromes.
Second, a direct link between genetic defect and its physical manifestations must be
plausible (Flint & Yule, 1994). 
Behavioral phenotypes in combination with speciﬁc cognitive strengths and weak-
nesses have offered clues to an underlying genetic cause for certain developmental and
behavioral difﬁculties and have sometimes led to the deﬁnition of a (new) syndrome. 
Aberrant behaviors can have a more signiﬁcant impact on the life of a child and the
family than the cognitive limitations associated with a syndrome. Behavioral problems
may inﬂuence the quality of interactions with others, but behavior may also be deter-
mined by the reactions of others to the distinct physical features and cognitive limitations
of the child. Obviously, children with a distinct genetic anomaly are also subject to social,
familial, psychological, and learning experiences that shape behavior and phenotypic pre-
sentations (Dykens, 2000), which in turn will have an effect on the architecture of the
brain. Interestingly, studies investigating reciprocal effects of genotype and behavior have
shown that phenotypes in genetically determined syndromes do not necessarily have
ﬁxed linear outcomes, and they can be inﬂuenced by social information (Oliver et al.,
2000; Dykens et al., 2006). And although causal direction remains unclear, cross–section-
al studies make it apparent that a solely linear perspective on syndromally determined
behaviors is insufﬁcient to explain the social, cognitive, and environmental contributors
to the phenotype and the changes that can take place over time (Pennington, 2009).
Deﬁning intellectual disability, autism spectrum disorder and adaptive skills
Rare disorders are deﬁned as disorders with an incidence of fewer than 2, 000 individu-
als per year in a population. While rare and ultra rare disorders comprise small groups
of individuals with a speciﬁc genetic etiology, collectively they are a large group and rep-
resent a substantial proportion of the group with developmental disability (Hennekam,
11
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2011). Behaviors targeted for study in this dissertation are: intellectual disability, adaptive
skills, and autism spectrum disorder. These are deﬁned in accordance with two organi-
zations, the American Association on Intellectual and Developmental Disability
(AAIDD) and the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition
(DSM IV), of the American Psychiatric Association (APA). 
The AAIDD deﬁnes intellectual disability as a disability originating before the age of
18 and characterized by signiﬁcant limitations in two domains: intellectual functioning
(reasoning, learning, problem solving), and adaptive behavior (covering many everyday
social and practical skills). Adaptive behavior is deﬁned by the AAIDD into three skills
levels namely conceptual (e.g. language, time concepts, self–direction), social (interper-
sonal relationships, self–esteem, social problem solving), and daily living skills (personal
care and hygiene, schedules, routines).
Autism spectrum disorders are deﬁned as pervasive, neurodevelopmental disabilities
with onset before 36 months of age and characterized by impairments in three domains:
reciprocal social interactions, communication skills and behavioral abnormalities (APA, 1994).
Studying rare and ultra rare disorders associated with intellectual disability requires
reframing traditional approaches to research. The prevalence of intellectual disability is
estimated to be 1–4% in the total population worldwide (Roeleveld et al., 1997). Esti-
mates for the Netherlands indicate that there are 125, 000 individuals with intellectual
disability, while 2, 000 babies are born each year with an ultra–rare disorder associated
with intellectual disability (Hennekam, 2011). 
Any group studied in a single location will by deﬁnition be small. Affected individu-
als are likely to be geographically dispersed. Research must then take into consideration
differences in language and health care systems. In the past this has required combining
multiple sites and multinational studies to compile information on a sufﬁcient numbers
of patients. Alternatively, or in combination with standard strategies, a Wiki can be used
as an online collaborative resource for compiling information from dispersed sources. In
the study of extremely rare conditions, such as Marshall–Smith syndrome described in
this dissertation (with less than 50 cases reported worldwide), the utility of a Wiki is an
obvious tool for overcoming language barriers and/or geographical distances. It offers
parents from all over the world the opportunity to add important information to the col-
lected data and makes it possible to include their perspectives on the communication
and social interaction skills, behavior, and developmental potential of their children.
Thus a Wiki can be considered an efﬁcient tool in gathering information on very rare dis-
orders (Hu et al., 2008; Shaw et al., 2010). 
The study of physical, behavioral and cognitive aspects of phenotype–genotype
associations in humans may beneﬁt greatly from studying more than one aspect of phe-
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notype and from using different and multidisciplinary approaches to do so. Studies have
time and time again demonstrated the pleiotropy of genes and the complexities
involved in mapping gene – brain – behavior pathways. Finding the genetic defect in syn-
dromes is only the beginning of understanding the expression and the role of the pro-
teins involved and the effects on phenotype, since such a defect may have an impact on
only some or on all (for example behavioral) traits. Therefore, careful study and detailed
descriptions of behaviors and comorbid conditions over a lifetime remain crucial and
continue to improve our understanding of the pathways involved (Harris, 2010). 
The study of risks associated with speciﬁc genetic compositions and translating the
knowledge acquired toward treatment interventions is called translational genetics.
One of its principal goals is to link genetic information to phenotypic outcome and risk
for disorders with the aim of eventually using this knowledge to devise treatments that
will ameliorate or modify etiology–speciﬁc predisposition and vulnerability to patholo-
gy. Studying the physical characteristics in combination with the behavioral and psychi-
atric aspects of a genetic syndrome not only enhances our knowledge of differences
among syndromes, but also sheds light on similarities, behavior clusters, and environ-
mental effects on development and outcome. 
Behavioral research within a syndrome is helpful to delineate the syndrome, as is
the study of those individuals with partial variants who exhibit some, but not all features
of the syndrome (Harris, 2010). Studying behavioral phenotypes in more prevalent
genetic syndromes associated with intellectual disability such as Fragile X syndrome or
Prader–Willi syndrome has signiﬁcantly added to our understanding of the behaviors
that commonly occur in people with these syndromes and the changes that may occur
over time (Whittington & Holland, 2010; Arron et al., 2011). 
The recognition of behavioral phenotypes and distinctive, etiology–speciﬁc behaviors
in genetic syndromes has sparked a great interest in the study and description of clinically
relevant issues pertaining to these behaviors. Increasingly, such studies have employed
multiple approaches to advance our understanding of both genes and phenotypes.
Many genetic syndromes associated with intellectual disability share commonali-
ties across phenotypes such as delays in speech/language development, problems with-
in social situations and interactions, lack of imaginative play, and other characteristics
which indicate similarities with the behaviorally deﬁned DSM–IV criteria for autism
spectrum disorders. While studies have found that in various syndromes with a known
genetic defect, autism or other psychiatric disorders may be part of the behavioral and
psychiatric phenotypes, researchers have also emphasized the difﬁculties in differentiat-
ing between genetically determined intellectual disability and autism spectrum disorder
or other psychiatric symptoms. In spite of these difﬁculties, the studies remain of impor-
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tance. In genetic syndromes where the cause is still unknown, investigating and accu-
rately describing the behavioral, linguistic and social difﬁculties and recognizing co–mor-
bid psychiatric symptoms can aid in the clinical diagnosis and may eventually lead to the
development of effective treatment interventions. 
Outline of this dissertation
This dissertation discusses several genetic syndromes associated with intellectual dis-
ability and their phenotypes. 
chapter 2 reviews various distinctive behavioral characteristics in well–known syn-
dromes associated with intellectual disability. The syndromes discussed in this chapter
were selected based on their prevalence and their syndrome–associated behavioral phe-
notype. More in–depth review and discussion of phenotypes in genetic syndromes
associated with intellectual disability and distinct behavioral abnormalities follow in
chapters 3 and 4. 
chapter 3 reviews the marked maladaptive and self–injurious behaviors and sleep
disturbances of the behavioral phenotype in Smith–Magenis syndrome, including psy-
chiatric and cognitive issues. 
chapter 4 presents an early clinical case in which Pitt–Hopkins syndrome, a rare dis-
order associated with intellectual disability and breathing abnormalities, was diagnosed
based on distinctive clinical manifestations of physical and behavioral phenotype. 
chapter 5 discusses results of a clinical study of Pitt–Hopkins syndrome in 10 indi-
viduals, and compares the results to those found in the literature worldwide. The clini-
cal study included assessments regarding behavior, development, adaptive and psycho-
logical functioning. 
A large, international collaborative research project studying, exploring, and further
delineating the developmental progression, physical and behavioral phenotype, cogni-
tion and autism in an ultra–rare disorder, Marshall–Smith Syndrome, is described in
chapters 6 and 7. 
Finally, chapters 8 and 9 describe the ﬁrst attempt to study the prevalence and pos-
sible risk factors of treated autism spectrum disorders in the Caribbean.
chapter 8 describes the prevalence project, whose aim was to expand autism–spe-
ciﬁc epidemiologic research beyond the developed world countries, which have domi-
nated the research literature. In chapter 9 paternal age was studied to examine the rela-
tionship between advanced paternal age and the risk of autism spectrum disorders in
Aruba’s distinctive sociocultural setting.
chapter 10 summarizes the studies presented in this dissertation and offers a dis-
cussion of the ﬁndings. 
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adapted from: Van Balkom et al., 1999
Syndroomgebonden gedragskenmerken bij verstandelijk gehandicapten.
Tijdschrift voor Kindergeneeskunde 67(1), 1–7
A B S T R AC T
It is becoming increasingly evident that genetically determined syndromes may be char-
acterized not only by speciﬁc dysmorphic features and congenital anomalies, but also by
speciﬁc behavioral and cognitive patterns. Knowledge of such behavioral phenotypes
and cognitive proﬁles provides the clinician new and additional tools in diagnosing and
delineating different syndromes. It allows parents and other caregivers to anticipate and
deal with abnormal behaviors of the child with the syndrome. Furthermore, studies of
behavioral and cognitive phenotypes in syndromes may lead to a better understanding
of the biological basis of human behavior. A number of frequent genetic syndromes with
a speciﬁc behavioral phenotype and cognitive proﬁle are described in brief in this review.
I N T RO D U C T I O N
Clinical genetics is often still considered a discipline primarily interested in diagnosing
remarkable physical features and anatomical anomalies, and in researching their genetic
causes. It has become increasingly clear over the last decade, however, that certain
impulsive behaviors such as for example violent, aggressive behavior and arson may also
be partly determined by genetic causes (Mazzocco & Reiss, 1994; Flint, 1995).
Research of cognitive proﬁles together with speciﬁc behavioral patterns has led to
the realization that certain syndromes or chromosomal anomalies may well be charac-
terized by speciﬁc behaviors or combination of behaviors (Mazzocco & Reiss, 1994; Flint,
1995). In several cases, these behavioral phenotypes in combination with certain cogni-
tive strengths and weaknesses, have offered clues to the underlying genetic cause for
the individual’s developmental and behavioral difﬁculties. In some cases they have actu-
ally led to the delineation of a syndrome. Two conditions are required to consider a com-
bination of behaviors and other features a behavioral phenotype (Flint & Yule, 1994; Turk
& Hill, 1995). First, a behavioral phenotype is deﬁned as a pattern of speciﬁc behaviors
seen in almost all affected cases, while rarely observed in other syndromes. Second, a
direct connection between genetic defect and physical manifestations is plausible (Flint
& Yule, 1994). 
In 1995 Turk and Hill proposed a broader deﬁnition of behavioral phenotype, one in
which not only cognitive aspects of known genetic defects were included but also syn-
dromes with as yet unknown etiology. They deﬁned a behavioral phenotype as a pattern
of behavioral and psychological characteristics present in many or most of the affected
individuals. They emphasized the clinical importance of a structured approach in
describing cognitive and behavioral functioning and proposed dividing these aspects
and symptoms into 5 groups namely: intelligence, speech and language, attentional
17
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defects, social impairments and other behavioral problems (Turk & Hill, 1995).
In this paper we review behavioral characteristics of some well–known syndromes
associated with intellectual disability. The syndromes described here were selected on
the basis of their prevalence and their syndrome based behavioral phenotype. For exam-
ple, in Down syndrome there are no speciﬁc behavioral characteristics, although the
syndrome occurs frequently. In Lesch–Nyhan syndrome there are striking behavioral
issues, but this entity is very rare. This led us to review the selected entities: Fragile X
syndrome, Rubinstein–Taybi syndrome, Prader–Willi syndrome, Velo–cardio–facial syn-
drome, Williams syndrome, and Cornelia de Lange syndrome. 
C L I N I C A L  D E S C R I P T I O N S
Fragile X syndrome
Fragile X syndrome (FXS) is characterized by intellectual disability, delay of motor devel-
opment and physical features such as a long face with prominent jaw and large protrud-
ing ears, and the development of macro–orchidism during or after puberty. The defect
is located on the distal end of the long arm of chromosome X (Xq27.3) and is caused by
expanded repeats of a speciﬁc triplet, causing transcriptional silencing of the fragile X
mental retardation gene (FMR1). The absence of the associated protein FMRP as a conse-
quence causes dysregulation of many genes, which in turn can lead to a neuropsychiatric
phenotype of hyperactivity, anxiety, epilepsy and autism spectrum disorder (ASD)
(Zafeiriou et al., 2007; D’Hulst & Kooy, 2009). FXS is now considered the most severe
expression of FMR1 mutation leading to gene silencing. It is part of a group of FMR1
mutation related disorders, termed fragile X–associated disorders. These include fragile
X–associated tremor/ataxia (FXTAS) and fragile X–associated primary ovarian insufﬁ-
ciency syndrome (Boyle et al., 2010).
Cognitive skills develop parallel to those of typically developing peers until puberty.
The psychological proﬁle shows performance skills are less developed than verbal capac-
ities. Speciﬁc defects are found, especially in information processing, abstract reasoning,
visual–spatial capacity, and auditory and visual short term memory; and these become
more noticeable with age (Flint & Yule, 1994; Merenstein et al., 1994; Turk & Hill, 1995;
Udwin & Dennis, 1995). From puberty on cognitive development seems to slow signiﬁ-
cantly (Flint & Yule, 1994; Turk & Hill, 1995; Udwin & Dennis, 1995). But this ﬁnding may
be better explained by the fact that in different age groups different skills are examined,
than by a true decline in intellectual skills. Adolescents and adults with FXS have difﬁ-
culties with cognitive tasks that require skills such as abstract reasoning, sequential pro-
cessing of information, and mathematics, these tasks however are increasingly part of
18
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psychometric measurements with increasing age. In addition, longitudinal studies have
shown that new skills are acquired at a slower rate, which can manifest itself as a decline
in IQ scores over time (Bolton & Holland, 1994; Flint & Yule, 1994; Merenstein et al., 1994;
Turk & Hill, 1995; Udwin & Dennis, 1995; Dykens et al., 2000).
Problems in speech and language may vary from a complete absence of speech to
mild communication issues. Studies in patients with Fragile–X syndrome showed not
only problems due to a general developmental delay, but also disorders of expressive
language and perseverative speech (Bolton & Holland, 1994; Merenstein et al., 1994; Turk
& Hill, 1995; Udwin & Dennis, 1995).
The observed problems in enunciation are probably due to physical anomalies, such
as a highly arched palate and weakness of the temporomandibular joint. Examples of
echolalia, repetitive, disorganized and perseverative speech in FXS have been described
as ‘cluttering’, talking at a fast and ﬂuctuating rate while speech is interspersed with rep-
etitions of sounds, words or phrases, and sentences are often incomplete (Flint & Yule,
1994; Turk & Hill, 1995; Udwin & Dennis, 1995).
Hyperactivity, impulsivity and signiﬁcant attention difﬁculties can be seen in 80% of
men with FXS. Hyperactivity usually diminishes with advancing age, but attention
deﬁcits and impulsivity often persist into adolescence and adulthood (Turk & Hill, 1995;
Udwin & Dennis, 1995). Approximately 30% of children with FXS meet criteria for
autism, while another 20% can be diagnosed with a broader deﬁned ASD (Hagerman et
al., 2008). The most frequently observed symptom (in 90% of cases) with respect to
autism symptomatology is difﬁculty in establishing and maintaining eye–to–eye con-
tact. Self–injury is associated with repetitive and impulsive behavior in FXS (Arron et al.,
2010). Stereotypies and self injurious behaviors such as hand ﬂapping, hand biting, and
head banging are as common to FXS as they are to ASDs. A notable difference between
FXS patients and patients diagnosed with autism seems to be the clear wish for social
interaction in FXS, although this is often hampered by anxiety and shyness (Bolton &
Holland, 1994; Flint & Yule, 1994; Merenstein et al., 1994; Turk & Hill, 1995; Udwin & 
Dennis, 1995). 
The verbal stereotypies and echolalia in expressive language seem to have an impor-
tant function in attempts to initiate and maintain social interactions by FXS patients
regardless of their difﬁculties in central processing of information (Turk & Hill, 1995;
Udwin & Dennis, 1995). Other autistic behaviors in FXS are related to difﬁculties on the
domains of social relatedness and communication. These include (social) anxiety,
unusual sensory interests with a hypersensitivity to touch, impulsivity, and attention
deﬁcits (Hagerman et al., 2008).
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Rubinstein–Taybi syndrome
Rubinstein–Taybi syndrome (RTS) is characterized by intellectual disability, postnatal
growth retardation (with short stature, broad thumbs and broad great toes, and typical
facial features with a large nose, convex nasal ridge, and protruding columella). Occur-
rence is usually sporadic, prevalence is 1 birth in 100, 000–125, 000 (Hennekam, 2006). In
some patients the syndrome is caused by a deletion on band 16p13.3, or a mutation in
gene Cyclic AMP responsive element Binding Protein (CBP) which is included in that part of
chromosome 16. Rarely, mutations in the E1A Binding Protein P300 (EP300) gene are
found. 
A Dutch study of the syndrome reported full scale intelligence levels between 25
and 79; in a small percentage of patients IQ levels precluded formal testing and levels
were estimated around 25. Mean IQ was around 35, with higher scores on performance
skills than on verbal skills (Hennekam et al., 1992). Sometimes there is a complete lack of
speech (Udwin & Dennis, 1995), but in most cases expressive language is limited with
difﬁculties in complex syntax and concept formation. In spite of these, most patients
make excellent use of their limited verbal skills in social communication (Hennekam et
al., 1992; Udwin & Dennis, 1995). Children with RTS show a preference for adult compa-
ny, most have attention deﬁcits, startle easily at loud noises and more than half of
patients exhibit stereotyped movements such as rocking, hand ﬂapping and spinning.
Resistance to change and distress caused by sudden events or unexpected changes in
daily routines are reported in approximately 75% of children. Older patients often show
mood swings and temper tantrums (Hennekam et al., 1992; Udwin & Dennis, 1995).
Behavioral problems most frequently reported by parents include: short attention span,
stubbornness, clinging behavior and sometimes aggressiveness in early adulthood (Hen-
nekam, 2006). Signiﬁcant numbers of individuals with RTS suffer from symptoms of
severe over–activity, short attention span, motor stereotypies, poor coordination,
mood swings, and aggressive outbursts in a cyclical pattern. Behavioral changes and
exacerbation of symptoms may occur with aging and these can lead to psychiatric diag-
noses of mood disorders, bipolar disorders and autism spectrum disorders (Hellings et
al., 2002; Galera et al., 2009; Verhoeven et al., 2010).
Prader–Willi syndrome 
Prader–Willi syndrome (PWS) is characterized by a combination of intellectual disabili-
ty, hypogonadism, and obesity. Birth incidence is approximately 1: 22, 000– 1: 25, 000
(Vogels et al., 2003). Two phases can be distinguished in the clinical phenotype from
neonate through to adulthood. The ﬁrst phase, the neonatal phase, is characterized by
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severe hypotonia, feeding difﬁculties, failure to thrive and delayed motor development.
This is followed by a second phase commencing between the ﬁrst and fourth year char-
acterized by hyperphagia, which can lead to excessive weight gain, gross obesity and
high mortality if these issues are not addressed (Whittington & Holland, 2010). Most
affected patients have a chromosome 15 abnormality (e.g. deletion, uniparental disomy,
structural rearrangement, methylation defects) at band q11–13 (Vogels et al., 2003). The
degree of the intellectual disability can vary considerably; IQ level varies between 20 and
90. There are indications that in as many as 50% of patients, intellectual level is border-
line between below–average functioning and mild mental retardation (Holm et al., 1993;
Flint & Yule, 1994; Udwin & Dennis, 1995; Cassidy, 1997).
There is an unusual cognitive proﬁle with strong visual organization and perception,
but relatively poor processing of auditory and sequential information. Individuals with
PWS typically perform well on tasks such as reading, development of vocabulary and
doing puzzles (Holm et al., 1993; Udwin & Dennis, 1995; Cassidy, 1997). However, most
patients have speciﬁc deﬁcits in math, writing, visual and auditory short term memory
and auditory attention (Turk & Hill, 1995; Udwin & Dennis, 1995; Cassidy, 1997). Motor
milestones are signiﬁcantly delayed due to the neonatal hypotonia. Children generally
achieve independent sitting around 12–13 months, and walking independently around 24
to 28 months. The delay in speech and language development is partly due to facial
anomalies and early hypotonia. Problems include mostly articulation problems and
hypernasal voice (Holm et al., 1993; Cassidy, 1997).
Expressive language skills are weaker than receptive language skills. Parents often
report verbal perseveration on a favorite topic as a distinctive, sometimes irritating
behavioral feature (Udwin & Dennis, 1995).
Insatiable appetite, constantly requesting or seeking food, and abnormal food
intake are the most characteristic clinical symptoms of the syndrome (Holm et al., 1993;
Bolton & Holland, 1994; Flint & Yule, 1994; Udwin & Dennis, 1995; Cassidy, 1997; Boer et
al., 1998; Whittington & Holland, 2010). The absence of a feeling of satiation causes the
PWS patient to continue eating, which may lead to extreme obesity beginning before
age six and an increased risk of obesity related complications in adulthood (Schrander–
Stumpel et al., 2004). In approximately 30% of cases bodyweight is more than 200% of
the ideal weight. It is unclear if this symptom can be attributed solely to the syndrome.
There are arguments that the behavior could also be classiﬁed as learned behavior.
Because food is kept out of reach from the patient and only offered at intervals, the
patient ‘learns’ to eat as much as possible in the short period of time that the food is
available (Flint & Yule, 1994). The obsession with food, as well as the continuous search
for food are examples of the severity of the eating disorder, and these become more
apparent beyond childhood (Holm et al., 1993; Flint & Yule, 1994; Udwin & Dennis, 1995;
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Cassidy, 1997; Boer et al., 1998).
Temperament and contingent behavior in PWS are considered syndrome speciﬁc.
The young child with PWS is usually described as stubborn. With advancing age patients
can show temper tantrums, obsessional thoughts and obsessive–compulsive behaviors.
They tend to be oppositional, rigid, manipulative and quarrelsome (Holm et al., 1993;
Bolton & Holland, 1994; Flint & Yule, 1994; Turk & Hill, 1995; Udwin & Dennis, 1995; Cas-
sidy, 1997; Boer et al., 1998). Self–injury is associated with repetitive and impulsive behav-
iors (Arron et al., 2010), and consists of highly prevalent (severe) compulsive skin picking
and gouging. It is often seen in older children and adults with PWS (Holm et al., 1993;
Flint & Yule, 1994; Bolton & Holland, 1994; Turk & Hill, 1995; Udwin & Dennis, 1995; Boer
et al., 1998; Dykens & Shah, 2003). The syndrome is associated with psychotic episodes,
which have been described in a small proportion of PWS patients. PWS resulting from
the maternal uniparental disomy genetic subtype is strongly associated with psychotic
episodes (Udwin & Dennis, 1995; Cassidy, 1997; Boer et al., 1998; Dykens & Shah, 2003;
Vogels et al., 2003; Soni et al., 2007, 2008; Ingason et al., 2011). The rigidity, repetitive
behaviors and restricted interests seen in PWS are similar to behaviors seen in autism
spectrum disorder (Whittington & Holland, 2010). It is primarily due to the maladaptive
behaviors that relatively few adult PWS patients are able to lead an independent lifestyle
(Udwin & Dennis, 1995; Cassidy, 1997).
Velo–cardio–facial syndrome
Velo–cardio–facial syndrome (VCFS), the most common contiguous gene syndrome, is
caused by a microdeletion on the long arm of chromosome 22, located at 22q11. The syn-
drome is autosomal dominantly inherited, but occurs in a majority of patients (85%) as
a spontaneous mutation. The deleted region contains approximately 50 genes, some of
which are implicated for psychiatric dysfunction. The gene catechol–O–methyl trans-
ferase (COMT) is within the deleted region for all patients with VCFS. Decreased
COMT–activity, linked to elevated dopamine levels in the brain, predisposes for psychi-
atric disorders such as bipolar disorder and schizophrenia (Dunham et al., 1992; Bassett
et al., 2007; Gothelf et al., 2009). 
VCFS has a signiﬁcant variability in phenotypic expression and no single clinical fea-
ture occurs in 100% of cases (Shprintzen, 2008). Most important physical characteristics
include overt or occult submucous cleft palate, congenital cardiac abnormalities (e.g.
ventricle septal defect, atrial septal defect, pulmonic atresia, tetralogy of Fallot) and a
distinctive, although not obviously abnormal face with long, straight proﬁle, prominent
nasal bridge, bulbous nasal tip, narrow nasal base, and narrow palpebral ﬁssures. Many
infants with VCFS are frequently ill with hospitalizations for failure to thrive, cardiac
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abnormalities and early hypotonia, chronic upper and lower respiratory complications
(Swillen et al., 2000; Shprintzen, 2008).
Ryan et al. (1997) compiled cognitive information on 558 patients and discovered
normal cognitive development in 32% of patients, mild mental retardation in 30% and
moderate to severe intellectual disability in 18%. Of the remaining 20% of patients cog-
nitive levels were unknown. Incidence of intellectual disability is higher in the group of
familiarly occurring VCFS than within the group of de novo occurring VCFS. Other stud-
ies have shown signiﬁcant numbers of VCFS patients had full scale IQ scores below 70,
with lower verbal than performance IQ scores (Shprintzen et al., 1978). Notable was the
fact that children with VCFS seem to perform relatively well compared to classmates
when still young (<5 years of age). Learning difﬁculties become more apparent during
later childhood and adolescence when the emphasis on abstract reasoning and concep-
tual learning increases, although in preschool children (aged <6 years) intelligence was
found to be within normal limits with a mean full scale IQ level of around 87 (Golding–
Kushner et al., 1985; Swillen et al., 1997).
In VCFS children a mild delay in speech and language development occurs with a
speciﬁc developmental pattern of early unintelligibility after the onset of speech and
subsequent hypernasal qualities. Children usually begin to develop ﬁrst words before
age 2, but do not acquire short phrases and sentences until the second or third year of
life. The hypernasal voice is due more to structural anomalies of the soft palate and
velopharyngeal insufﬁciency, than to hearing loss caused by hypoplasia of Eustachian
tubes (Shprintzen et al., 1981). 
VCFS is associated with alarmingly high prevalence rates for psychiatric morbidity
(Jolin et al., 2006). Recent research found that psychiatric issues in VCFS seem to follow
a developmental pattern, with psychotic and mood disorders rarely occurring during
childhood but dramatically increasing during young adulthood. In early childhood,
behavior and social relatedness are negatively affected by severe separation anxiety,
simple phobias, and generalized anxiety, although it is likely that the expressive language
impairment also contributes to the social withdrawal and the avoidance of verbal con-
tact. Careful monitoring of psychiatric symptoms during childhood, adolescence and
young adulthood is warranted (Shprintzen et al., 1992; Green et al., 2009). 
Golding–Kushner et al. (1985) noted that patients with VCFS were socially isolated
and had ‘extremes of behavior’ evidenced in impulsivity, distractibility, shyness and
facial mannerisms with lack of expression or affect. More recent studies have noted
major depressive disorders, attention deﬁcit disorders and behavioral impairments and
hypothesized that the increase of social difﬁculties with age could be a factor in the
development of mood disorders in adolescence or adulthood (Antshel et al., 2006; Jolin
et al., 2006; Aneja et al., 2007). 
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These and other published studies have shown that psychiatric illness should be
considered a primary feature of VCFS, and although clinically there is overlap in diag-
nostic categories with changes during the lifetime, most reported diagnoses are: anxiety
disorders, ADHD, depressive disorders, bipolar disorder, schizo–affective disorder, and
schizophrenia (Shprintzen et al., 1992; Karayiorgou et al., 1995; Gothelf et al., 1997; Bas-
sett et al., 1998; Jolin et al., 2006; Antshel et al., 2006; Aneja et al., 2007; Shprintzen, 2008;
Gothelf et al., 2009).
Williams syndrome
Williams and co workers (1961) were the ﬁrst to suggest an association between multi-
ple physical features as cardiovascular abnormalities, failure to thrive, dental abnormali-
ties and hypersensitivity to sound, mental retardation and speciﬁc behavioral features
(Williams et al., 1961). Williams syndrome (WS) is caused by the deletion of approxi-
mately 25 genes on chromosome 7q11.23. The deletion includes the gene for elastin
(ELN), detecting the absence of one copy of the gene for ELN conﬁrms the diagnosis of
WS. The prevalence of WS is estimated at 1: 20, 000 (Jarvinen–Pasley et al., 2008).
Mental retardation may vary between mild and moderate. Intellectual functioning
usually remains on a stable level during childhood with no apparent decline in cognitive
abilities over time. Long term follow–up showed little educational progress beyond
early teenage years (Udwin & Yule, 1990a; Bellugi et al., 2000). Speciﬁc areas of weakness
include difﬁculty with abstract concepts, spatial cognition and abstract reasoning, visu-
al–spatial construction disability, and major defects in planning and problem solving
(Gosh et al., 1996; Bellugi et al., 2000; Mervis & Klein–Tasman, 2000; Jarvinen–Pasley et
al., 2008; Morris, 2010). Dysmorphic facial characteristics are often difﬁcult to recognize
at a very young age, but features usually become more apparent with age. These features
include pufﬁness around the eyes, a small upturned nose, long philtrum, wide mouth,
full lips, and a small chin. Blue and green–eyed individuals with the syndrome can have
a distinctly beautiful “starburst” or white lacy pattern on their iris. Early symptoms in
infancy and childhood include failure to thrive, and feeding difﬁculties due to hypotonia.
Muscle tone tends to improve with age. Developmental disabilities and cardiovascular
complications can become apparent later in childhood. 
A distinctive cognitive proﬁle was described as early as 1978. It showed a signiﬁcant
discrepancy between verbal and performance skills resulting in relative strengths in
aspects of language and facial processing, and severely impaired spatial cognition in
addition to poor perceptual ability. Although this unusual neuropsychological proﬁle is
not necessarily unique to WS, it is not often seen in children with mental retardation of
different origin and it is considered an important syndrome feature useful in syndrome
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identiﬁcation (Bennett et al., 1978; Bellugi et al., 2000; Jarvinen–Pasley et al., 2008).
Further features include selective attention to parts or details and difﬁculty in
assembling the whole, with the exception of a particular skill in face perception and
recognition (Tager–Flusberg et al., 2003). This last feature is also seen in individuals with
right hemisphere damage. Such damage is consistent with relatively spared language
abilities, primarily in the areas of grammar and vocabulary also found in individuals with
WS. There are indications of augmented amygdala volume in WS. The amygdala has a
crucial role in social cognition, and regulating responses to social–emotional stimuli
(Jarvinen–Pasley et al., 2008; Morris, 2010). Bilateral damage may be linked to a lessened
ability to perceive fear towards strangers (Jarvinen–Pasley et al., 2008). 
Early anecdotal reports have highlighted great language ability and verbal expres-
sions, and later studies have conﬁrmed that although expressive language is usually ﬂu-
ent with an abundance of social phrases, chit–chat and clichés, the content of conversa-
tion can often be odd or out of context (Bellugi et al., 1990; Jarvinen–Pasley et al., 2008).
Later research with varying outcomes to assessments of speech and language ques-
tioned whether greater than typical language ability is a consistent manifestation of the
syndrome (Udwin, 2005; Mervis & Becerra, 2007).
Speech is often qualiﬁed as ‘unusual’ probably also as a consequence of the rela-
tively spared language, the frequent use of neologisms (Bellugi et al., 1990) and stereo-
typical use of sentences, words, and adult sounding phrases (Udwin & Yule, 1990b). The
voice is usually deep and hoarse.
Adverse reactions to certain sounds is present in almost all persons with WS (96%),
usually manifesting itself in distressed reactions on hearing sudden loud noises (Dilts et
al., 1990; Levitin et al., 2005). This causes heightened distractibility to all noises and prob-
ably explains some of the hyperactivity, attention deﬁcits and restlessness. Additional
issues reported include concentration difﬁculties, excessive anxiety and impairments in
social relatedness with peers (Udwin & Yule, 1990a; Greer et al., 1997) and perseveration
in thought processes (Greer et al., 1997).
The syndrome speciﬁc temperament in WS shows increased sociability and empa-
thy in social interaction. Paradoxically, numerous reports over time have also empha-
sized maladaptive behaviors, limited social judgment, a greater interest in contact with
adults than with peers and a limited ability to use skills in a general social context (Tomc
et al., 1990; Plissart et al., 1996; Jarvinen–Pasley et al., 2008). Studies have shown that 2/3
of children between 3 and 7 years have a difﬁcult or relatively difﬁcult temperament
(Tomc et al., 1990). However, concurrent with difﬁcult behavior children with WS will
also show active, social behavior, especially by seeking contact with or socially engaging
the other, possibly resulting in the lessening of other, more negative aspects of tem-
perament during short observations. 
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Parents have reported that their children with WS are typically unafraid of strangers
(Gosch et al., 1994) and in general show a greater interest in contact with adults than
with their peers. They are frequently troubled by fears and anxieties related to non–
social circumstances (Mervis & Klein–Tasman, 2000; Morris, 2010). The development of
adaptive behaviors, daily living skills and independent functioning is hampered by anxi-
ety, distractibility, overfriendliness, lack of perseverance, and insufﬁcient motor skills. It
seems that adults with WS need more support and a larger social support network
when compared to adults with a similar cognitive developmental level (Plissart et al.,
1996; Greer et al., 1997). The domain of daily living skills such as showering and dressing
is one of the least developed adaptive behavioral domains in WS (Greer et al., 1997).
Common psychiatric diagnoses in WS include attention deﬁcit hyperactivity disorder
(ADHD) and clinically evident anxiety disorders such as speciﬁc phobias, generalized
anxiety disorder, or separation anxiety disorder (Morris, 2010).
Cornelia de Lange syndrome
Cornelia de Lange syndrome (CdLS) was ﬁrst described in 1933 by the ﬁrst female pro-
fessor of pediatrics in the Netherlands: Cornelia de Lange (de Lange, 1933). The inci-
dence of CdLS is unclear, but is estimated worldwide to occur at 1 in 37, 000 to 50, 000
persons (Dorsett & Krantz, 2009).
The defect in the syndrome can be determined in about half of patients with the
syndrome as a mutation in the Nipped–B homolog (Drosophila) (NIPBL) gene, on the
short arm of chromosome 5 (5p13.2). In a small subset of male patients the syndrome is
caused by a change in the structural maintenance of chromosomes 1A (SMC1A) gene locat-
ed on the X–chromosome, and very rarely mutations in structural maintenance of chro-
mosomes 3 (SMC3) are found. All genes causally implicated in the syndrome have a func-
tion in the division of individual chromosomes, but it is still unclear how this results in
the characteristic syndrome symptomatology. 
CdLS is characterized by mental retardation (Kline et al., 1993), short stature, limb
abnormalities and distinctive facial features such as conﬂuent eyebrows, long eyelashes,
low nasal bridge and thin, down turned lips. In 65–70% of CdLS patients, a form of autism
spectrum disorder has been described in which the problems in social interaction and
communication, and in behavior have been signiﬁcant (Bhuiyan et al., 2006).
The syndrome can be expressed in two clinical dichotomous forms, one a classic
form in which intellectual disability is severe, while patients with the milder form show
less retardation of cognitive development and growth. Autism spectrum disorder can be
found as part of the clinic of both forms. There is no regression of skills. Most children
with the syndrome are able to acquire new skills until well into their teenage years
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depending on their cognitive level. Visual–spatial memory is usually well–developed.
Research has shown that those children with a combination of low birth weight
(below 2, 500 grams), microcephaly, and severe anomalies of the arms tend to have a
higher risk of speech and language delay. Difﬁculties in reciprocal social interaction are
pronounced with a lack of social–emotional reciprocity, mask–like facial expressions and
rejection of physical contact through body posture. Severe problems with the develop-
ment of speech and language or complete lack of speech may be negatively impacted by
frequent auditory issues (Jackson et al., 1993). If language and speech do occur, expressive
language skills and speech are less developed than comprehension and passive language.
Stereotyped and self–injurious behaviors seem to be characteristic of the group
with classic CdLS (Basile et al., 2007) and seem to be associated with repetitive and
impulsive behaviors (Arron et al., 2010). The stereotypies, repetitive and self injurious
behaviors consist predominantly of a fascination for own hands and hand movements,
motor mannerisms, ﬁnger biting, head banging, poking behind the ear with one ﬁnger
and scratching. Maladaptive behaviors in children with a severe form of CdLS have been
observed and documented through videotaping. Several behavioral characteristics
included, e.g. rejecting social and physical contact with the mother and unfamiliar oth-
ers, the masque like face with lack of emotional expression, frequent stereotyped, repet-
itive and self–stimulating movements, and reacting with pleasure to vestibular stimula-
tion. One characteristic movement that may be interpreted as rejection is bending
further backwards when the child is carried horizontally. It is important for parents to
understand that these behaviors should not be interpreted as rebuffs but rather these
are behaviors occurring with the syndrome. Communication with others may improve
with increasing age (Johnson et al., 1976). Self–injury is found more often in patients over
age 12 and usually occurs in response to stress, frustration, anxiety or fear. Fascination
with own hands and typical hand movements are often accompanied by grimacing and
teeth grinding. It is difﬁcult to attract the attention of the child or distract it at these
times (Sarimski et al., 1997).
Other adverse behavioral issues such as aggressive episodes directed toward
objects and persons and serious temper tantrums were associated with co–morbid
autism spectrum disorder. In addition, there are behaviors that are also common in chil-
dren with intellectual disability, such as hyperactivity, passivity and stereotypical behav-
iors (Sarimski et al., 1997).
Sleep disturbances are common in children with CdLS with autism spectrum disor-
der and clinical presentations include irregular sleep patterns, insomnia or interrupted
sleep, and daytime drowsiness (Berney et al., 1999; Bhuiyan et al., 2006).
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D I S C U S S I O N
Improved knowledge of syndromically determined behavioral characteristics allows par-
ents the possibility to anticipate this behavior, and it can improve recognition and diag-
nosis of the syndrome. Furthermore, a better understanding of the genetic basis of
deviant behavior can also increase understanding of the biological basis of normal
behavior and cognition (Mazzocco & Reiss, 1994; Flint, 1995; Turk & Hill, 1995; Walter et
al., 2009).
The great inter–individual variability can make it difﬁcult to come to concurrent pro-
ﬁles for behavior and cognition in the syndromes described, making it clear that behav-
ioral characteristics in any syndrome are not solely determined by genetics (Harris,
2010). Too strong an emphasis on the biological determinants of behavior should be
avoided: for example just as not every patient with Williams syndrome will have a
supravalvular aortic stenosis so may a behavioral and cognitive proﬁle of the syndrome
not always be fully evident. 
Behavior is also inﬂuenced by interactions with the environment and by the reac-
tions from that environment to temperament, external features and neuropsychological
deﬁcits. Furthermore, it is possible that the variability described in the international lit-
erature could be explained by methodological differences across studies. 
For parents it is of great value to realize that certain behavioral characteristics of
their child are associated with the syndrome, and that his behavior should not be inter-
preted as a personal rejection. This realization may greatly reduce feelings of guilt,
incomprehension and irritation in parents and other caregivers (Hennekam et al., 1992;
Turk & Hill, 1995; Udwin & Dennis, 1995).
It is important that parents do not accept certain behaviors associated with the syn-
drome as inevitable and unalterable, thereby not reacting in appropriately corrective
ways to behavioral abnormalities in the child with the possibility of further exacerbation
(‘self–fulﬁlling prophecy’) and even stigmatization. Determining whether (child psychi-
atric) interventions are possible to ameliorate or manage severe behavioral problems
associated with the syndrome is desirable from both a scientiﬁc and clinical perspective.
CO N C LU S I O N
Increasingly the causes of more syndromes with speciﬁc behavioral phenotypes will be
isolated with advances in cytogenetic/molecular genetics. Interdisciplinary collabora-
tion will contribute to the development of more reﬁned, structured measures of behav-
ior and cognition in these syndromes, which in concert with genetic information will
contribute greatly to our understanding of human behavior.
28
chap ter  2
References
Aneja, A., Fremont, W. P., Antshel, K. M., Faraone, S. V., Abdulsabur, N., Higgins, A. M., Shprintzen, R., et al.
(2007). Manic symptoms and behavioural dysregulation in youth with velocardiofacial syndrome
(22q11.2 deletion syndrome). J Child Adolesc Psychopharmacol 17(1),105–114.
Antshel, K. M., Aneja, A., Strunge, L., Peebles, J., Fremont, W. P., Stalone, K., Abdulsabur. N., et al. (2007).
Autistic spectrum disorders in Velo–cardio Facial Syndrome (22q11.2 deletion). J Autism Dev Disord
37(9), 1776–1786.
Arron, K., Oliver, C., Moss, J., Berg, K. & Burbridge, C. (2010).The prevalence and phenomenology of self–
injurious and aggressive behaviour in genetic syndromes. J Intellect Disabil Res 55(2), 109–120. 
Basile, E., Villa, L., Selicomi, A. & Molteni, M. (2007). The behavioural phenotype of Cornelia de Lange
Syndrome : a study of 56 individuals. J Intellect Disabil Res 51(9), 671–681.
Bassett, A. S., Caluseriu, O., Weksberg, R., Young, D. A., Chow, E. W. (2007). Catechol–O–methyl transferase
and expression of schizophrenia in 73 adults with 22q11 deletion syndrome. Biol Psychiatry 61(10), 1135–
1140.
Bellugi, U., Bihrle, A., Jernigan, T., Trauner, D. & Doherty, S.(1990). Neuropsychological, neurological, and
neuroanatomical proﬁle of Williams syndrome. Am J Med Genet Suppl 6, 115–125.
Bellugi, U., Lichtenberger, L., Jones, W., Lai, Z. & St. George, M. (2000). The neurocognitive proﬁle of
Williams syndrome: A complex pattern of strengths and weaknesses. J Cogn Neurosci 12 (Supplement
1), 7–29.
Bennett, F. C., La Veck, B. & Sells, C. J. (1978). The Williams elﬁn facies syndrome: the psychological proﬁle as
an aid in syndrome identiﬁcation. Pediatrics 61(2), 303–306.
Berney, T. P., Ireland, M. & Burn, J. (1999). Behavioural phenotype in Cornelia de Lange syndrome. Arch Dis
Child 81(4), 333–336.
Bhuiyan, Z. A., Klein, M., Hammond, P., van Haeringen, A., Mannens, M. M., van Berckelaer–Onnes, I. &
Hennekam, R. C. (2006). Genotype–phenotype correlations of 39 patients with Cornelia de Lange
syndrome: the Dutch experience. J Med Genet 43(7), 568–575.
Boer, H., Clarke, D. J., Webb, T., Holland, A. J. & Curfs, L. M. G. (1998). Het syndroom van Prader–Willi: van
gen naar gedrag, Tijdschr Psychiatr 40(2),108–114.
Bolton, P. & Holland, A. (1994). Chromosomal abnormalities. In: Rutter M, Taylor E, Hersov L. (red). Child and
adolescent psychiatry. Modern approaches, third edition. (pp. 152–171). London: Blackwell Science Ltd. 
Boyle, L. & Kaufmann, W.E. (2010). The behavioral phenotype of FMR1 mutations. Am J Med Genet C Semin
Med Genet 154(4), 469–476.
Cassidy, S. B. (1997). Prader–Willi syndrome. J Med Genet 34(11), 917–923.
D’Hulst, C. & Kooy, R. F. (2009). Fragile X syndrome: from molecular genetics to therapy. J Med Genet 46(9),
577–584.
Dilts, C. V., Morris, C. A., & Leonard, C.O. (1990). Hypothesis for development of a behavioural phenotype in
Williams syndrome. Am J Med Genet Suppl 6, 126–131.
Dorsett, D. & Krantz, I. D. (2009). On the molecular etiology of Cornelia de Lange Syndrome. Ann N Y Acad
Sci 1151, 22–37.
Dunham, I., Collins, J., Wadey, R. & Scambler, P. J. (1992). Possible role for COMT in psychosis associated with
velo–cardio–facial syndrome. Lancet 340(8831), 1361–1362.
Dykens, E., Hodapp, R. & Finucane, B. (2000). Genetic and mental retardation syndromes. Baltimore: Paul H.
Brookes Publishing Co.
Dykens, E. & Shah, B. (2003). Psychiatric disorders in Prader–Willi Syndrome: epidemiology and
management. CNS Drugs 17(3), 167–178.
29
b ehavi o r al  ph en ot y pe s  i n  s y n d rome s  with  i ntel l ec tual  d i sab i l it y
Flint, J. (1995). Pathways from genotype to phenotype. In: O’Brien G, Yule W. (red). Behavioural phenotypes.
Clin Develop Med 138. (pp. 79–89). London: Mac Keith Press.
Flint, J. & Yule, W. (1994). Behavioural Phenotypes. In: Rutter M, Taylor E, Hersov L. (red). Child and
adolescent psychiatry. Modern approaches, third edition. (pp. 666–687). London: Blackwell Science
Ltd.
Galera, C., Taupiac, E., Fraisse, S., Naudion, S., Toussaint, E., Rooryck–Thambo, C., Delrue, M. A., et al. (2009).
Socio–Behavioral Characteristics of Children with Rubinstein–Taybi Syndrome. J Autism Develop Dis
39(9), 1252–1260.
Golding–Kushner, K. J., Weller, G. & Shprintzen, R. J. (1985). Velo–cardio–facial syndrome: Language and
psychological proﬁles. J Craniofac Genet Dev Biol 5(3), 259–266.
Gosch, A. & Pankau, R. (1996). Longitudinal study of the cognitive development in children with Williams–
Beuren syndrome. Am J Med Genet 61(1), 26–29.
Gosch, A., Stading, G. & Pankau, R. (1994). Linguistic abilities in children with Williams–Beuren syndrome.
Am J Med Genet 52(3), 291–296.
Gothelf, D., Frisch, A., Michaelovsky, E., Weizman, A. & Shprintzen, R. J. (2009). Velo–cardio–facial
syndrome. J Ment Health Res Intellect Disabil 2(2), 149–167.
Gothelf, D., Frisch, A., Munitz, H., Rockah, R., Aviram, A., Mozes, T., Birger, et al. (1997). Velocardiofacial
manifestations and microdeletions in schizofrenic inpatients. Am J Med Genet 72(4), 455–461.
Green, T., Gothelf, D., Glaser, B., Debbane, M., Frisch, A., Kotler, M., Weizman, A., et al. (2009). Psychiatric
disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion)
syndrome. J Am Acad Child Adolesc Psychiatry 48(11), 1060–1068.
Greer, M. K., Brown, F. R., Shashidhar Pai, G., Chowdhry, S. & Klein, A. (1997). Cognitive, adaptive, and
behavioural characteristics of Williams syndrome. Am J Med Genet 74(5), 521–525.
Hagerman, R. J. & Harris, S. W. (2008). Autism Proﬁles of Males with Fragile X Syndrome. Am J Ment Retard
113(6), 427–438.
Harris, J. C. (2010). Advances in understanding behavioral phenotypes in neurogenetic syndromes. Am J Med
Genet C Semin Med Genet 154(4), 389–399.
Hellings, J. A., Hossain, S., Martin, J. K. & Baratang, R. R. (2002). Psychopathology, GABA, and the
Rubinstein–Taybi syndrome: a review and case study. Am J Med Genet 114(2), 190–195.
Hennekam, R. C., Baselier, A. C., Beyaert, E., Bos, A., Blok, J. B., Jansma, H. B., Thorbecke–Nilsen, V. V., et al.
(1992). Psychological and speech studies in Rubinstein–Taybi syndrome. Am J Ment Retard 96(6), 645–
660.
Hennekam, R. C. M. (2006). Rubinstein–Taybi syndrome. Eur J Hum Genet 14(9), 981–985.
Holm, V. A., Cassidy, S. B., Butler, M. G., Hanchett, J. M., Greenswag, L. R., Whitman, B. Y. & Greenberg, F.
(1993). Prader–Willi syndrome: Consensus diagnostic criteria. Pediatrics 91(2), 398–402.
Ingason, A., Kirov, G., Gieglin, I., Hansen, T., Isles, A. R., Jakobsen, K. D., Kristinsson, K. T., et al. (2011).
Maternally derived microduplications at 15q11-13: implication of imprinted genes in psychotic illness.
Am J Psychiatry 168(2), 408-417.
Jackson, L., Kline, A. D., Barr, M. A. & Koch, S. (1993). de Lange syndrome: a clinical review of 310 individuals.
Am J Med Genet 47(7), 940–946.
Jarvinen–Pasley, A., Bellugi, U., Reilly, J., Mills, D. L., Galaburda, A., Reiss, A. L. & Korenberg, J.R. (2008).
Deﬁning the social phenotype in Williams Syndrome: a model for linking gene, the brain, and behavior.
Dev Psychopathol 20(1), 1–35.
Johnson, H. G., Ekman, P. & Friesen, W. (1976). A behavioural phenotype in the Lange syndrome. Pediatr Res
10(10), 843–850.
30
chap ter  2
Jolin, E. M., Weller, E. B. & Weller, R. A. (2006). Velocardiofacial syndrome: is there a neuropsychiatric
phenotype? Curr Psychiatry Rep 8(2), 96–101.
Karayiorgou, M., Morris, M. A., Morrow, B., Shprintzen, R. J., Goldberg, R., Borrow, J., Gos, A., et al. (1995).
Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad
Sci U S A 92(17), 7612–7616.
Kline, A. D., Stanley, C., Belevich, J., Brodsky, K., Barr, M. & Jackson, L. (1993). Developmental data on
individuals with the Brachmann–de Lange syndrome. Am J Med Genet 47(7), 1053–1058.
de Lange, C. (1933). Sur un type nouveau de degeneration (typus Amstelodamensis). Arch Med Enfants 36,
713–719.
Levitin, D.J., Cole, K., Lincoln, A. & Bellugi, U. (2005). Aversion, awareness, and attraction: investigating
claims of hyperacusis in the Williams syndrome phenotype. J Child Psychol Psychiatry 46(5), 514–523.
Mazzocco, M. M. M. & Reiss, A. L. (1994). Genetic disorders and advances. Curr Opin Psychiatry 7(5), 392–
396.
Merenstein, S. A., Shyu, V., Sobesky, W. E., Staley, L., Berry–Kravis, E., Nelson, D. L., Lugenbeel, K. A., et al.
(1994). Fragile X syndrome in a normal IQ male with learning and emotional problems. J Am Acad Child
Adolesc Psychiatry 33(9), 1316–1321.
Mervis, C. B. & Becerra, A. M. (2007). Language and communicative development in Williams syndrome.
Ment Retard Dev Disabil Res Rev 13(1), 3–15.
Mervis, C. B. & Klein–Tasman, B. P. (2000). Williams syndrome: cognition, personality and adaptive behavior.
Ment Retard Dev Disabil Res Rev 6(2),148–158.
Morris, C. A. (2010). The behavioral phenotype of Williams syndrome: a recognizable pattern of
neurodevelopment. Am J Med Genet C Semin Med Genet 154(4), 427–431.
Plissart, L., Borghgraef, M. & Fryns, J. P. (1996). Temperament in Williams syndrome. Genet Counsel 7(1), 41–
46.
Ryan, A. K., Goodship, J. A., Wilson, D. I., Philip, N., Levy, A., Seidel, H., Schuffenhauer, S., et al. (1997).
Spectrum of clinical features with interstitial chromosome 22q11 deletions: a European collaborative
study. J Med Genet 34(10), 798–804.
Sarimski, K. (1997). Communication, social–emotional development and parenting stress in Cornelia de
Lange syndrome. J Intell Disabil Res 41(1), 70–75.
Schrander–Stumpel, C. Th. R. M. , Curfs, L. M. G., Sastrowijoto, P., Cassidy, S. B., Schrander, J. J. P. & Fryns, J.
P. (2004). Prader–Willi Syndrome: causes of death in an international series of 27 cases. Am J Med
Genet A 124(4), 333–338.
Shprintzen, R. J. (2008). Velo–cardio–facial syndrome: 30 years of study. Dev Disabil Res Rev 14(1), 3–10.
Shprintzen, R. J., Goldberg, R. B., Lewin, M. L., Sidoti, E. J., Berkman, M. D., Argamaso, R. V. & Young, D.
(1978). A new syndrome involving cleft palate cardiac anomalies, typical facies, and learning disabilities:
Velo–cardio–facial syndrome. Cleft Palate J 15(1), 56–62.
Shprintzen, R. J., Goldberg, R., Golding–Kushner, K. J. & Marion, R. W. (1992). Late–onset psychosis in the
velo–cardio–facial syndrome. Am J Med Genet 42(1), 141–142.
Shprintzen, R. J., Goldberg, R. B., Young, D. & Walford, L. (1981). The velo–cardio–facial syndrome: a clinical
and genetic analysis. Pediatrics 67(2), 167–172.
Soni, S., Whittington, J., Holland, A. J., Webb, T., Maina, E., Boer, H. & Clarke, D. (2007). The course and
outcome of psychiatric illness in people with Prader–Willi syndrome: implications for management and
treatment. J Intellect Disabil Res 51(1), 32–42.
Soni, S., Whittington, J., Holland, A. J., Webb, T., Maina, E. N., Boer, H. & Clarke, D. (2008). The
phenomenology and diagnosis of psychiatric illness in people with Prader-Willi syndrome. Psychol
31
b ehavi o r al  ph en ot y pe s  i n  s y n d rome s  with  i ntel l ec tual  d i sab i l it y
Med 38, 1505-1514.
Swillen, A., Devriendt, K., Eyskens, B., Gewillig, M. & Fryns, J. P. (1997). Intelligence and psychosocial
adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS. J Med
Genet 34(6), 453–458.
Tager–Flusberg, H., Plesa–Skwerer, D., Faja, S. & Joseph, R. M. (2003). People with Williams syndrome
process faces holistically. Cognition 89(1), 11–24.
Tomc, S. A., Williamson, N. K. & Pauli, R.M. (1990). Temperament in Williams syndrome. Am J Med Genet
36(3), 345–352.
Turk, J. & Hill, P. (1995). Behavioural phenotypes in dysmorphic syndromes. Clin Dysmorphol 4(2), 105–115.
Udwin, O. & Dennis, J. (1995). Psychological and behavioural phenotypes in genetically determined
syndromes: a review of research ﬁndings. In: O’Brien G, Yule W, (red). Behavioural phenotypes. Clin
Develop Med 138. (pp. 115–167). London: MacKeith Press. 
Udwin, O. & Yule, W. (1990a). A cognitive and behavioural phenotype in Williams syndrome. J Clin Exp
Neuropsychol 13(2), 232–244.
Udwin, O. & Yule, W. (1990b). Expressive language of children with Williams syndrome. Am J Med Genet
Suppl 6, 108–114.
Verhoeven, W. M. A,, Tuinier, S., Kuijpers, H. J. H., Egger, J. I. M. & Brunner, H. G. (2010). Psychiatric proﬁle in
Rubinstein–Taybi syndrome a review and case report. Psychopathology 43(1), 63–68.
Vogels, A., Matthijs, G., Legius, E., Devriendt, K. & Frijns, J–P. (2003). Chromosome 15 maternal uniparental
disomy and psychosis in Prader–Willi syndrome. J Med Genet 40(1), 72–73.
Walter, E., Mazaika, P. K. & Reiss, A. L. (2009). Insights into brain development from neurogenetic
syndromes: evidence from Fragile X syndrome, Williams syndrome, Turner syndrome and
Velocardiofacial syndrome. Neuroscience 164(1), 257–271.
Whittington, J. & Holland, A. (2010). Neurobehavioral phenotype in Prader–Willi Syndrome. Am J Med
Genet C Semin Med Genet 154(4), 438–447.
Williams, C. P., Barratt–Boyes, B. G. & Lowe, J. B. (1961). Supravalvular aortic stenosis. Circulation 24(6), 1311–
1318.
Zafeiriou, D. I., Ververi, A. & Vargiami, E. (2007). Childhood autism and associated comorbidities. Brain Dev
29(5), 257–272.
32
chap ter  2
33
b ehavi o r al  ph en ot y pe s  i n  s y n d rome s  with  i ntel l ec tual  d i sab i l it y
chapter 3
Severe behavioral




Ingrid D.C. van Balkom
Frits A. Beemer
Raoul C.M. Hennekam
adapted from: Van Balkom et al., 2004
Ernstige gedragsproblemen bij kinderen met een verstandelijke handicap:
het Smith–Magenis syndroom
Tijdschrift voor Psychiatrie 46(11), 747–754
A B S T R AC T
background – Smith–Magenis syndrome is a genetically determined syndrome char-
acterized primarily by unusual behavior. The syndrome is still insufﬁciently recognized,
although it has an incidence of 1: 25,000, which is just as high as that of Prader–Willi syn-
drome and Williams syndrome. 
aim – To increase awareness of the syndrome among professionals by brieﬂy summariz-
ing the cause, the most important physical manifestations and the cognitive proﬁle, and
by describing the unusual behavioral pattern associated with the syndrome. Therapeu-
tic aspects will also be discussed.
method – Relevant literature was traced via the Pubmed database using the search
terms ‘Smith–Magenis syndrome’ and ‘deletion 17p11.2’. No exclusion criteria were used. 
results – The literature search in Pubmed and through cross–references yielded 52 arti-
cles with clinical descriptions of Smith–Magenis syndrome. 
conclusion – Smith–Magenis syndrome is a genetically determined syndrome charac-
terized by moderately severe mental retardation (average IQ between 40 and 55),
unusual facial features (broad face, deep–set eyes, ﬂat midface, broad mouth with down
turned corners and prominent chin) and especially by behavioral problems: low frustra-
tion tolerance, sudden mood swings and excessive irritability. Highly characteristic
behavior of children with Smith–Magenis syndrome includes self–hugging, polyem-
bolokoilomania (insertion of objects into body cavities), onychotillomania (pulling out
ﬁnger– and toenails) and sleep disturbances.
keywords: behavioral disorders, genetics, sleep disorders, Smith-Magenis syndrome
Part I – Peer reviewed article in 2004
Children with an intellectual disability of genetic syndromal origin are usually diagnosed
based on speciﬁc physical features, sometimes in combination with internal anomalies
(Gorlin et al., 2001). Sometimes, however, a speciﬁc behavior or combination of behav-
iors can lead to the diagnosis. Abnormal behavior can have a more signiﬁcant impact on
the life of the child than cognitive limitations associated with a syndrome. Behavioral
problems may inﬂuence the quality of interaction with others, while conversely behav-
ior may also be determined by the reaction of others to the distinct physical appearance
and cognitive limitations (van Balkom et al., 1999). 
Smith–Magenis syndrome (SMS) is an example of a syndrome that is primarily
characterized by marked behavioral problems. The incidence of SMS is equal for both
sexes and is estimated at 1 per 25, 000 births, which is comparable to the incidence of
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Angelman syndrome, Prader–Willi syndrome and Williams syndrome. This paper sum-
marizes cause, distinct physical features, cognitive proﬁle, behavioral patterns and sleep
disturbances associated with SMS.
M E T H O D
Searches were performed in Pubmed employing the search terms ‘Smith–Magenis syn-
drome’ and ‘deletion 17p11.2’; no exclusion criteria were used. As no minimal diagnostic
criteria are available, the inclusion criteria consisted only of the before mentioned search
terms in published papers, where the diagnosis was judged as probable. 
R E S U LT S
From the literature search method in Pubmed and through cross–referencing 52 articles
were selected with clinical descriptions of SMS. None of the articles describing one or
more individuals with SMS were excluded. All articles retrieved were systematically
assessed. In the reference list, only those articles actually used in this paper were listed. 
The salient features of SMS are summarized in Table 3.1 (physical features) and 
Table 3.2 (behavioral characteristics). 
SMS was ﬁrst described in 1982 by Ann Smith, Ellen Magenis and colleagues (Smith et
al. 1982) in two patients with congenital heart defects and cleft, where the symptoms
were caused by a deletion on the short arm of chromosome 17. Later, awareness of the
syndrome improved mainly through studies by the clinical geneticist Frank Greenberg.
Currently there are over 100 patients described in literature (Smith et al., 1982, 1986,
1998a, b; Stratton et al., 1986; Colley et al., 1990; Allen et al., 1991; Greenberg et al., 1991,
1996; Finucane et al., 1994, 2001; Dykens et al., 1997; Allanson et al., 1999; Potocki et al.,
2000;  De Leersnyder et al., 2001, 2003). Subsequent studies have shown that palate
clefts, contrary to what was initially described, are not a main characteristic of the syn-
drome.
Cause
SMS has a genetic cause. Most patients have a microdeletion of chromosome 17p11.2. In
determining this, use of a speciﬁc laboratory technique is needed, as the defects are
often too small to be detected by routine chromosomal investigation. The cause of the
microdeletions is unknown; in almost all cases the deletion was de novo – so no defect
could be found in either parent. The probability of recurrence in subsequent children is
36
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Table 3.1  Most frequent physical features in Smith–Magenis syndrome  
  
Short stature 78% 
Brachycephaly 83% 
Prominent forehead 64% 
Myopia 30% 
Broad nasal bridge 81% 
Flat midface 94% 
Deep, hoarse voice 82% 
Prominent chin 51% 
Ear abnormalities 68% 
Hearing impairments 68% 
Scoliosis 65% 
Brachydactyly 81% 
Peripheral neuropathy 75% 
Congenital heart defects 37% 
Congenital renal anomalies 35% 
  
Greenberg et al., 1991, 1996  
Table 3.2  Most frequent behavioral issues and cognitive levels in Smith–Magenis syndrome 
  
Sleep disturbances 75% 
Self–injurious behaviors:  
Hand biting 93% 
Head banging 55% 
Trichotillomania 34% 




Cognitive development:  
IQ <25 12% 
IQ 25–39 16% 
IQ 40–54 44% 
IQ 55–69 24% 
IQ 70–79 4% 
  
Finucane et al., 1994; Smith et al.,1998a  
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therefore very small. If the deletion is caused by a more complicated mechanism, such
as a translocation in one of the parents with one of the deleted sites also involving the
17p11.2 region, there could be an increased risk of recurrence. 
Recently it has been determined that the syndrome can also be caused by a point
mutation in the Retinoic Acid Induced 1 (RAI1) gene, which is located in the 17p11.2 region
(Slager et al., 2003). This gene codes for a protein of which the function is still fairly
unknown. It is thought that the protein has a function in nerve–cell–differentiation and
in transcription of parts of our DNA. Children and adults with SMS caused by either a
17p11.2 deletion or a point mutation of RAI1 cannot be identiﬁed based on facial features,
behavior or development. However, heart and kidney anomalies do not occur in patients
with a point mutation whereas they do occur in patients with a deletion of a larger part
of chromosome 17p11.2. This ﬁnding suggests that other genes, located close to the RAI1
gene on chromosome 17p, are responsible for these anomalies instead. So far all point
mutations in RAI1 developed anew in the patients themselves, and could not be deter-
mined in either of the parents. Therefore, it is assumed that the chance of recurrence is
probably quite low, although the number of patients in whom this speciﬁc defect has
been determined is still small. 
Physical features 
The facial features in babies are often described as cherubic with prominent rosy cheeks
and wonderful smiles. Due to the social smiling and alert impression of babies the
remarkable facial features usually remain unnoticed. Mothers often describe their
babies as perfect children with a happy disposition. One noticeable physical feature in
babies are the extra rolls of fat on the arms and legs (‘Michelin doll’), which disappear as
the child ages (Allen et al., 1991; Smith et al., 1998a;  Allanson et al., 1999).
Distinctive facial features are noticeable in younger children: there is a wide, square face
with a prominent forehead, a down–turned mouth, eyebrows that meet in midline (syn-
ophrys), deep–set eyes, a ﬂattened midface, a wide mouth with down turned corners,
ﬂeshy everted upper lip, and a prominent chin for their age (see Figure 3.1). With increas-
ing age the facial features become more subtle. The most signiﬁcant features are brachy-
cephaly, ﬂattened mid–face, heavy eyebrows, broad nasal bridge and prominent lower
jaw; the whole of the face can be perceived as somewhat coarse (Stratton et al., 1986;
Allen et al., 1991; Greenberg et al., 1991, 1996; Finucane et al., 1994; Allanson et al., 1999).
In all age groups the ears can be oddly shaped, and positioned slightly posteriorly
(Greenberg et al., 1991, 1996). A cleft palate is found in 9% of patients (Greenberg et al.,
1991). Velopharyngeal weakness with hypernasal speech can be found in an even higher
percentage of the patients, which, together with the deformities of ears and the mid–
face hypoplasia, may lead to diagnostic confusion with velo–cardio–facial syndrome
(Greenberg et al., 1996).
Patients with SMS often have eye problems, varying from myopia or strabismus to
cataract, microcornea and iris anomalies (Colley et al., 1990; Allen et al., 1991; Greenberg
et al., 1991, 1996; Finucane et al., 2001). Hearing impairment (conductive with/without
sensorineural hearing loss) occurs in 68% of patients, possibly coinciding with a history
of recurring mid–ear–infections (Stratton et al., 1986; Colley et al., 1990; Allen et al., 1991;
Greenberg et al., 1996; Smith et al., 1998b; Finucane et al., 2001). Approximately 75% of
the patients have signs of peripheral neuropathy, with decreased reﬂexes, elevated pain–
and temperature thresholds, and hollow or ﬂat feet (Allen et al., 1991; Greenberg et al.,
1991, 1996; Smith et al., 1998b). Patients can also have short, wide hands (brachydactylia)
and often there is growth retardation (Colley et al., 1990; Allen et al., 1991; Greenberg et
al., 1991, 1996). Scoliosis is present in 65% of patients and can exacerbate with age. Con-
genital heart defects (37%) are usually present as ventricular or atrial septal defects and
valve defects (Greenberg et al., 1991). In a multidisciplinary study by Greenberg et al.
39
smith - m ag en i s  s y n d rome
Figure 3.1  Patient with Smith–Magenis syndrome at 8 years  
 
Note broad midface, small and deeply set eyes, long eyebrows, flat midface, short  
nose with prominent nasal tip, everted upper vermillion, and slightly malformed ears. 
 
(1996) borderline hypothyroidism and borderline hypogammaglobulinaemia were
found in 25% of the patients.
Cognitive development 
Evidence of non–progressive moderate to severe intellectual disability and develop-
mental problems can be found in most patients with SMS. Cognitive impairments often
warrant placement in special educational settings. In patients investigated using the Bay-
ley Scales of Infant Development or one of the Wechsler–scales, measured intelligence
levels are between 20 and 78. Most patients function in the mild to moderate range of
intellectual functioning, with IQ levels between 40 and 55 (Stratton et al., 1986; Green-
berg et al., 1996; Dykens et al., 1997; Smith et al., 1998a). 
The cognitive proﬁle shows weaker verbal than performance skills. In psychometric
examination of 10 patients Dykens et al. (1997) found that sequential processing and
short term memory were relatively weak, while long term memory and visuoperceptu-
al abilities were relatively strong. A severe delay in development of speech–language
either with or without associated loss of hearing occurs in 95% of the patients; there is a
hoarse, deep voice in 82% of patients. In general, development of expressive language is
more delayed than receptive language, often giving rise to frustration in the child when
interacting with others. Speech therapy and sign language can be helpful in some cases
(Allen et al., 1991; Greenberg et al., 1991, 1996; Smith et al., 1998a).
Behavior
A recognizable pattern of behavioral problems both at home and at school is seen in at
least 60–80% of patients and often arises at a young age. The behavioral problems
include low frustration tolerance, resistance to changes, sudden mood changes and
temper tantrums or explosive outbursts, attention–deﬁcit–hyperactive–disorder
(ADHD), self injury, sleep disorders, bruxism, and repetitive, stereotypic, impulsive and
aggressive behaviors (Smith et al., 1986, 1998a ; Allen et al., 1991; Dykens et al., 1997;
Allanson et al., 1999; Finucane et al., 2001). 
Smith et al. (1998a) mention a fascination for electronics, such as computers and
video cameras/ recorders, while Dykens et al. (1997) noted repetitive, quick ﬂipping of
pages of books and licking ﬁnger (‘lick and ﬂip’). 
In contrast to children with autism spectrum disorders who have similar behavioral
problems, most children with SMS have good eye–to–eye gaze and social smiling
(Smith et al., 1998a). Because of their impulse regulation problems, distractibility and
attention problems, children with SMS usually perform better in smaller groups within
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well-structured settings. Due to the relative strength in visual perception teaching can
be aided by the use of pictograms, while a predictable, structured daily routine can pre-
vent explosive outbursts that accompany unexpected changes to the schedule. The
self–injurious behaviors, in the form of head banging, hitting and biting oneself, and the
constant attention seeking behaviors, can complicate the interaction of these patients
with their parents, teachers and caregivers (Colley et al., 1990;  Allen et al., 1991; Smith et
al., 1998a). 
A curious phenomenon that seems to affect many patients with SMS is the stereo-
typic self–hugging or hand–clasping, which mostly seems to occur as an expression of
happiness or excitement. This behavior was described by Finucane et al. (1994) based on
observations in an institute where it was mainly seen in children and adolescents with
SMS. The behavior is described as short, serial, random ‘spasms’ or ‘tics’, often while gri-
macing or making noise. Two types of behavior are distinguished: the spasmodic upper–
body squeeze and hand clasping at chest or chin level. This behavior was not observed
in patients during tantrums or when upset. Besides self–hugging, patients also tend to
repetitively and forcefully hug others (Smith et al., 1998a). 
Most of the self–injurious behaviors in SMS become apparent at age 2 and are not
speciﬁc for the syndrome. These behaviors mainly include biting wrists and hands, head
banging, hitting oneself, scratching the skin or picking at small wounds (Smith et al.,
1986, 1998a ; Colley et al., 1990; Greenberg et al., 1991; Dykens et al., 1997; Finucane et al.,
1994, 2001). However, there are two self–injurious behaviors that are distinctive to the
syndrome, these can be observed mostly in older patients (Greenberg et al., 1991; Finu-
cane et al., 2001): polyemboikoilomania (inserting objects into body cavities) and ony-
chotillomania (pulling out of ﬁnger– and toenails), seemingly without pain to the
patient. It is unknown whether this high threshold for pain can be accounted for by a
peripheral neuropathy, an altered emotional response to pain, or both (Greenberg et al.,
1991; Finucane et al., 1994, 2001).
Most patients have already had different treatments with psychotropic medication
to modify behavior before the correct diagnosis can be made. Stimulants (usually
methylphenidate) and anticonvulsive (carbamazepine) medication usually prove inef-
fective in the long–term modiﬁcation of behavioral abnormalities (Dykens et al., 1997;
Smith et al., 1998a).
Sleep disorders
Signiﬁcant sleep disturbances are present in almost all patients with SMS and these have
a negative impact – not only on the patient, but also on parents and other family mem-
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bers, who themselves can become sleep deprived. Sleep deprivation can subsequently
be a factor in behavioral problems during the day, disrupted communication, high
parental stress, and learning issues (Colley et al., 1990; Greenberg et al., 1991, 1996; Finu-
cane et al., 1994, 2001; Dykens et al., 1997; Smith et al., 1998b; Potocki et al., 2000; De Leer-
snyder et al., 2001, 2003; Turk, 2003). Sleep disorders occurring in the syndrome include
difﬁculties falling asleep, frequent night time awakenings and (partially as a consequence
of these) excessive daytime sleepiness with more ‘sleep attacks’ and naps at the end of
the day. Enuresis nocturna is also common (Smith et al., 1998b). Total sleeping time is
reduced and REM sleep is diminished (Greenberg et al., 1991; Potocki et al., 2000; De
Leersnyder et al., 2003). Inversion of the circadian rhythm of melatonin was found in
most patients: during the day melatonin production was higher than at night, with para-
doxical daytime secretion. Temper tantrums and tiredness occur when the melatonin
level increases. Children with SMS take daytime naps or have sleep ‘attacks’ when mela-
tonin production peaks in the afternoon and evening (Smith et al., 1998b; Potocki et al.,
2000; De Leersnyder et al., 2001, 2003; Turk, 2003). In a Belgian study a group of children
with SMS was treated with acebutolol (β–adrenerge antagonist), to reduce daytime
melanin production and thus improve night time sleep. The trial showed not only a pos-
itive impact on sleep, but the medication also seemed to improve the concentration of
the children during the day, while the frequency of tantrums decreased and interper-
sonal interactions improved (De Leersnyder et al., 2001). In a different study De Leer-
snyder et al. (2003) reported a positive effect of a morning dose of acebutolol accompa-
nied by an evening dose of melatonin. Acebutolol suppressed elevated plasma
melatonin levels in the morning, resulting in a decrease of restlessness, aggressive out-
bursts and daytime napping. The evening dose of melatonin subsequently improved
sleep patterns in all tested children.
Although more research is needed, it seems likely that the sleep disorders can be
effectively treated with melatonin. 
CO N C LU S I O N  PA RT  I
Since the initial description of the syndrome in 1982, biological and molecular–genetic
mechanisms have become increasingly clear. The behavioral phenotype with the unusu-
al, often severe, behavioral abnormalities, the self–injurious behavior and the sleep dis-
turbances are usually the primary reason for referral for psychiatric evaluation and treat-
ment. In the differential diagnosis of children with intellectual disability and a pattern of
unusual behavior Smith–Magenis syndrome needs to be considered. For the assessment
of distinctive physical features a clinical geneticist or pediatrician should be consulted.
Subsequent molecular–genetic testing can conﬁrm the suspected diagnosis of SMS.
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In management, medication for regulating and modifying behavior and impulsive-
ness may have an important role, and improvement of expressive language through
speech therapy and other ways to communicate such as sign language should be con-
sidered in efforts to prevent or limit frustration in interactions and communications. The
use of melatonin to regulate the day–night rhythm has shown promise in research and
clinical practice and may contribute not only to improved sleep but also to a subsequent
decrease in behavioral problems.
Part II – Update on clinical and behavioral features in SMS
Since our publication in 2004 a number of papers have expanded our knowledge on clin-
ical features and behavioral aspects of SMS (Sarimski, 2004; Shelley et al., 2005; Girira-
jan et al., 2006; Gropman et al., 2006; Madduri et al., 2006; Martin et al., 2006; Tomona
et al., 2006; Andrieux et al., 2007; Edelman et al., 2007; Gropman et al., 2007; Elsea & Giri-
rajan, 2008; Taylor & Oliver, 2008; Wolters et al., 2009). In the following paragraphs we
highlight additional or new ﬁndings and evidence in SMS from these papers with respect
to the subjects presented in our earlier publication.
Cause
In a study of phenotypic comparison between individuals with the 17p11.2 deletion and
those with the RAI1 mutation Girirajan and co–workers (2006) found that most of the
common features associated with SMS were found in patients with haploinsufﬁciency of
RAI1 (Girirajan et al., 2006). Functional abrogation of the RAI1 gene should therefore be
considered primarily responsible for the most common clinical features of SMS, with
other genes within the deletion interval likely accounting for the more variable features
of the syndrome and adding to the overall severity of phenotype (Girirajan et al., 2006;
Gropman et al., 2007; Elsea & Girirajan, 2008). 
Physical features
Intellectual disability, neurobehavioral problems and signiﬁcant sleep disturbances are
consistently part of the clinical manifestations of the syndrome regardless of cause. In
recent studies it has become more evident that the severity of the phenotype increases
with increased deletion size, as is the case in those who carry 17p11.2 deletion. These indi-
viduals are more likely to have additional issues such as cardiac anomalies, severe speech
and motor delay, short stature, and hearing problems (Girirajan et al., 2006; Andrieux et
al., 2007; Gropman et al., 2007). Tomona et al. (2006) investigated dental and craniofa-
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cial ﬁndings in SMS as part of an ongoing study of the natural history of the syndrome.
They found a strikingly high incidence of two developmental dental abnormalities, tooth
agenesis and taurodontism. Tooth agenesis most commonly affects the mandibular sec-
ond premolars. Taurodontism, which is characterized by prism shaped molars with large
pulp spaces, affects both primary and secondary teeth. Tonoma and coworkers suggest
that these ﬁndings may facilitate early diagnosis in preschool children (Tonoma et al.,
2006).
Cognitive development 
Assessments of cognitive function in various studies since 2004 conﬁrmed earlier ﬁnd-
ings in most SMS patients of mild to moderate intellectual disability (Madduri et al.,
2006; Martin et al., 2006; Wolters et al., 2009).
Behavior 
In a meta–analysis of a large group of SMS individuals to analyze genotype–phenotype
differences, Edelman et al. (2007) found that those with the RAI1 mutation were more
likely to show behavioral abnormalities such as overeating, polyembolokoilomania, and
self–hugging than those with the deletion on 17p11.2 (Edelman et al., 2007). 
The distinctive behaviors accompanied by delays in speech and language develop-
ment often lead to a diagnosis of autism in toddlerhood, although infants with SMS can
seem to develop typically due to their socialization skills, friendly demeanor and the lack
of behavioral problems (Gropman et al., 2007; Wolters et al., 2009). Long term follow-
up has shown that many individuals with SMS eventually do attain acceptable levels of
expressive language. Once verbal they are often described as interactive, sociable and
communicative, which seems to support reports of relative strengths in socialization,
but could also refute an earlier diagnosis of autism (Martin et al., 2006). However, many
of the distinctive behaviors observable, such as stereotypic and repetitive behaviors e.g.
body rocking, self–hugging, spinning objects, as well as self injurious and attention seek-
ing, adult oriented behaviors, and intrusiveness during conversation seem to indicate
that qualitative impairments on the three core domains in autism spectrum disorders
(communication, social skills and behavior) persist or exacerbate with increasing age
despite relative strengths noted (Sarimski, 2004; Gropman et al., 2006; Madduri et al.,
2006; Gropman et al., 2007). Behavioral problems in SMS usually exacerbate with the
onset of puberty, depending also on severity of intellectual disability, comorbid somat-
ic conditions and sleep disorders (Edelman et al., 2007; Elsea & Girirajan, 2008). With
increasing age, relative strengths in socialization seem to remain when compared to
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adaptive functioning. Especially with respect to communication and daily living skills
measured with the Vineland Adaptive Behavior Scale as shown in a study by Taylor and
Oliver (2008), although their small study sample precluded statistical analysis of these
ﬁndings (Taylor & Oliver, 2008). 
Sleep disorders 
In a study Gropman et al. (2007) found that although sleep disturbances can be found at
a very early age, these can undergo developmental changes with increasing age. Mani-
festing in infancy ﬁrst as decreased 24–h sleep in infants, in toddlers and school age chil-
dren shortened sleep cycles are further complicated by frequent, prolonged night time
awakenings and excessive daytime sleepiness and napping. From adolescence addition-
al sleep disturbances reported are increased evening arousal and difﬁculty falling asleep,
which often continue into adulthood (Gropman et al., 2007).
CO N C LU S I O N  PA RT  I I
In addition to the conclusions already mentioned in our manuscript published in 2004
we would like to conclude from studies since then, that it is likely that early recognition
and diagnosis could prevent some of the disruption of development through improve-
ment of communication skills in interactions with both adults and peers, and through
early interventions with respect to sleep disturbances and maladaptive behaviors. How-
ever, despite the facial features in infancy, deﬁnitive diagnosis of Smith–Magenis syn-
drome is often delayed due to the infant’s complacent temperament, social smiling and
lack of recognizable behavioral problems until the distinctive behaviors fully emerge and
signiﬁcant sleep disturbances become more evident.
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A B S T R AC T
We present a patient with distinctive clinical manifestations resembling those ﬁrst
described by Pitt and Hopkins in 1978 as a separate entity. Cardinal ﬁndings in this syn-
drome are mental retardation, ‘‘coarse’’ face, and an abnormal breathing pattern. The
symptoms in this patient are different from those in Joubert syndrome, Rett syndrome,
Rett–like variants, and of a case reported by Leifer et al. (1991). The manifestations in our
patient and in the case described by Singh (1993) seem to conﬁrm the delineation of this
syndrome, the cause of which remains unknown. 
keywords: mental retardation, coarse face, hyperbreathing, Pitt–Hopkins syndrome,
Joubert syndrome, Rett syndrome
I N T RO D U C T I O N
In 1978 Pitt and Hopkins described two unrelated patients with similar clinical manifes-
tations, mainly consisting of a wide mouth, an abnormal respiratory pattern, clubbing of
the ﬁngers, and mental retardation. Singh (1993) reported a male patient with the same
abnormal breathing pattern, facial ﬁndings, and mental retardation. We report on an
adult female with a similar combination of symptoms, and compare these symptoms
with the earlier patients described and with other related entities.
C L I N I C A L  R E P O RT
The patient was the ﬁrst–born child of healthy, non–consanguineous parents. Her two
brothers and a sister were healthy. The pregnancy was uneventful, and there was no
known exposure to teratogens. Weight at birth was 2,750 g (10th centile); length and
head circumference were not recorded. The neonatal period was complicated by pro-
longed feeding problems. Her motor development has always been severely delayed,
without any period of regression: sitting was at 4 years of age, standing at 6, and walking
at 7. There has never been any language development. She did not suffer from seizures.
Age at menarche is unknown, and her menstruation pattern has been regular. At 26
years, she was operated on because of club feet. Examination at the age of 40 years
showed a severely intellectually disabled woman with no expressive speech (Figure 4.1).
Usually, her respiratory pattern was normal, but there was daily episodic hyperbreath-
ing, which caused massive swallowing of air, necessitating changing to clothes of a larg-
er size during the daytime because of abdominal distension (Figure 4.2). Height (148 cm)
and head circumference (50 cm) were below the 3rd centile. She had coarse hair, heavy
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Note the heavy eyebrows, flared nares, wide mouth, and thick lips. 
Figure 4.1  Proposita at age 40 years 
Figure 4.2  Frontal (a) and lateral (b) truncal radiographs of the proband showing massive 
distension of the colon 
Figure 4.2  Frontal (a) and lateral (b) truncal radiographs of the proband showing massive 
distension of the colon 
Figure 4.2  Frontal (a) and lateral (b) truncal radiographs of the proband showing massive 
eyebrows, a broad nasal bridge, large nose, ﬂared nares, wide mouth with thick, ﬂeshy
lips, a broad palate, and an abnormal ear with a dysplastic helix on the right side. Her
shoulders were narrow, she had a mild thoracolumbar scoliosis, and thin limbs with poor
muscular development and small hands (16.0 cm, below the 3rd centile). All ﬁngers
showed clubbing, which was most pronounced on the 2nd ﬁngers (Figure 4.3). Second-
ary sexual characteristics were normal. The great toes were clubbed, somewhat short
and proximally implanted; the other toes were normal. Acral circulation was good. Addi-
tional investigations included chest X–rays, ECG, full internal screen, and extensive uri-
nary metabolic investigations, all with normal results. The karyotype was normal
(46,XX) and molecular analysis was negative for a methylation defect on chromosome
15 (Angelman syndrome). A recent CT scan of the brain showed no cerebral malforma-
tion or atrophy, and the cerebellum was normal.
D I S C U S S I O N
The similarity of clinical ﬁndings in the present patient and in the two cases described by
Pitt and Hopkins (1978) and in the patient described by Singh (1993) suggests the exis-
tence of a speciﬁc syndrome characterized by a ‘‘coarse’’ face, with wide mouth, everted
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Clubbing is especially clear on the second finger. 
3  Right hand, showing relatively long slender fingers  
Figure 4.3  Right hand, showing relatively long slender fingers  
thick lips, and large nose, severe psychomotor retardation and voluntary, episodic over-
breathing (Table 4.1). The clubbing of the ﬁngers may well be related to the unusual
breathing pattern. Additional reports are needed to deﬁne all the characteristics typical
of this syndrome. Several entities bear resemblance to the presently described patient.
Joubert syndrome (Joubert et al., 1969; Saraiva & Baraitser, 1992) is characterized by
episodic hyperpnoea, agenesis of the cerebellar vermis, abnormal eye movements, and
ataxia. The abnormal respiration usually becomes apparent soon after birth, the periods
of abnormal breathing intensify with stimulation, and respiratory abnormalities tend to
improve with age. The absence of ataxia and the normal conﬁguration of the cerebellum
on the CT scan in our patient allows differentiation with the Joubert syndrome.
Rett syndrome (Hagberg, 1989) and atypical Rett syndrome (Hagberg & Skjeldal,
1994; Akesson et al., 1995) show some similarity, also, especially in the voluntary over-
breathing. However, the present proposita showed no sequential stages of Rett syn-
drome, no dyspraxia, and no stereotypic hand movements. Leifer et al. (1991) reported
an adult woman with mental retardation, microcephaly, minor facial anomalies, seizures,
loss of ability to walk, stereotypic hand movements, and limb anomalies. A CT scan
showed central atrophy with dilatation of the lateral ventricles and cerebellar atrophy.
Although the minor anomalies and mental retardation resembled the ﬁndings in our
patient, an abnormal breathing pattern was conspicuously absent in the patient
described by Leifer et al. (1991) and further differentiation by neuroradiologic studies
was possible. The cause for the combination of ﬁndings in our patient remains unknown:
all cases have been isolated, there has been no report of consanguinity, the parental ages
were normal, and chromosomal studies have been noncontributory.
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Table 4.1  Comparison of present patient with published cases, and with Rett syndrome, and 
Joubert syndrome* 










       
Sex M F M F F 2M:1F 
Height ø P3 − + + + − − 
OFC ø P3 − + − + + − 
Mental retardation + + + + + + 
Poor motor development +  + + + + 
No language development    + + − 
Voluntary overbreathing + + + + + + 
Hand stereotypies − − − − + − 
CNS       
Atrophy/agenesis vermis   + − + + 
Cerebellar hypoplasia   + − + + 
Seizures   + − + − 
Hypotonia − − − − − + 
Abnormal eye 
movements − − − − − + 
Cranial       
Coarse hair    + − − 
Heavy eyebrows   + + − − 
Chorioretinal coloboma − − − − − + 
Wide nasal bridge + + + + − − 
Prominent nose + + + + − − 
Flared nares + + + + − − 
Macrostomia + + + + − − 
Thick, fleshly lips + + + + − − 
Dysmorphic ear(s)    R
b
 − − 
Clubbing of fingers + + + + − − 
Simian crease L
b
    B
b
 − − 
Polydactyly −   − − − 
Club foot +  + + − − 
Short great toes  +
a
  + − − 
Scoliosis    + + − 
       
 
*  Findings were scored positive if specifically mentioned in the text, or if they could be reliably 
concluded from the pictures. 
a
  Personal communication (Pitt, 1990). 
b
  L = left; R = right; B = bilateral. 
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chapter 5
Behavior and cognition in
Pitt–Hopkins syndrome






A B S T R AC T
Pitt–Hopkins syndrome (PHS) is a rare genetic syndrome characterized primarily by
intellectual disability, distinctive facial characteristics, breathing abnormalities, and
repetitive behaviors. Classic PHS and PH–like syndromes are caused by genetic dele-
tions/mutations, speciﬁcally TCF4 haploinsufﬁciency, NRXN1, and CNTNAP2 alterations.
Changes in TCF4, NRXN1 and CNTNAP2 have been implicated in intellectual disability,
epilepsy, autism, and schizophrenia. Though this syndrome clearly has important devel-
opmental, cognitive, and behavioral consequences, there has been little systematic
study of the psychiatric dimension of the disorder. 
We assessed behavioral, adaptive, and psychological functioning and autism symptoms
in 10 individuals with molecularly conﬁrmed classic PHS via direct psychiatric and neu-
ropsychological assessments, parental interviews, and questionnaires. Relevant litera-
ture was reviewed with speciﬁc attention to descriptions of cognition and behavior in
both classic and recessive forms of PHS. We compared our ﬁndings to those found in lit-
erature. 
Participants all showed (very) profound intellectual disability, amiable demeanor
with minimal maladaptive behaviors, severe impairments in communication and lan-
guage with failure to engage socially, and intense, frequent motor stereotypies. Autism
spectrum disorder can also be a component of the phenotype of classic PHS, albeit pre-
senting in varying degrees of severity. 
Systematic collection of developmental and behavioral data in rare disorders, such
as PHS, improves clinical recognition of physical, developmental, behavioral and psychi-
atric features. This is important for the diagnosis and prognosis of the disorder, and for
adequate counseling of families. It also increases our understanding of shared etiologies,
comorbid conditions, and the inﬂuence of social and learning environments on gene
expression and eventual outcome.
keywords: Pitt–Hopkins syndrome, TCF4 mutations, autism, intellectual disability,
motor stereotypies
INTRODUCTION
Pitt and Hopkins ﬁrst described the syndrome that bears their name in 2 unrelated
patients with intellectual disability, an abnormal breathing pattern, and distinctive facial
features, including a wide mouth, heavy eyebrows, and postnatal microcephaly (Pitt &
Hopkins, 1978). In later publications, the phenotype of Pitt Hopkins syndrome (PHS) was
further deﬁned to include severe developmental delays in motor and speech/language
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development, episodic diurnal hyperventilation with apnea, and frequent epilepsy
(Singh, 1993; van Balkom et al., 1998; Orrico et al., 2001; Peippo et al., 2006). The domi-
nant form of PHS is caused by deletions/mutations in Transcription Factor 4 (TCF4) on
chromosome 18 in 18q21 (Amiel et al., 2007; Brockschmidt et al., 2007; Zweier et al., 2007,
2008; Andrieux et al., 2008; Giurgea et al., 2008; de Pontual et al., 2009; Takano et al.,
2010). Recessive forms of a PHS–like disorder have been identiﬁed and are caused by
mutations in NeuReXiN 1 (NRXN1) on chromosome 2 and the CoNTactiN Associated Pro-
tein–like 2 (CNTNAP2) on chromosome 7 (Stefansson et al., 2009; Zweier et al., 2009;
Blake et al., 2010). 
PHS is best known for breathing abnormalities. However, they may not be a cardinal
manifestation of the syndrome, as already suggested in earlier publications (Singh, 1993;
van Balkom et al., 1998; Orrico et al., 2001; Peippo et al., 2006). Not all molecularly con-
ﬁrmed cases show intermittent overbreathing. PHS studies have cited severe develop-
mental delay and intellectual disability, motor abnormalities (late or absent walking,
repetitive movements of hands and head), and behavioral traits such as autistic symp-
toms, a quiet, pleasant disposition in most cases, and in other cases sudden aggression
towards others in association with sudden changes in daily routine. Some of these
behaviors are consistent with the deﬁnition of an autism spectrum disorder (Giurgea et
al., 2008; de Pontual et al., 2009; Zweier et al., 2009; Takano et al., 2010). To date there
have been no studies focusing speciﬁcally on cognition, behavior and autism in PHS.
Though PHS and PH–like syndromes clearly have important developmental, cogni-
tive, and behavioral consequences, there has been little systematic study of the psychi-
atric dimension of the disorder. Here we review behavioral and cognitive data from the
literature on PHS, and the association of the genes involved in PHS and PH–like syn-
drome with psychiatric disorders. Subsequently we report an exploratory investigation
of behavior and cognition in 10 individuals with molecularly conﬁrmed PHS, with speciﬁc
attention to possible autism spectrum disorder characteristics. 
M E T H O D S
Literature review
Relevant literature was searched for in all Ovid resources, the EMB database, and
PubMed (basic and advanced searches) using as search terms: ‘Pitt–Hopkins syndrome,’
‘TCF4 haploinsufﬁciency’, and ‘deletion 18q21’. Papers had to have been published in
peer–reviewed journals in English, German, French, or Dutch. No other exclusion crite-
ria were used. All retrieved publications were hand–searched for further relevant
papers. This search yielded a total of 30 articles (Pitt & Hopkins, 1978; Wilson et al., 1979;
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Petty et al., 1987; Seshadri et al., 1992; Singh, 1993; van Balkom et al., 1998; Gustavsson et
al., 1999; Orrico et al., 2001; Engelen et al., 2003; Peippo et al., 2006; Amiel et al., 2007;
Brockschmidt et al., 2007; Flora et al., 2007; Zweier et al., 2007, 2008, 2009; Andrieux et
al., 2008; Cisse et al., 2008; Giurgea et al., 2008; Kalscheuer et al., 2008; Kim SK et al.,
2008; Ouvrier, 2008; de Pontual et al., 2009; Rosenfeld et al., 2009; Stefansson et al.,
2009; Blake et al., 2010; Brzozka et al., 2010; Kato et al., 2010; Taddeucci et al., 2010; Takano
et al., 2010). Only those publications that included clinical descriptions, development,
and behavior of individuals or groups of individuals were selected for inclusion in Tables
5.1 and 5.2. 
A similar literature search was conducted with regard to psychiatric aspects, using
as search terms ‘psychiatric syndromes/disorders and/or chromosome 18 and/or TCF4,
and/or deletion 18q, and/or chromosome 2 and/or NRXN1, and/or chromosome 7 and/or
CNTNAP2, and/or TCF4 mutations and/or deletions, and/or TCF4 haploinsufﬁciency’.
We applied the same language criteria and no exclusion criteria. All retrieved manu-
scripts were again hand–searched for other relevant publications. The search in these
databases and cross–references yielded a total of 49 articles (Asschauer et al., 1993; Stine
et al., 1995; DeLisi et al., 1995; Fang et al., 1995; de Bruyn et al., 1996; Breschel et al., 1997;
Mors et al., 1997; van Broeckhoven & Verheyen 1998; Grierson et al., 1999; Hallmayer
1999; Hampson et al., 1999; van Broeckhoven & Verheyen, 1999; Verheyen et al., 1999;
Del–Favero et al., 2002; Kamnasaran, 2003; McInnis et al., 2000; Pickard et al., 2005;
Walss–Bass et al., 2005; Feng et al., 2006; Hayden & Nurnberger, 2006; Strauss et al.,
2006; Abrahams et al., 2007; Alarcón et al., 2008; Arking et al., 2008; Bakkaloglu et al.,
2008; Blackwood et al., 2008; Friedman et al., 2008; Kim HG et al., 2008; Kim SK et al.,
2008; Kirov et al., 2008, 2009; Vernes et al., 2008; Walsh et al., 2008; Jackman et al., 2009;
Carroll & Owen, 2009; Rujescu et al., 2009; Williams et al., 2009; Zavala et al., 2009;
Ching et al., 2010; Mefford et al., 2010; Newbury & Monaco, 2010; Scott–van Zeeland et
al., 2010; Tan et al., 2010; Wang et al., 2010; Gauthier et al., 2011; Lennertz et al., 2011; Müh-
leisen et al., 2011; Nord et al., 2011; Williams et al., 2011).
Participants
Parents of 10 PHS individuals were recruited through the Dutch PHS Family Association.
The Family Association knows of 21 PHS individuals; participation in the study was deter-
mined on the basis of the distance between the family residence and the research cen-
ter, and the availability of the family within the time frame of the study. The study group
consisted of 4 girls and 6 boys, 7 were born between 1998 – 2008, and 3 between 1987–
1991. All had a molecularly conﬁrmed TCF4 mutation. Participating families resided in the
Netherlands and in Belgium. All parents gave written informed consent, and the central
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Medical Ethical Review Committee (Mental Health) gave permission to perform the
study.
Test instruments
All participants were examined by the same child psychiatrist (IvB) and neuropsycholo-
gists (PJV, MF). The child psychiatrist is experienced in assessing individuals with autism
and other developmental disabilities (van Balkom et al., 1998, 2002, 2004, 2009). In–per-
son interviews with parents were used to assess past and current development, and
functioning for the domains communication, (adaptive) behavior, and social–emotional
development. Parents were invited to provide further information through a standard-
ized questionnaire assessing emotional and behavioral problems. Only validated instru-
ments to study individuals with intellectual disabilities were used to assess cognitive and
behavioral functioning.
Bayley Scales of Infant Development
Mental and motor functioning was assessed using the Dutch version of the Bayley Scales
of Infant Development (BSID–II) (van der Meulen et al., 2002) with Dutch norms for
developmental ages between 0–48 months. The BSID–II is considered a reliable and
valid instrument (Provost et al., 2000, 2004). The raw scores on the motor and mental
scale were converted into age equivalents to determine level of motor and mental func-
tioning. 
Snijders–Oomen Nonverbal Intelligence Test 
For participants older than 18 years, whose developmental level was likely to be greater
than the 48 month cut–off of the Bayley Scales, the Snijders–Oomen Nonverbal Intelli-
gence Test – Revised (SON–R 2½–7) was selected (Tellegen et al., 1996) to assess over-
all cognitive functioning, abstract and concrete reasoning, spatial ability, and visual per-
ception. Test reliability and validity are considered good (Evers et al., 2000). 
Autism Diagnostic Interview – Revised 
In addition to an in–person psychiatric examination of all participants by an experienced
child psychiatrist, one or both parents of 8 children were interviewed using the Autism
Diagnostic Interview–Revised (ADI–R) (Lord et al., 1994; de Jonge et al., 2007); the par-
ents of 2 participants could not be interviewed for practical reasons. The ADI–R is con-
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sidered a reliable and valid instrument (Rutter et al., 2003; Le Couteur et al., 2008; Cic-
chetti et al., 2008). The ADI–R is a semi–structured diagnostic interview designed to col-
lect developmental information, a history focused on autism–speciﬁc criteria, and infor-
mation on actual behavior as manifested in the child’s daily life. The instrument carries
the risk of over classiﬁcation of autism when used in the assessment of individuals whose
mental age–equivalent is less than 24 months. The severity of intellectual disability asso-
ciated with PHS demands that ADI–R results should be interpreted with great caution,
but we considered the ADI–R a useful tool to establish a developmental history, collect
data on current behaviors, and supplement the direct assessments of the participants.
Indeed the ADI–R has previously been used with individuals functioning below a mental
age of 24 months, as there is a dearth of adequate instruments available for individuals
with severe intellectual disability and possible comorbid autism spectrum disorder
(Howlin, 2000; Battaglia et al., 2010; Bruining et al., 2010; van Balkom et al., 2011).
Vineland Adaptive Behaviour Scales 
The Vineland Adaptive Behaviour Scales – Survey Form (VABS) was used to assess per-
sonal and social self–sufﬁciency (Sparrow et al., 1984). The VABS measures the level of
adaptive functioning with regard to communication, daily living skills, and socialization.
These measures provide an overall adaptive composite score, allowing for a classiﬁcation
in adaptive levels. The VABS has good psychometric properties (Sparrow et al., 1984).
Decile scores were also determined. These scores are likelihood assertions concerning
the level of cognitive functioning based on a Dutch sample (n=826) of children between
the ages 5 and 18 years with an IQ <70 (de Bildt & Kraijer, 2003). 
Developmental Behaviour Checklist
The Developmental Behaviour Checklist–Primary Carer (DBC–P) for the children and
the Developmental Behaviour Checklist for Adults (DBC–A) for those above 18 years
were used to assess behavioral and emotional problems. The DBC–P is a 96–item check-
list speciﬁcally developed to assess a broad range of behavioral and emotional problems
in individuals with intellectual disability (ID) (Einfeld & Tonge, 2002). Parents rate items
on a 3 point scale. The DBC–P is considered reliable and has been validated in a large
sample of Dutch children with ID (Dekker et al., 2002; Einfeld & Tonge, 2002). The DBC–
A is a 107 item instrument with similar properties but suited for adults. The question-
naire is completed by someone who knows the person well. The DBC–A has acceptable
reliability, good validity and satisfactory psychometric properties (Mohr et al., 2005).
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R E S U LT S
Literature review
The major ﬁndings in the literature for cognition and behavior in patients with molecu-
larly conﬁrmed PHS are summarized in Table 5.1 (deletions of TCF4) and Table 5.2 (muta-
tions in TCF4). Among the physical manifestations only hearing and vision impairments
are shown as these are considered risk factors for the development of repetitive behav-
iors (McClintock et al., 2003).
Classic autosomal dominant PHS is caused by a deletion on the long arm of chro-
mosome 18 (del 18q21), resulting in haploinsufﬁciency of TCF4 (Gustavsson et al., 1999;
Amiel et al., 2007; Brockschmidt et al., 2007; Zweier et al., 2007; Andrieux et al., 2008;
Kato et al., 2010). Normally, TCF4 is highly expressed in the central nervous system, and
deregulation of TCF4 results in interference with brain development, cognitive func-
tioning, and memory (de Pontual et al., 2009; Stefansson et al., 2009). Brzozka and co–
workers hypothesized that while haploinsufﬁciency for TCF4 causes PHS, more subtle
changes at transcript level such as a trinucleotide repeat in intron 3 and a single
nucleotide polymorphism (SNP) in intron 4 might be associated with increased risk for
neuropsychiatric disorders in adolescence and in adulthood (Brzozka et al., 2010). Meta–
analysis of several genomic–wide association studies showed SNPs in intron 3 and 4 of
TCF4 to be associated with schizophrenia (Stefansson et al., 2009; Blake et al., 2010;
Lennertz et al., 2011; Williams et al., 2011). Both schizophrenia and bipolar disorder have
been studied in relation to chromosome 18 alterations (Stine et al., 1995; Breschel et al.,
1997; Mors et al., 1997; Blake et al., 2010; Lennertz et al., 2011; Williams et al., 2011).
A recessive form of PHS or a PH–like syndrome is caused by changes in NRXN1. The
NRXN1 locus is situated at 2p16.3, and codes for neurexins and associated cell–surface
proteins that help neurons to adhere to one another, creating synaptic connections nec-
essary for communication between neurons. NRXN1 is highly expressed in the brain and
plays an important role in synaptic function and specialization. Neurexins and associated
cell–surface proteins mediate essential signaling between pre– and postsynaptic special-
izations and neurotransmitter release from pre–synaptic vesicles (Feng et al., 2006; Bucan
et al., 2009; Glessner and Hakonarson, 2009; Kirov et al., 2009). Additionally, research
ﬁndings have suggested that disruption of these mechanisms through Copy Number
Variants (CNVs), deletions or haploinsufﬁciency might constitute fundamental common-
alities in genetic susceptibility for schizophrenia and autism (Kirov et al., 2008; Walsh et
al., 2008; Rujescu et al., 2009). Deletions and CNVs involving one or more exons in NRXN1
have been implicated in autism spectrum disorders and intellectual disability, although
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the clinical signiﬁcance and range of phenotypic expression remains unclear (Feng et al.,
2006; Friedman et al., 2008; Kim HG et al., 2008; Ching et al., 2010). The interpretation of
the signiﬁcance of disruptions is complicated by incomplete penetrance. It has been sug-
gested that changes disrupting NRXN1 may act as a predisposing factor for autism spec-
trum disorders and that additional inﬂuences (such as genetic, epigenetic, and environ-
mental factors) are necessary to result in the complete phenotype (Guilmatre et al.,
2009). Various studies have provided compelling evidence that deletions of NRXN1 con-
fer an increased risk of schizophrenia and autism spectrum disorders (Friedman et al.,
2008; Kim HG et al., 2008; Kim SK et al., 2008; Walsh et al., 2008; Kirov et al., 2008, 2009;
Rujescu et al., 2009; Gauthier et al., 2011). Other studies have added evidence suggesting
that rare CNVs at numerous loci are involved in the etiology of intellectual disability,
autism spectrum disorder, and schizophrenia. These three conditions share many pheno-
type similarities in their atypical responsiveness to environment and impaired ﬁltering of
stimuli that may disrupt information processing with regard to emotional, social, lan-
guage, communication, and executive functioning abilities (Kirov et al., 2008; Cheung et
al., 2010; Gauthier et al., 2011). Indeed, the phenotype of individuals with NRXN1 deletions
or mutations is variable and includes intellectual disability, autism spectrum disorders,
and schizophrenia. NRXN1 variants may also contribute to anxiety and mood disorders,
and to alcohol and nicotine dependence (Hallmayer, 1999; Kim SK et al., 2008; Bucan et al.,
2009; Ching et al., 2010; Wi niowiecka–Kowalnik et al., 2010; Gauthier et al., 2011). 
Another autosomal recessive form of PHS or PH–like syndrome is caused by alter-
ations involving CNTNAP2 on chromosome 7q35–36.1 (Stefansson et al., 2009; Zweier et
al., 2009; Blake et al., 2010). CNTNAP2 encodes a synaptic protein that plays an important
role in neuronal development and connectivity. It is highly expressed in the frontal lobe
circuits of the brain, where it is thought to inﬂuence the development of brain structures
involved in speech, language and thought (Vernes et al., 2008; Wang et al., 2010). The
gene may be involved in autism spectrum disorders (Alarcón et al., 2008; Bakkaloglu et al.,
2008; Tan et al., 2010). Children with autism tended to have a higher rate of thymine in a
single segment of the genetic code instead of adenine, which was found more likely to
have been inherited from mothers than from fathers (Arking et al., 2008). CNTNAP2 may
also be linked to developmental language disorders, intellectual disability, epilepsy, and
schizophrenia (Strauss et al., 2006; Friedman et al., 2008; Vernes et al., 2008; Mefford et
al., 2010). In their study of early language development in the general population, White-
house and collaborators found that common variants in the exon 13–15 region of CNT-
NAP2 inﬂuenced early language acquisition (assessed at age 2) and proposed that these
variants conferred increased risk of language disorders and autism when occurring
together with other risk factors (Whitehouse et al., 2011). Genetic variation at CNTNAP2
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impacts brain connectivity, especially in the frontal lobe (Hallmayer, 1999; Strauss et al.,
2006; Abrahams et al., 2007; Alarcón et al., 2008; Arking et al., 2008; Bakkaloglu et al.,
2008; Vernes et al., 2008; Scott–van Zeeland et al., 2010; Tan et al., 2010). 
In summary, while the genetic origin of PHS and related syndromes may vary, they
have similar effects, e.g., intellectual disability, autism, schizophrenia.
Clinical study
Results of the present clinical study including extensive descriptions of child assess-
ments with observations of interaction and behavior, measurements of cognitive and
adaptive functioning, assessments of past and current development, and assessments of
behavioral and emotional problems are included in this paper. Table 5.3 compares fre-
quently reported features of TCF4 deletions with ﬁndings in the present study. 
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s and TCF4 mutations to 
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., 2003; Amiel et al., 
drieux et al., 2008; 
Taddeucci et al., 2010; 
Table 5.3  Comparison of literature cases with TCF4 deletions and TCF4 mutations t  
patients with Pitt–Hopkins syndrome in the present study 
 
Literature cases with TCF4 
deletions and mutations* 
Present study 
   
Number of cases  52  10 
Number of males (M), females (F)  27M, 25F  6M, 4F 
Severe intellectual disability  94%  100% 
Severely limited/absent language  96%  90% 
Pleasant temperament  83%  90% 
Unassisted walking   35%  40% 
Self–injury  10%  50% 
Aggression towards others  6%  40% 
Stereotypies hands / fingers  42%  100% 
Stereotypies head/ trunk / body  29%  50% 
Breathing abnormalities   58%  60% 
Epilepsy  27%  10% 
Nystagmus  6%  0% 
Strabismus  48%  0% 
Myopia  48%  20% 
 
* Seshadri et al., 1992; Gustavsson et al., 1999; Engelen et al., 2003; Amiel et al., 
2007; Brockschmidt et al., 2007; Zweier et al., 2007, 2008; Andrieux et al., 2008; 
Giurgea et al., 2008; Rosenfeld et al., 2009; Kato et al., 2010; Taddeucci et al., 2010; 
Takano et al., 2010 
Clinical narrative descriptions
In this section we present narrative descriptions of individual child psychiatric assess-
ments, and clinical observations of interaction and behavior.
Case 1 
Case 1 was a toddler, but seemed younger due to her lack of active interaction. She had
no somatic complaints, with the exception of constipation for which she has medication.
Her mother mentioned that her breathing would become irregular when angry, this was
noticed from a very young age. There had been one incident of overbreathing when she
was visiting her grandparents. At second meeting she sat clutching a puffed rice cake in
one hand and had little eye–to–eye gaze; and little reciprocity. In addition there was lit-
tle integration of gaze, facial expression, vocalization and gesture. Her mother men-
tioned that she did have eye contact with her daughter, but that it was always of brief
duration. She would cuddle up with her mother, sometimes biting her mother’s neck. If
unhappy she could cry uncontrollably and become extremely upset, sometimes ending
up having a temper tantrum. She would smile and laugh without obvious cause, some-
times giving the impression of laughing at others. She liked staring into lamps. Both
spontaneous expressive language and comprehension of verbal communication were
severely limited. She had less than 5 words, but was able to vocalize sounds in differing
intonations and would sometimes scream loudly when excited or happy. For up to 5
minutes, her capacity to attend to different tasks (such as toys or objects) was observed,
to conclude whether her attention span was deemed short/sufﬁcient. These observa-
tions showed that her attention span was very short; she would lose interest quickly
after bringing the object to her mouth, drop it from her hand and stare off in the dis-
tance. She enjoyed manipulating toys with sounds. Most motor milestones had not
been reached, she was not able to walk independently, but would stand and step along
while holding on to parents’ hands with both her own. She would frequently ﬂap her
hands or clap them, and sometimes also rocked her upper body back and forth. There
was no head banging. She could hold her bottle with both her hands and drink from it
while lying on her back. Her parents were currently trying to teach her to drink while in
a sitting position. Her mood was usually pleasant; she smiled and laughed often
although the cause of it was not clear. Her mother mentioned that she was an easy sleep-
er but always needed a paciﬁer, and she enjoyed her food. 
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Case 2 
Case 2 was a withdrawn, but active toddler with a pleasant demeanor. He had no current
somatic complaints, but had been prescribed glasses from age 1 due to severe myopia (–
15). Bowel control had not been achieved, although he would sometimes indicate that he
wanted a diaper change by hitting the back of one hand with the other hand. No breath-
ing abnormalities had been noticed by his mother. His eye–to–eye gaze was limited, and
he showed little reciprocity or spontaneous initiation of contacting or engaging the
other. At home he would get upset and fearful when hearing sharp and loud sounds,
covering his ears when the hair dryer or the mixer were used. His mother noted that he
insisted aspects of the daily routine remained the same, for example if his usual bedtime
was delayed he could be difﬁcult for the rest of the week. He liked staring into lamps and
enjoyed looking at spinning objects. He did not have spontaneous expressive language,
but would make some sounds while occasionally screaming or yelling. There seemed to
be no comprehension of verbal communication. He had no understanding of the mean-
ing of simple words, like ‘yes’ or ‘no’. For up to 5 minutes, his capacity to attend to dif-
ferent tasks (such as toys or objects) was observed, to conclude whether his attention
span was deemed short/sufﬁcient. These observations showed that his attention span
was short, he was restless and overactive. When presented with a new toy he would ﬁrst
carefully touch the toy, instead of grabbing it immediately, and then bring it to his
mouth. He would subsequently rapidly lose interest (within seconds). He did not show
any attempts to imitate the other. His mother mentioned that he enjoyed listening to
the same music over and over again, and he enjoyed looking at the same books. He
would ﬁddle toys and objects repetitively, and bobbed his head when listening to music.
He frequently used both hands to hit on the table or on toys that were in his vicinity. This
behavior would sometimes occur when he was enthusiastic, but also sometimes for no
apparent reason. He tried to put every object he would get his hands on in his mouth.
Most motor milestones had not been reached. He was not able to walk independently,
but demonstrated great ﬂexibility and dexterity with his ﬁngers when he played with his
own hands, although his grasp of objects showed immature motor skills. He regularly
ﬂapped his hands and rocked his body, sometimes hitting himself, this behavior would
increase when he was excited. His mood was usually happy, he would laugh and giggle
without obvious cause. 
Case 3 
Case 3 was an alert boy of preschool age with a pleasant demeanor. While he extended
his hand at ﬁrst meeting when prompted by his mother to shake hands, he did not make
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eye contact when doing so. He had no somatic complaints, except for recurring consti-
pation. His mother had not noticed any breathing abnormalities. He was ﬁtted with lower
leg splints to aid leg function for walking. He smiled without obvious cause and without
making eye contact with the examiner. There was some reaction to his own name, but
not consistently. There was little visible response to the examiner’s facial expression, ori-
entation or smiles. His eye–to–eye gaze was limited, and there was little reciprocity or
spontaneous initiation of contacting or engaging the other. He would often raise his face,
glance at the ceiling and stare into lamps, according to his mother this behavior had been
more prominent at a younger age. His mother mentioned that he would put up his arms
to be lifted; he had little response to the examiner’s attempts to draw his attention to dis-
tant objects although he had an obvious interest in a ball when it was close. When the ball
was thrown out of his eyesight he would not search for it with his eyes. His mother men-
tioned that he understood many words, including names of familiar people, food items,
and toys and he was able to follow verbal instructions e.g. when instructed to ‘go get a
cookie from the drawer’ he would go, open the drawer and get the cookie. While his
spontaneous expressive language was limited, he did use at least ﬁve different words
every day and was able to vocalize sounds in differing intonations. For up to 5 minutes, his
capacity to attend to different tasks (such as toys or objects) was observed, to conclude
whether his attention span was deemed short/sufﬁcient. These observations showed
that his attention span was short, he was easily distracted by outside noise and would
quickly lose interest. He would handle the object, bring it to his mouth and then hurl it
away. He would sometimes reach with open hand for a toy, but would not point to it to
indicate a desire to play with it. His mother said at home he liked watching television. He
would handle toys put near him, often bringing these to his mouth and then throwing
them, but would not point. He regularly ﬂapped his arms and hands, this behavior would
increase when he was excited. Walking independently had not been achieved yet, he
moved around the house easily by hopping up and down on his bottom. His mood was
usually happy, he would laugh when physical games such as tickling and romping about
were initiated by his parents and siblings. His mother mentioned that he could also
become very angry sometimes without apparent reason and could lash out angrily hit-
ting, biting or pulling hair of siblings or companions at school. 
Case 4 
Case 4 was an alert boy of preschool age with a pleasant, but withdrawn demeanor at
ﬁrst meeting, his mouth was open and he drooled a bit. Although he did make eye con-
tact with his parents while producing sounds, his eye–to–eye gaze with others was lim-
ited. He wore glasses to correct myopia, and used medication for hyperbreathing. His
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mother noticed that he would still sigh regularly. He had also used medication, since age
3, to reduce his hyperactive, impatient behavior. Bowel and bladder control had not
been achieved. He showed little reciprocity or spontaneous initiation of contacting or
engaging the other. He had a tendency of standing too close to others, sometimes rock-
ing his body back–and–forth while standing. At home he would get upset at hearing
unexpected, loud noises. His mother noted that he would sometimes eat non–food
items, such as dirt or grass. He did not have expressive language, but would sponta-
neously hum, yell or scream. His mother had noticed a decrease in his screaming and
yelling with use of medication. There seemed to be little to no comprehension of verbal
communication. For up to 5 minutes, his capacity to attend to different tasks (such as
toys or objects) was observed, to conclude whether his attention span was deemed
short/sufﬁcient. These observations showed that his attention span was short, he was
restless and impatient. He would get up and move around, bring objects to his mouth
without looking at them before losing interest altogether and ﬂinging them away. He
was fascinated by door knobs, and light switches and he would also stare into lamps. He
seemed interested in the feel of different surfaces. His play was mostly linked to stereo-
typed use of parts of toys, and he would play repetitively with toy cars by ﬁrst bringing
them to his mouth and then spinning their wheels. He moved to music and enjoyed lis-
tening to favorite songs over and over again. Most motor milestones had not been
reached. He was not able to walk independently, but did crawl in a peculiar fashion by
ﬁrst moving both hands forward and then following on both knees simultaneously. He
regularly bit his hand, according to his mother this behavior would increase when he was
frustrated and she had noticed that he seemed to have a high threshold for pain. He
clapped with his ﬁsts together and ﬂapped his hands regularly. He would sometimes lash
out, kicking or hitting the other, but his mood was usually happy.
Case 5 
Case 5 was of primary school age, at second meeting she sucked a paciﬁer and her moth-
er mentioned that she would grab it from the table at every opportunity to stick it into
her mouth. Her tongue regularly protruded from her mouth, sometimes she closed her
eyes while moving her tongue. She had no somatic complaints, although she suffered
from constipation sometimes, and used no medication. Bowel and bladder control had
not been achieved. Her mother mentioned that she would sometimes ‘gasp’ for breath
when panicked or upset. She had little eye–to–eye gaze; and little reciprocity with little
integration of gaze, facial expression, vocalization and gesture. Her mother mentioned
that she did sometimes have eye contact with her daughter, but it was mostly of brief
duration. Her mother had noticed from an early age that she did not follow with her eyes
and that she lacked responsiveness to her surroundings. She had pulled her own hair and
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banged her head for a short period when younger. She would smile often without obvi-
ous cause, and would sometimes smile when seeing her parents or grandmother. She
tended to stare into lighted lamps for prolonged periods of time, although this behavior
had diminished somewhat with advancing age. Both spontaneous expressive language
and comprehension of verbal communication were severely limited. She had less than 5
words, but she had some comprehension of the word ‘no’ and seemed to understand
names of favorite objects or words within familiar routines (e.g. the word ‘toothbrush’
for brushing teeth). For up to 5 minutes her capacity to attend to different tasks (such as
toys or objects) was observed, to conclude whether her attention span was deemed
short/sufﬁcient. These observations showed that her attention span was short; she
would tilt her head to look at objects from different angles but would lose interest quick-
ly after 1 minute and stare off into the distance. While she would grab building blocks,
she did not construct anything with them or try to imitate when shown. She seemed
interested in the feel of different surfaces, e.g. often licking the table. She enjoyed
manipulating musical toys or books with crinkly sounds. She enjoyed individual atten-
tion, liked to go swimming and would become visibly happy when listening to music or
singing. When approached by others she sometimes reacted by wildly and unexpected-
ly waving her arms. Most motor milestones had not been reached, she was not able to
walk independently, but she had just started to stand and step along while holding on to
her parents’ hands. She would frequently ﬂap her hands when excited, and sometimes
also rocked her upper body back and forth. She tended to rub one hand over the other
repetitively. Her mood was usually happy; although she could become grumpy and start
pinching or biting the other when the social situation was unclear to her.
Case 6 
Case 6 was of primary school age and had a withdrawn demeanor, drooling a little at sec-
ond meeting. He had no current somatic complaints and used no medication, but he had
suffered from constipation before his ﬁrst birthday and hearing in one ear was found to
be reduced. Bowel and bladder control had not been achieved. No breathing abnormal-
ities were noticed by his mother. His mother thought him a very easy, contented baby,
not even crying to be fed. During assessments he stared into ceiling lamps for prolonged
periods of time and showed little reaction to attempts to engage his attention. He would
repeatedly slap his hands against his own face, wring or ﬂap his hands and grind his teeth.
There was little eye–to–eye gaze during examination and observation; and although rec-
iprocity was limited he did sometimes show a reaction to his own name. From a very
young age he could get somebody to do something for him by smiling winningly and his
mother also mentioned that he would sometimes take her hand to pull her towards
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something of interest without using words, and without pointing or coordinating his
action with eye gaze. Sometimes he would bite the table, but he did not lick objects. He
liked to open and close doors repetitively. Although spontaneous expressive language
was severely limited with no daily use of words, his mother mentioned that his compre-
hension of verbal communication included names of familiar persons, food items, and
simple instructions such as ‘wait your turn’, ‘another time’ and ‘get ready for bed’. For up
to 5 minutes, his capacity to attend to different tasks (such as toys or objects) was
observed, to conclude whether his attention span was deemed short/sufﬁcient. These
observations showed that he had a very short attention span, and while he would
extend his hand to receive an object he would mouth it for a short time and then hurl it
away within one minute. He reacted to every sound but lost interest quickly. He would
repetitively play and ﬁddle with toys. He walked independently from approximately age
6, his gait was broad based. Fine motor skills were immature, he would grab a piece of
bread with the whole hand and hold it in his ﬁst. He almost continuously showed hand
and ﬁnger movements, and often rocked his body. His mood was hard to gauge at the
assessments, as there seemed to be little emotional reciprocity or visible affect, but his
mother mentioned that he would laugh when physical games such as tickling, hide–
and–seek, running and football were played with him. 
Case 7
Case 7 was of primary school age and had a pleasant demeanor at second meeting, he
sat in a wheelchair with one leg atop the other bended at the knee. He announced his
arrival by continuously clapping his hands in the corridor and stamping his feet on his
wheelchair footboard. He had no current somatic complaints, he used medication to
prevent constipation. Hearing and vision had been found to be normal. Bowel and blad-
der control had not been achieved. His mother noticed that he would sigh when happy,
while at other times he seemed to hold his breath for brief periods. His mother had wor-
ried about his development from a very early age, noting how he showed little initiative
to move, was unable to roll over at 12 months and tended to repetitively ﬂap hands or
move legs. He had at some time been able to hold a cookie in one hand and bring it to
his mouth, but seemed to lose this ability around 11 months. Mother mentioned that he
would repeatedly bang his hands against his own chin when frustrated. During assess-
ments there was little eye–to–eye gaze, he would glance off in the distance and reci-
procity was limited. His mother noted that he was able to look her directly in the face,
but this direct gaze was usually of short duration and seemed to have little communica-
tive purpose. He would smile when his grandmother visited and seemed to recognize
her face. Spontaneous expressive language was severely limited with no daily use of
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words, his mother mentioned that his comprehension of verbal communication was
also limited although he did have some understanding of ‘no’, names of familiar persons,
and food items. He was able to vocalize different sounds with differing intonations, his
mother mentioned that he seemed to make one distinct sound when he was unhappy.
For up to 5 minutes, his capacity to attend to different tasks (such as toys or objects) was
observed, to conclude whether his attention span was deemed short/sufﬁcient. These
observations showed that he had a poor attention span, and could not attend to one
activity or object for any length of time. He was also easily distracted by outside sounds.
He enjoyed swimming and horseback riding according to his mother, but he showed no
spontaneous imaginative play nor imitated others. When aged 4 he had played with cars
by turning these upside down and repetitively spinning the wheels. He now liked to clap
his hands excitedly when others sang, would cry at sad melodies, and enjoyed watching
TV. If he was close enough with his wheelchair he would repetitively ﬂick light switches
on and off when given the chance. He liked to snuggle and hug indicating this by inclin-
ing his head forward. He was sometimes responsive when approached by other chil-
dren, but could react in unpredictable ways suddenly pulling the other’s hair, hitting or
ﬂapping his arms. He disliked holding objects in his hand, would almost continuously
ﬂap his hands and frequently grinded his teeth. When younger he had also frequently
shown midline wringing hand movements, but these were infrequent now according to
his mother. Walking independently had not been achieved yet, although he could walk
short distances with his mother walking behind him and holding both his hands. He
could not wave goodbye. His mood was mostly happy, he tended to giggle and laugh
without clear cause and his mother thought that he had a full range of facial expressions.
Case 8 
Case 8 was an adolescent with a withdrawn, but amiable demeanor. He extended his
hand at second meeting when prompted by his parents to shake hands, but did not
make eye contact when doing so. He had no current somatic complaints, he had no
hyperbreathing but would sometimes noticeably sigh. Hypoplasia of the corpus callo-
sum had been conﬁrmed at an early age. Bowel and bladder control had not been
achieved. His mother thought him a contented baby, not even crying to be fed and lying
quietly when awake. He used lower leg splints to aid leg function for walking. There was
little visible response to the examiner’s facial expression, orientation or smiles, although
he sometimes seemed to cock his head to listen. Both his eye–to–eye gaze and range of
facial expressions were limited, and there was little reciprocity or spontaneous initiation
of contacting or engaging the other. His mother considered him very sociable at a young
age, he smiled from the age of 3 months and was quick to smile at a camera. Both spon-
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taneous expressive language and comprehension of verbal communication were severe-
ly limited. He had 1 word, and his production of sounds was also limited. For up to 5 min-
utes, his capacity to attend to different tasks (such as toys or objects) was observed, to
conclude whether his attention span was deemed short/sufﬁcient. These observations
showed that his attention span was sufﬁcient, he especially enjoyed spinning the wheels
on a toy car with one hand and kept doing that until the car was removed from his grasp.
There was no play involving others. He was able to drink from a covered cup with one
hand; to sip water with a straw. He had no unprompted spontaneous attempts to point
to objects of interest. His mother mentioned that he would handle objects, bringing
them to his mouth, but not biting or licking them. His mother said he liked musical toys
and enjoyed watching television. He also loved to take the other’s hands and clap them
together, often not realizing his own strength and clapping them very hard. He would
often make rapid stereotyped movements with his head, sometimes completing a ﬁg-
ure–8, sometimes just rapidly going back and forth. There was no head banging. His par-
ents mentioned that he could make movements within a contextualized setting, such as
lifting his arms high when his father announced that he was going to remove the coat.
He repetitively clasped his hands together in the midline and also had frequent hand and
ﬁnger movements. He could walk independently, but would need to grasp one ﬁnger of
his Dad’s hand to get up from the chair and start moving. When he was unsure of his sur-
roundings he would stop walking and stand. Sometimes he was hesitant when walking
and he could suddenly grab onto somebody standing close by. He was usually even–
tempered, and he always slept well and enjoyed his food. 
Case 9 
Case 9 was a self–absorbed young adult with her tongue protruding from her mouth.
She sat quietly in her chair while playing with musical toys at ﬁrst meeting. She had no
visible reaction to the introduction, did not make eye contact nor extended her hand
when prompted. She received medication for epilepsy, but otherwise had no somatic
complaints. She would sigh, and she regularly overbreathed during short periods with
quick breaths interspersed with very slow ones. Bowel and bladder control had not been
achieved. There was little integration of gaze, facial expression, vocalization and gesture.
Her mother mentioned that her range of facial expressions was limited, usually giving a
neutral impression while she had a blank stare. Although she had grinded her teeth
repetitively when younger, this behavior had lessened over time. There was no sponta-
neous expressive language and comprehension of verbal communication was also
severely limited. She had no words, but was able to vocalize some sounds, sometimes
screaming or yelling. Her capacity to attend to different tasks (such as toys or objects)
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was observed for up to 5 minutes, to conclude whether her attention span was deemed
short/sufﬁcient. These observations showed that her attention span was very short; she
would repeatedly bring the object to her mouth, drop it from her hand and stare off in
the distance. She had a preference for musical toys with pulling cords, choosing these
toys from a basket next to her chair. She would sometimes pull the cord with great
strength, disrupting the musical mechanism and drop one toy on the ﬂoor with a quick
right handed gesture, then grab another with the same hand. Her mother mentioned
that she could also play the whole day with the same musical toy, repetitively pulling the
cord to start the music. She was able to walk independently from age 4, but her mother
and sibling described her as mostly passive and prone to sit by herself without interact-
ing with others. She would frequently rock her upper body back and forth. There was no
head banging. She could hold her uncovered drinking cup in one hand and sip from it.
Her mood was hard to gauge, her mother and sibling often wondered if she was happy.
Her mother mentioned that she slept well and enjoyed her food, she also often ate non–
food items such as sand or grass. 
Case 10 
Case 10 was a boisterous young adult at second meeting, willingly shaking hands when
prompted by her parents and talking repetitively about the car drive. She made a rest-
less impression and tended to keep moving around within the room, sitting down for
only short periods of time. She had no somatic complaints. No breathing abnormalities
had been noticed by her parents. Daytime bladder control had been achieved around
age 10. Nighttime bladder control and bowel control had been achieved around 12 years.
Her parents considered her sociable from an early age, but also mentioned that she
always sought the other’s attention and would need to be entertained. She would some-
times stand too close to others and she could be stubborn, bossy and uncooperative.
Eye–to– eye gaze was sufﬁcient and she seemed interested in making contact with oth-
ers although this included little reciprocity and could largely be determined as attention
seeking behavior. She would repeatedly interrupt her father’s conversation. She grinded
her teeth repetitively. There was spontaneous expressive language and comprehension
of verbal communication included understanding more than 50 words, names of famil-
iar others, toys and food items. She had babbled from the age of 20 months, and had
started short sentences around age 11, usually indicating a wish for food or need to visit
the toilet. She tended to speak loudly, but she would modulate her voice when encour-
aged to do so. Her father mentioned that she could sit on the sofa and could repetitive-
ly and relentlessly call for his attention and continuing this behavior even when she was
corrected and told to wait. After correction she would sometimes start calling her Mom
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repetitively. She would offer videos that she would like to see on the TV or sometimes
asked her parents to inquire if she could go to tea at a friend. For up to 5 minutes, her
capacity to attend to different tasks (such as toys or objects) was observed, to conclude
whether her attention span was deemed short/sufﬁcient. These observations showed
that her attention span was poor, she could not attend to one activity or object for any
length of time and she was continuously distracted by her own or outside sounds. She
tended to ﬂit from one object to the next, unable to stay on task. At home she enjoyed
going for walks outside and liked to watch favorite DVDs. She sometimes repeated parts
of sentences she heard in TV commercials. She was able to walk independently from age
7, would frequently ﬂap her hands and sometimes banged her head. She could keep
moving around the room with no apparent purpose. Her mood was mostly happy.
Child assessments
Bayley Scales of Infant Development 
The scores for mental age and motor development as measured using the BSID–II are
shown in Figure 5.1. As participants had severe intellectual disability and a chronological
age above the norms of the BSID–II, only age–equivalent scores are shown and no stan-
dard scores. The chronological age of the participants lies between 32 and 289 months
and the developmental age between 3.5 and 15 months for the mental scale and
between 4 and 19 months for the motor scale. With the exception of one young child,
all participants performed better on the motor scale than on the mental scale.
Snijders–Oomen Nonverbal Intelligence Test (SON–R) 
As none of the participants had a developmental level beyond 48 months, the SON–R
was not used.
Autism Diagnostic Interview – Revised (ADI–R) 
Highest scores for all participants were found on the domain of social interactions and
play. Eight subjects scored at or above cut–off scores on social and communication
domains (Table 5.4). Subjects 6 and 10 did not score above cut–off for the behavioral
domain. These ADI–R scores in themselves should not be interpreted as conclusive for
autism or indicative of symptom severity, especially since mental age equivalents in this
group were lower than minimum developmental level described in the ADI–R manual.
However, they add to and corroborate other ﬁndings.
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Figure 5.1  Developmental level of mental and motor functioning, measured by the BSID, compared to 
chronological age 
 
Table 5.4  Item scores on the three domains of the Autism Diagnostic Interview – Revised  
  Participant # 
Test domain Cut–off 1 2 3 4 5 6 7 8 9 10 
            
Social skills and play 10 15 X 15 25 X 22 17 23 26 16 
Communication (verbal & non–verbal) 8 NS X 8 NS X NS NS NS NS 18 
Communication (non–verbal only) 7 10 X NS 8 X 10 12 14 14 NS 
Behavioral abnormalities 3 6 X 4 4 X 2 4 6 4 0 
            
NS = no score; X = not measured            
 
 
Vineland Adaptive Behavior Scales (VABS)
VABS results (Figure 5.2) were determined with age–equivalent scores. None of the par-
ticipants, except the eldest, performed beyond a developmental age of 20 months. 
The domains of daily living skills and communication appear to be relative strengths,
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Figure 5.2  Developmental level on the three domains and total adaptive behavior score of the 
Vineland, compared to chronological age 
Table 5.5  Likelihood assertions concerning level of cognitive functioning  
Participant Total score Decile scores Description 
    
1 42 1 (too young) (very profound ID)  
2 38 1 (too young) (very profound ID) 
3 84 2 profound ID 
4 55 1 very profound ID 
5 62 1 very profound ID 
6 67 1 very profound ID 
7 50 1 very profound ID 
8 75 1 (norm table 14–18) (very profound ID) 
9 59 1 (norm table 14–18) (very profound ID) 
10 140 1 (norm table 14–18) (very profound ID) 
 
de Bildt & Kraijer, 2003 
with weaker functioning in the domain of socialization. It also seems that with increas-
ing age very little progress in adaptive functioning could be accomplished.
The decile scores in the present study showed a very profound intellectual disabili-
ty in 7 of 8 participants and profound disability in one participant (Table 5.5). In the case
of 2 participants, their young age prevented calculation of a decile score. The 3 partici-
pants >18 years were categorized as category 1 (lowest category), although they fall out-
side the age range of 14 – 18 years. However, because they are older and fall within cate-
gory 1 it is unlikely that we are underestimating their cognitive functioning. 
Developmental Behaviour Checklist (DBC) 
The DBC assessment showed 2 participants (cases 6 and 10) with scores above the clin-
ical cut–off level for problem behaviors for age group (Figure 5.3). Clinical cut–off scores
for the age group below 18 (at 46) and for the age group above 18 (at 51) are shown in 
Figure 5.3 as separate dotted lines. Total problem behavior in case 6 was caused by a high
score on the Self–Absorbed scale, while case 10 had high scores on the Communication
Disturbance and Disruptive Behavior scales.
All participants had high scores on self–absorption. Five of the 7 subjects below 18
years scored just above threshold on the DBC Autism Screening Algorithm. This algo-
rithm is not available for adults using the Developmental Behaviour Checklist for Adults. 
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Figure 5.3  Total problem behavior scores and autism screening algorithm scores with their cut–off 
lines, measured with the Developmental Behaviour Checklist 
D I S C U S S I O N
This is the ﬁrst study of cognition and behavior in classic PHS. Results from this
exploratory study show that all subjects share (very) profound intellectual disability,
severe impairments in social interactions, severe impairments in communication and
language, and highly frequent, intense stereotyped behavior consisting primarily of
repetitive hand and ﬁnger ﬂapping/twisting and/or rocking. Findings show that 90% of
participants are functionally nonverbal, and breathing abnormalities are present in 60%
and range from overbreathing and breath holding spells to gasping or sighing. Aggres-
sion towards self is present in 50%, towards others in 40%. Most participants have an
amiable demeanor, but also show high levels of self–absorption and failure to engage
socially. In comparison to an earlier study of Marshall–Smith syndrome with a similar
methodology (van Balkom et al., 2011), the ﬁndings in this study indicate that in classic
PHS not only the difﬁculties in engaging and communicating with others are more pro-
nounced, but the individuals with PHS also show a much higher occurrence and level of
severity of repetitive motor stereotypies. Stereotypies in our group are also more preva-
lent than reported in several genetic studies of PHS (see Table 5.3), suggesting that these
behaviors may be less recognized as a distinct characteristic of PHS. Higher levels of
repetitive motor behaviors may be associated with the lower levels of adaptive and cog-
nitive skills found in our sample, or may be part of a phenotype of autism spectrum dis-
order. Severity of intellectual disability is considered a risk factor for difﬁculties in com-
munication and social interactions, sometimes resulting in behavioral problems
(McClintock et al., 2003; Szatmari et al., 2006). Previous publications have emphasized
the increased vulnerability to co–morbid psychopathology to which individuals with
developmental disability are subject (Dykens, 2000; Leyfer et al., 2006; Matson & Shoe-
maker, 2009). Co–morbidities associated with intellectual disability include a high preva-
lence of epilepsy, behavioral, psychiatric, and sensory disorders. Higher prevalence and
severity of co–morbid disorders is closely related to lower levels of intellectual func-
tioning (Matson & Shoemaker, 2009; Saemundsen et al., 2010). In addition, when intel-
lectual disability is highly prevalent in one speciﬁc diagnostic group, clinician expecta-
tion of an individual’s developmental potential may be biased. This fact, combined with
the lack of suitable instruments for severe intellectual disability and associated behav-
ioral problems, may prevent more thorough evaluations of cognitive and adaptive func-
tioning in both clinical and research settings (Sanz et al., 2010). In the study of genetic
syndromes, differentiating between deﬁcits related to intellectual disability with severe
developmental delay and deﬁcits related to autism remains difﬁcult (Percy et al., 1990;
Mazzocco et al., 1998; Howlin, 2000; Cohen et al., 2005; Leyfer et al., 2006; Hagerman &
Harris, 2008; Battaglia et al., 2010). Speciﬁc brain regions serve aspects of cognition and
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behavior, and neural development and functioning of these regions may be disturbed
due to genetic risk factors. Brain–behavior relationships develop as a result of brain pro-
gramming and functional connectivity within neural circuits and networks determined
by gene expression. Findings in recent years have increased our understanding that
causal effects in brain–behavior relations are neither unidirectional nor invariant. These
brain–behavior relations may change over the course of development, contingent also
on the effects of experiences within rearing environments, learning and social contexts
(Oliver et al., 2000; Rutter, 2005; Pennington, 2006; Guilmatre et al., 2009; Karmiloff–
Smith, 2009; Pennington, 2009; Saemundsen et al., 2010). 
Similar phenotypes emerging from distinctly different genetic defects are thought
to be caused by the multidirectional interaction between etiological risk and protective
factors from both genetic and environmental perspectives. Conversely, a given geno-
type can give rise to different phenotypes depending on environmental circumstances.
A single genetic alteration will often affect more than one neural system, subsequently
inﬂuencing the development and function of other neural systems downstream. These
neural systems may in turn be inﬂuenced by interactive processes in the social and phys-
ical environment and have eventual effects ‘upstream’ on the way genes work, affecting
different regions to a greater or lesser degree and changing overall developmental out-
come (Bateson et al., 2004; Pennington, 2006: Blackwood et al., 2008; Geschwind, 2008;
Diamond, 2009; Karmiloff–Smith, 2009). 
Many recent genetic studies have investigated chromosome regions and possible loci
on various chromosomes regarding their possible contribution to the cause of autism 
spectrum disorder, intellectual disability, and schizophrenia. Several of these studies con-
cluded that the genomic abnormalities investigated were not disease speciﬁc. Rather they
contribute to the expression of various overlapping neurodevelopmental phenotypes, and
challenge longstanding ideas of how disorders can be delineated and differentiated from
one another. Research into the involvement of Copy Number Variants (CNVs) in intellec-
tual disability, autism spectrum disorders, and schizophrenia has also suggested outcome
similarity and overlap with regard to synaptic formation, function, and neurotransmission.
The chromosomes involved in PHS and PH–like syndromes have all been investigated for
their association with neurodevelopmental and psychiatric disorders. Structural changes,
deletions, and mutations in TCF4, NRXN1, and CNTNAP2 have been implicated in brain
dysfunction, and they may contribute to neuronal networks that lead to psychiatric phe-
notypes (Kirov et al., 2008, 2009; Walsh et al., 2008; Rujescu et al., 2009; Stefansson et al.,
2009; Zweier et al., 2009; Blake et al., 2010). In a meta–analysis of datasets of brain imaging,
Cheung et al. (2010) found that in schizophrenia and autism there are structural concor-
dances with abnormalities of the limbic loop (cingulated, striatum, and thalamus), sug-
gesting shared etiologies and partly explaining shared socio–emotional symptoms. 
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Schizophrenia and autism differ in the localization of lower grey matter volume (autism:
left putamen; schizophrenia: left fronto–striatal–temporal region). 
NRXN1 and CNTNAP2 play important roles in creating effective connections for sig-
nals between neurons (Feng et al., 2006; Bucan et al., 2009; Glessner & Hakonarson, 2009;
Kirov et al., 2009; Stefansson et al., 2009; Zweier et al., 2009; Blake et al., 2010). As CNT-
NAP2 is highly expressed in the frontal lobes, it may inﬂuence the development of brain
structures involved in speech, language, and thought, and may thus be instrumental in
reducing gray and white matter volume in particular brain regions, and increasing sus-
ceptibility for autism spectrum disorders, language disorders, intellectual disability, and
epilepsy (Strauss et al., 2006; Alarcón et al., 2008; Bakkaloglu et al., 2008; Tan et al., 2010).
Comparable impairments in social communication in autism, intellectual disability, and
schizophrenia may be caused by impaired ﬁltering and information processing at brain
level, and by atypical responsiveness to social and learning environments at the behav-
ioral level. It has been hypothesized that these effects may be determined at different lev-
els within mirror neuron networks that impact learning behaviors, resulting in deﬁcits in
gestures and language, and in imitative capabilities which are important in learning (Frith
& Frith, 2010; King & Lord, 2011). Researchers have also postulated that functional con-
nectivity deﬁcits in key brain networks and their effects on long–range interactivity with
other regions may underlie shared phenotypes, regardless of the initial starting point at
the genetic level (Oliver et al., 2000; Pennington, 2009; Ching et al., 2010; King & Lord,
2011). The impact of alterations in these genes includes outcome effects on, among oth-
ers language, thought, social cognition, and memory. This effect can be understood as a
multilevel and long–range inﬂuence on neuronal development and connective function-
ing in the brain and primarily affects the frontal lobe, and gray and white matter. 
The study of PHS and PH–like syndromes shows that different genomic alterations
can result in similar phenotypes, and it is clear that there is still much to learn to improve
our understanding of the delineation between typical and atypical behavior and about
the signiﬁcance of genomic changes with regard to the expression of overlapping phe-
notypes and their diagnostic boundaries. 
Strengths and limitations of the present clinical study 
Major strengths of our study are that participants comprised a diagnostically homoge-
nous group with a diagnosis of PHS caused by TCF4 alterations, that all subjects were
directly assessed through individual psychiatric examinations and a robust, comprehen-
sive battery of tests, and that they had a wide (chronological) age distribution, which
allowed assessments from toddler– to young adulthood. Nonetheless, the following
limitations regarding the present study also need to be considered. First, our sample of
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10 participants is relatively small, although it could be considered substantial in light of
the rarity of the syndrome. Second, the lack of suitable instruments to measure 
cognitive functioning directly in individuals with severe intellectual disability required an
a priori judgment of approximate cognitive level through clinical psychiatric assessment.
In our study, all subjects scored within developmental levels that could be measured by
our instrument of ﬁrst choice (Bayleys), and the use of the other instrument (SON–R)
was not necessary. Similarly, it should be noted that use of the ADI–R to assess individ-
uals whose mental age–equivalent is below a developmental level of 24 months carries
the risk of over–classiﬁcation of autism. However, in this study the results of the ADI–R
were used to add to other data collected through individual psychiatric assessments,
informant reports, and individualized standardized testing. 
Conclusion
This ﬁrst exploratory study of cognition and behavior in classic PHS shows (very) pro-
found intellectual disability, severe impairments in communication and language with
failure to engage socially and very frequent and intense motor stereotypies. We con-
clude that autism spectrum disorder may be part of the phenotype of classic PHS, albeit
presenting in varying degrees of severity.
Changes in TCF4, NRXN1 and CNTNAP2 in PHS and PH–like syndromes have been
implicated in outcomes of intellectual disability, epilepsy, autism, and schizophrenia,
through their impact on the development and function of neuronal networks. Contin-
ued studies of rare genetic disorders will eventually, through longitudinal data, allow for
improved recognition of shared etiologies and co–morbid conditions. They will increase
our understanding of signiﬁcant contributions from social and learning environments,
shed more light on individual and group level developmental trajectories, on changes
over time, and suggest possibilities to improve outcomes. 
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A B S T R AC T
Marshall–Smith syndrome (MSS) is a distinctive entity of unknown etiology with fewer
than 50 patients described in the medical literature to date. Through an International
collaboration and use of an online wiki to facilitate data collection and sharing, we fur-
ther delineate the phenotype and natural history of this syndrome. We present 15 new
patients, the oldest being 30 years, provide an update on four previously published
cases, and compare all patients with other patients reported in literature. Main clinical
features are moderate to severe developmental delay with absent or limited speech,
unusual behavior, dysharmonic bone maturation, respiratory compromise secondary to
upper airway obstruction, short stature, and kyphoscoliosis. Facial features are charac-
teristic with high forehead, underdeveloped midface, proptosis, anteverted nares, and
everted lips. Minor abnormalities of brain morphology such as hypoplasia of the corpus
callosum are common. Mortality from respiratory complications is high, but airway sup-
port increasingly allows survival into adulthood. Array–CGH was performed on 12 of the
cohort and no copy number variants of clear clinical relevance were identiﬁed. The pres-
ent study is the ﬁrst reported use of an online wiki to aid delineation of a genetic syn-
drome, and illustrates its value in collecting detailed data in rare conditions.
keywords: Marshall–Smith syndrome, mental retardation, dysostosis, kyphoscoliosis,
natural history, wiki
I N T RO D U C T I O N
In 1971, the physicians R.E. Marshall, C.B. Graham, C.R. Scott, and D.W. Smith reported
two unrelated male infants with unusual facial features, failure to thrive, developmental
delay, and what was described as marked early acceleration of osseous maturation (Mar-
shall et al., 1971). The facial appearance was very similar in both and characterized by
prominent eyes, thick eyebrows, depressed nasal bridge, and a small upturned nose with
prominent nares. Both patients had respiratory difﬁculties, and one of them had died at
20 months of age. To date, at least 43 cases with this phenotype have been described in
the literature, and the entity has become known as the Marshall–Smith syndrome
(MSS). The majority of reported cases died in infancy or early childhood, but prolonged
survival of some cases especially due to improved management of the respiratory difﬁ-
culties, suggested such early demise is not inevitable.
The majority of previous reports have been of single patients, with the largest pub-
lished series comprising 5 new cases (Adam et al., 2005), collated through an internation-
al collaboration. Meaningful study of ultra–rare phenotypes such as MSS, necessitates
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large–scale collaboration between clinicians. The apparent difﬁculty in amassing sizable
cohorts to date may be compounded by inefﬁcient means of effective data sharing,
inconsistent data–sets, and difﬁculty tracing patients who are not under active follow–up.
The use of evolving web–based data sharing methods such as a wiki, may provide a solu-
tion to some of these problems and aid delineation of rare phenotypes. Wikis are easy–
to–use text–based data repositories that can be accessed through a web browser and
allow any individual with world–wide–web access to read the content and add their own
text. Wikis may be open–access or available only to registered users and can easily be cre-
ated using a number of free open–source or commercial software products.
Here we provide the phenotype and natural history of 15 new and 4 previously pub-
lished patients on whom data were in–part collected and shared using a secure online
wiki resource. Three patients are aged over 16 years and allow us to further describe the
adult phenotype of MSS.
M E T H O D S
A literature search was performed using ‘‘Marshall–Smith’’ as search term. The refer-
ence lists of all manuscripts thus retrieved were searched manually for further reports.
Patients were referred to us by colleagues around the world and through the inter-
national Marshall–Smith Support group. All patients referred have been personally eval-
uated by at least one of the authors. In addition to medical assessment and clinical exam-
ination, personal history and additional information on the patients were assimilated
using an online wiki. An early draft of this paper consisting of the general description of
the syndrome and medical complications, was re–written in lay language and translated
into French, German, Dutch, Norwegian, Portuguese, Spanish, and Croatian. The trans-
lated text was uploaded to a secure wiki website, accessible to registered clinicians and
members of the International MSS patient support group (www.marshallsmith.org).
Families were encouraged to read the text and add their own data and comments.
Agilent Technologies 244 K genome–wide arrays were used for the patient testing.
In brief, genomic DNA from the patient and from a single sex–matched reference were
double–digested using the restriction endonucleases AluI and RsaI (Promega, Wiscon-
sin) and puriﬁed using Microcon centrifugal ﬁlter devices (Millipore Corporation, Mas-
sachusetts). 1.5 mg of the digested products were differentially labeled by random prim-
ing with Cy3–dUTP and Cy5–dUTP (Perkin Elmer, Massachusetts) and co–hybridized to
the arrays for 48 hr at 65°C in a rotating oven (Agilent Technologies, Inc., Illinois).
Hybridized arrays were washed according to Agilent Technologies, Inc. protocols
(www.agilent.co.uk) with the exception that the ﬁnal stabilization step was not per-
formed. Hybridized arrays were scanned at 5 mM resolution immediately following
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washing using an Agilent DNA Microarray Scanner. Image data were extracted using
Agilent Feature Extraction software version 8.5 and analyzed using Agilent CGH Analyt-
ics software version 3.4 (z–score method setting). Potential genome imbalances were
recorded if 4 or more consecutive oligonucleotide probes gave values that fell outside
the log10 Cy–dye threshold ratios. This gave an average resolution of 40 kb. The posi-
tions of proximal and distal oligonucleotides showing potential imbalances were noted
and the regions queried both in the Database of Genomic Variants (Iafrate et al., 2004)
and the laboratory’s own database. Approval from the NHS (UK) National Research
Ethics Service was obtained prior to the study commencement.
R E S U LT S
Clinical data on all patients are summarized in Table 6.1, and patients 1–18 are illustrated
in Figure 6.1. A detailed description of the oldest patient, aged 30, is provided below and
she is illustrated in Figure 6.2. Four patients have been previously described in the med-
ical literature: Patient 13 (Deshpande et al., 2006), Patient 14 (Adam et al., 2005), Patient
15 (Dernedde et al., 1998), and Patient 17 (Williams et al., 1997).
Mean maternal age at birth was 29.3 years, and mean paternal age at birth was 33.2
years. The mean parental ages for normal populations vary year by year and by country.
Although comparison of the parental age for each patient with published data on mean
paternal and maternal age for the corresponding year of birth is difﬁcult due to the vary-
ing countries of origin, it is unlikely that these data are signiﬁcantly deviated from the
mean, suggesting no parental age effect in the cohort. Mean birth weight for term deliv-
eries was 2,936 g for males and 3,229 g for females. Mean and median times to concep-
tion were 5 and 1 month, respectively.
Respiratory problems were present in 14 patients. The majority presented at birth
or shortly after with upper airway obstruction or apneas. Laryngomalacia was not
uncommon (four subjects), but in most patients the obstruction appeared secondary to
the combined changes to craniofacial anatomy, where retrognathia, an underdeveloped
midface, narrow choanae, and anteriorly placed larynx reduced airway patency. Treat-
ment was by tracheostomy in ﬁve subjects, nasopharyngeal airway in six subjects and
positive pressure ventilation in one patient. In two individuals, surgery was performed
to relieve the obstruction. Obstructive sleep apnea was common in older children and
adults (nine subjects) including those who did not experience respiratory problems in
infancy (two patients).
Spastic quadraparesis presented in the ﬁrst year of life in two patients, secondary
to dysplasia of the upper cervical vertebrae. Both patients recovered fully following
cervicomedullary decompression. 
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 Figure 6.2  Changing phenotype over time in patient 19 from 3 weeks to 30 years  
 
Figure 6.1  Facial pictures of the presented patients with Marshall–Smith syndrome  
 
 
Age at imaging is shown in the figure (w, weeks; m, months; y, years). 
 
Patients are identified by their number in the figure. Age at imaging is as follows:  
Patient 1, 2 weeks; Patient 2, 6 months; Patient 3, 3 months; Patient 4, 2 years;  
Patient 5, 20 months; Patient 6, 4 years; Patient 7, 6 years; Patient 8, 5 years;  
Patient 9, 5 years; Patient 10, 6 years; Patient 11, 8 years; Patient 12, 7 years;  
Patient 13, 6 years; Patient 14, 12 years; Patient 15, 13 years; Patient 16, 13 years;  
Patient 17, 16 years; Patient 18, 20 years.  





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Patient 14 had asymptomatic narrowing of the cervical spine noted on imaging per-
formed as surveillance. Corneal scarring occurred peri–operatively in three patients
secondary to proptosis and incomplete eye closure. All subjects had moderate to
severe mental retardation with limited or absent speech. Parents frequently reported a
strong attachment to a favorite toy which remained for years. More detailed evaluation
of the neurocognitive proﬁle will be presented elsewhere (van Balkom et al., 2011).
Clinical report
This 30–year–old woman was diagnosed with MSS at age 2 months. There were no ante-
natal concerns and she breathed spontaneously at birth with no airway support required.
She had feeding difﬁculties in the neonatal period with a weak suck, taking over an hour
to complete a feed. She developed upper respiratory tract obstruction as an infant and
eventually required an emergency tracheostomy at 13 months. Her feeding problems and
neurocognitive development improved substantially afterwards. The tracheostomy
remained in place until 4 years and there have been no further respiratory problems
since. Menarche occurred at 14 years and was normal. She had a single seizure at the age
of 6. She had very narrow ear canals and had a canaloplasty aged 8 years. Facial hirsutism
became marked aged 16, and has been successfully treated with laser removal. She
walked unaided from 9 years on but in the last years her mobility reduced and she devel-
oped severe osteoarthritis. She was continent from the age of 3. Her ﬁrst words were at
10 years, but she had only 3 or 4 words in total. She communicated well through point-
ing and leading the way. She was a happy and sociable lady who enjoyed music, visiting
family and shops. Linear growth was normal in childhood, but she stopped growing at
around 13 years. She lost height due to scoliosis and current adult height is 127 cm. Bone
age at 2 months was approximately 4 years, and at 8 chronological years was 10 years.
She always had typical facial features (Figure 6.2). Her eyebrows and eyelashes were
particularly thickened and coarse. She had a wide mouth, protruding tongue, irregular
teeth, and everted, prominent lips, and depressed nasal bridge. She had a soft, supple
skin with hypertrichosis on areas that have not received depilatory treatment. She had a
scoliosis of 60 degrees, marked thoracic kyphosis, and a cautious gait with externally
rotated hips. Her muscle tone was high and she had strong power. She appeared shy
with gaze avoidance, but smiled, laughed and enjoyed company.
Array–CGH results
Genomic DNA samples from Patients 1, 3, 5, 6, 7, 8, 10, 13, 14, 15, 17, and 18 were available
for aCGH testing. For patients 3, 5, 6, 7, 10, 13, 14, 15, and 17 only genome
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imbalances/CNVs that have been noted in the Database of Genomic Variants (DGV)
(http:// projects.tcag.ca/variation/), or observed many times in our own sample sets,
were identiﬁed. In patients 1, 8, and 18, several putative genomic imbalances were iden-
tiﬁed, but follow–up studies using a combination of FISH, MLPA, and study of parental
samples, suggested none of the changes were likely to be of clinical signiﬁcance.
D I S C U S S I O N
We found 43 patients with MSS or a very similar phenotype described in the literature
(Marshall et al., 1971; Nabrady & Bozalyi, 1973; Tipton et al., 1973; Visveshwara et al., 1974;
De Toni et al., 1976; Hassan et al., 1976; Perrin et al., 1976; Iafusco et al., 1977; Ferran et al.,
1978; Flatz & Natzschka, 1978; LaPenna & Folger, 1982; Johnson et al., 1983; Menguy et al.,
1986; Roodhooft et al., 1988; Yoder et al., 1988; Smyth et al., 1989; Charon et al., 1990; Eich
et al., 1991; Pappas & Rekate, 1991; Sperli et al., 1993; Sharma et al., 1994; Endo et al., 1995;
Cullen et al., 1997; Williams et al., 1997; Antila et al., 1998; Chatel et al., 1998; Dernedde et
al., 1998; Seidahmed et al., 1999; Summers et al., 1999; Moon et al., 2002; Sumiya et al.,
2002; Wang, 2002; Diab et al., 2003; Watanabe et al., 2003; Butler, 2004; Adam et al., 2005;
Deshpande et al., 2006; Travan et al., 2008). A summary of the major manifestations of
39 published cases (excluding the 4 that have been updated here) is shown in Table 6.2.
We have excluded ﬁve possible cases due to difﬁculty interpreting language or insufﬁ-
cient information to conﬁrm the diagnosis (de la Torre Cecilia et al., 1989; Moon et al.,
2002; Watanabe et al., 2003; Kubota et al., 2005; Mandim et al., 2007). Some additional
cases cited in the literature are likely to have alternative diagnoses such as Marshall–
Stickler syndrome (Cooley et al., 2004) and Weaver syndrome (Jalaguier et al., 1983).
The major manifestations of MSS from patients described in the literature and the
present studied cohort are summarized in Table 6.3. Features described in most patients
are the moderate to severe developmental delay, severe respiratory difﬁculties, distinc-
tive facial features (high forehead; proptosis; anterverted nares; retrognathia), abnormal
bone ossiﬁcation, and failure to thrive. We consider these ﬁndings, in particular the
abnormal radiographs, required to make the diagnosis. Other highly prevalent features
are blue sclerae, hypertrichosis, gingival hypertrophy, and the development of
kyphoscoliosis in later childhood and adolescence. The six oldest individuals in the
cohort (aged over 13 years) and one 8–year–old had short stature (SDS < 2.0) `
suggesting this is also a consistent feature of the adult phenotype, compounded by
kyphoscoliosis.
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The typical facial phenotype consists of a high and prominent forehead, shallow orbits,
ﬂat midface, prominent premaxilla, and small and retracted mandible. The nose is fre-
quently short, with upturned tip and anteverted nares, the philtrum may be long in
infancy but in time may become short and everted. In older children the lips are fre-
quently full and everted making the gingival hypertrophy and markedly irregularly
placed teeth well visible in most patients. Two of the adult patients had a protruding
tongue, but it is uncertain whether this is a frequent feature of the adult phenotype. The
ears may be low set and minor anomalies of morphology are common. Facial hair is nor-
mal, including secondary hair in males.
Ophthalmology
The eyes are large and the orbits shallow, which both contribute to the proptosis. High
myopia is present but glasses are frequently not tolerated which impairs visual develop-
ment. Glaucoma, when present, is due to congenital anomalies of morphology of the
anterior chamber or trabecular meshwork and affects about 30% of patients. Optic
nerve hypoplasia has been found in some with glaucoma, but also in absence of glauco-
ma suggesting it to be a primary phenomenon. Several patients experienced corneal
ulceration peri–operatively due to incomplete eye closure, and this should be highlight-
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Table 6.3  Most common manifestations of Marshall–Smith syndrome
Manifestation Literature (n = 39) Present study (n = 19) Total 
Dysharmonic bone maturation 100% 100% 100% 
Psychomotor delay 100% 100% 100% 
Typical facial appearance a 100% 100% 100% 
Failure to thrive 96% 100% 97% 
Respiratory problems 89% 74% 84% 
Blue sclerae 86% 79% 83% 
Hypertrichosis 82% 83% 83% 
Kyphoscoliosis 39% 53% 46% 
Gum hypertrophy — 41% 41% 
Umbilical hernia 53% 12% 31% 
Cardiac defect 22% 12% 17%
a High forehead, proptosis, underdeveloped midface, anteverted nares, and retrognathia
ed as a preventable complication. Patients should have regular ophthalmologic evalua-
tion due to the range of pathologies, the difﬁculty of patients to self–report symptoms,
and the importance of early intervention to reduce secondary phenomena.
Respiratory complications
The frequent and signiﬁcant respiratory difﬁculties in MSS result from a combination of
pathologies, mainly upper airway obstruction (retrognathia; choanal stenosis; abnormal
larynx), and aspiration pneumonia (secondary to underdeveloped epiglottis and pha-
ryngeal incoordination). Retrognathia is a frequent sign in MSS and contributes to both
upper airway obstruction and poor visualization of the anatomy on laryngoscopy.
Choanal stenosis occurred in six of our cohort and in four additional cases from litera-
ture (Tipton et al., 1973; Visveshwara et al., 1974; Flatz & Natzschka, 1978; Summers et al.,
1999) suggesting an incidence of 5–10%. It presents later than classical choanal atresia,
and other cases have been reported with partial stenosis making passage of feeding
tubes difﬁcult (Perrin et al., 1976; Menguy et al., 1986) suggesting that the stenosis fea-
tures a spectrum of expression and is possibly caused by midface underdevelopment.
Analysis of the laryngeal features in MSS is hampered by the variety of terms used to
describe similar ﬁndings such as laryngomalacia, laryngeal stenosis, glottic stenosis,
anteriorly placed larynx, and rudimentary epiglottis. In some patients, the larynx is
described as anatomically normal, but with a functional obstruction. Irrespective of the
cause the upper airway obstruction leads to an increase in negative thoracic inspiratory
pressure, increasing the risks of aspiration and increasing pulmonary venous return con-
tributing to increased pulmonary vascular pressure. Pulmonary hypertension with evi-
dence of right ventricular hypertrophy has been reported in four cases in the literature
and one of our series, and has a poor prognosis (LaPenna & Folger, 1982; Johnson et al.,
1983; Yoder et al., 1988; Adam et al., 2005).
Airway support is required in the majority of cases either via tracheostomy or a tube
keeping the nasopharyngeal airway open. This is most commonly required in the ﬁrst
week of life and may be required for several years, or even lifelong. Several patients have
had reconstructive surgery incorporating mandibular distraction to improve airway
competence, with varying degrees of success. Once no longer dependent on such airway
support, many patients have continued to experience airway incompetence, usually pre-
senting as obstructive sleep apnea. This may require airway support into adulthood,
either with positive pressure ventilation or nasopharyngeal airway at night. General
anesthesia appears safe in experienced hands with several techniques adopted to aid
intubation, including ketamine induction, use of a laryngeal mask, and use of a nasopha-
ryngeal airway (Antila et al., 1998; Dernedde et al., 1998; Machotta & Hoeve, 2008).
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Hearing
Minor anomalies of external ear morphology and narrow ear canals are common. Many
patients have sensorineural or mixed conductive hearing loss in the moderate range.
Inner ear malformations have not been noted.
Bone and connective tissue
The bone age is invariably reported as advanced at birth and in childhood. Full skeletal
surveys however, do not show an advanced bone age elsewhere and only mild abnormal
bone maturation in the long tubular bones (wide epiphyses). In the hand, the carpus
appears more advanced in age than the phalanges. Therefore it seems more justiﬁed to
state bone maturation in MSS is abnormal instead of advanced. We consider it as being
a dysostosis. Typically the proximal and middle phalanges are wide, bullet shaped or rec-
tangular and terminal phalanges short and narrow (Figure 6.3).
MSS has been considered as an example of an overgrowth syndrome. However,
stature is typically normal in infancy and early childhood, and in the second decade
height progressively diverges from normal so that ﬁnal height is >6 standard deviations
below the mean. This is compounded to some degree by (kypho)scoliosis. There does
not appear to be a growth spurt associated with puberty (the timing of which is normal).
Thoracic kyphoscoliosis becomes evident in childhood and appears universal by adult-
hood. No structural abnormalities of the vertebral bodies are usually seen. Surgical rod
implants impair already limited growth and mobility, but make lifting and handling easi-
er. Non–traumatic fractures and osteopenia have been reported in some however sev-
eral patients have sustained signiﬁcant trauma without fracture, and osteopenia is not
universal. Blue–gray sclerae are evident in two thirds of cases, and all patients with non–
traumatic fractures had this feature.
Umbilical hernia occurs in around 30% of cases but herniation at other sites are not
widely reported. One patient had recurrent herniation after abdominal surgery sug-
gesting a possible defect in connective tissue healing. Scar formation however appears
to be normal, and although skin texture is frequently described as soft, there is no evi-
dence of a tendency to bruise easily, and no reports of abnormal bleeding. Joint laxity
may be present in the periphery in younger patients, although mild contractures and
high muscle tone may also occur. Pes planus appears universal. Gingival hyperplasia is
frequent and present in 40%. It may require surgery to maintain oral hygiene. Histology
has not been reported so the etiology of this manifestation is unclear.
Abnormalities of the upper cervical spine and skull base have been noted with
appearances of hyperostosis, dysplasia, and sclerosis. Radiological evaluation of the cer-
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vical spine and skull base with ﬂexion/extension views or other imaging modalities is
warranted. Neurological complications are discussed below.
Development and behavior
Patients show a moderate to severe cognitive deﬁcit, with several behavioral character-
istics that were common to many in the cohort. Subjects mostly have a happy demeanor
and especially enjoy social interactions with friends and family (van Balkom et al., 2011).
A fascination for a favorite toy with which they tend to play in a repetitive, stereotypical
manner, appears a common phenomenon. This is often a toy designed to stimulate sev-
eral senses at once, perhaps appealing to children with impaired hearing and vision.
Speech milestones are markedly delayed with many subjects never attaining spoken lan-
guage, presumably in part due to anomalies of laryngeal and facial anatomy. Motor mile-
stones are also severely delayed with several patients remaining non–ambulant.
Neurology
MSS patients have usually truncal hypotonia and peripheral hypertonia with brisk deep
tendon reﬂexes. This phenotype is present from childhood and appears non–progres-
sive. Drooling of saliva is common and may stem in part from oromotor dysfunction, but
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Figure 6.3  X–rays of hands  
(A) newborn (Patient 4) (B) 5 years (Patient 8)  (C) 12 years (Patient 14) 
 
is compounded by facial anatomy promoting an open mouth. Two patients developed
spastic tetraparesis in infancy secondary to cervical spine compression and another
patient had asymptomatic cervical spine stenosis noted on MRI. Neuroradiological
imaging has shown a number of structural anomalies such as absent or underdeveloped
callosal body; ventriculomegaly; pachygyria; polymicrogyria; and septo–optic dysplasia.
Occasional seizures occur but they are not common and no patient is receiving anti–
convulsant therapy. We recommend brain imaging in infants presenting with MSS and
there should be awareness of the risk of cervicomedullary compression.
Other ﬁndings
Two male patients have developed hypertrophic pyloric stenosis, with a classical pres-
entation at around one month of age. The ﬁnding of pyloric stenosis in 2 out of 19 cases
may be coincidence, or may be related to other common ﬁndings in infants with MSS,
such as advanced carpal bone maturation and gingival hypertrophy. One patient of the
present cohort developed unilateral Wilms tumor at the age of 4 years. No other patient
has been reported with any type of malignancy, but most cases were very young when
reported. Further long–term follow–up and cohort studies will be required to establish
whether individuals with MSS have an increased susceptibility to Wilms tumor or other
forms of cancer. No screening is currently warranted. Craniosynostosis occurred in one
patient and is reported in three from the literature. The affected sutures were the
metopic suture in three patients and the posterior segment of the sagittal suture in one.
All patients have a thin build with reduced muscle bulk.
Adult phenotype
The general adult phenotype is characterized by moderate to severe mental retardation,
including little or no speech and limited mobility. Adult height and weight are signiﬁ-
cantly reduced but head circumference is normal. The facial features become more obvi-
ous, especially in the proptosis, short nose with anteverted nares, and thick, everted lips.
The mouth is often held open showing prominent and irregularly placed teeth and thick
gingiva. The tongue may be large and protuberant and drooling is common. Individuals
of both sexes are hirsute, particularly on the limbs and back. Adults are cheerful and
pleasant in nature, although stubbornness and obsessive traits also occur. Medical prob-
lems identiﬁed in adulthood are obstructive sleep apnoea, aspiration pneumonia, pul-
monary hypertension, and early onset osteoarthritis.
116
chap ter  6
Differential diagnosis
Much debate can be traced in medical literature whether Marshall–Smith and Weaver
syndromes are distinct entities, in part because both syndromes were ﬁrst described
around the same time with advanced skeletal maturation as a principal feature. Careful
delineation of the phenotype however, with particular regard to the facial features, radi-
ological ﬁndings and natural history, suggests signiﬁcant differences (Fitch, 1980). Other
syndromes with overlapping phenotypes include Desbuquois chondrodystrophy, Fine–
Lubinsky syndrome, pyknodysostosis, Antley–Bixler syndrome, Ehlers–Danlos type VII,
galactosyltransferase I deﬁciency and Lysyl hydroxylase 3 deﬁciency (Hennekam et al.,
2010). The combination, however, of the distinctive radiological ﬁndings, facial dysmor-
phism, and upper airway pathology, make MSS an easily recognisable and unique entity.
Etiology
All deﬁnite cases of MSS have occurred sporadically with, no familial recurrence or
parental consanguinity. The gender ratio of reported cases is roughly equal, and there is
not an increased prevalence of sub–fertility or miscarriage in the parents of affected
individuals. Although one report in the literature described a brother and sister with fea-
tures suggestive of MSS (Jalaguier et al., 1983), we posit that the clinical features are
more suggestive of Weaver syndrome than MSS. One patient with a phenotype sug-
gestive of MSS was found to have an inverted duplication of chromosome 2q (Sei-
dahmed et al., 1999), but other patients with trisomy for this region did not resemble
MSS, and no other chromosome abnormalities have been reported. In the present
cohort paternal or maternal age at conception was not advanced beyond that of the gen-
eral population.
The analysis of 12 patient samples by array–CGH did not identify any recurrent path-
ogenic CNVs within this sample set. These results indicate that at the resolution tested,
MSS is not a genomic disorder caused by a recurrent pathogenic CNV.
Marshall–Smith syndrome wiki
The term wiki is derived from the Hawaiian phrase for quick, and is used for an online
collaborative resource for compiling information from numerous authors. MSS is an
extremely rare condition with less than 50 cases reported worldwide, and traditional
methods of collating a large series of patients are hampered by geographical distances,
underdeveloped healthcare systems in developing countries, and language differences.
Compiling anonymous phenotype data on a wiki allowed parents and carers to add com-
117
m ar s hall- smith  s y n d rom e  
ments on aspects of the phenotype or natural history based on their own experiences,
thus giving a deeper insight into the natural history of the syndrome and facilitating dia-
logue between clinicians and families that were spread across 11 countries in Europe and
the Americas. This technique also aided recognition of common traits, as sharing expe-
riences allowed families to remember important or signiﬁcant facts that they had for-
gotten to report to their clinician. Responses from all families were compiled and used
as a basis for re–writing of the ﬁnal draft of this manuscript. Using the wiki facilitated the
development of a much more complete and consistent data–set than would have been
possible using retrospective case–note review. It may therefore be a useful adjunct if
evaluation of all subjects by a single observer is impractical due to the geographical
spread of the patients. Wikis are starting to be used in many areas of science, as a way of
more efﬁciently utilizing collective expertise and sharing information that would other-
wise remain hidden in personal ﬁles or memories (Hu et al., 2008). We recommend this
technique for future studies attempting to describe the phenotype and natural history
of (very) rare diseases.
Conclusion
We present a relatively large series of patients with MSS. By including previously report-
ed cases, adults and information obtained from families using a wiki resource, we could
further delineate this distinctive and severe multisystem disorder, have gained insight
into the natural history of the entity and suggested recommendations for management.
Discovery of the molecular cause and evaluation of the long–term physical and medical
consequences will further aid medical management, lead to potential treatments and
reveal important biological mechanisms in human development and function.
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A B S T R AC T
background – Marshall–Smith syndrome (MSS) is an infrequently described entity
characterized by failure to thrive, developmental delay, abnormal bone maturation and
a characteristic face. In studying the physical features of a group of patients, we noticed
unusual behavioral traits. This urged us to study cognition, behavioral phenotype and
autism in six patients.
methods – Information on development, behavioral characteristics, autism symptoms,
and adaptive and psychological functioning of six MSS children was collected through
in–person examinations, questionnaires, semi–structured interviews of parents and
neuropsychological assessments.
results – Participants showed moderate to severe delays in mental age, motor devel-
opment and adaptive functioning, with several similarities in communication, social
interactions and behavior. There was severe delay of speech and motor milestones, a
friendly or happy demeanor and enjoyment of social interactions with familiar others.
They exhibited minimal maladaptive behaviors. Deﬁcits in communication and social
interactions, lack of reciprocal social communication skills, limited imaginary play and
the occurrence of stereotyped, repetitive behaviors were noted during assessments.
conclusions – Systematic collection of developmental and behavioral data in very rare
entities such as MSS allows recognition of speciﬁc patterns in these qualities. Clinical
recognition of physical, developmental and behavioral features is important not only for
diagnosis, prognosis and counseling of families, but also increases our understanding of
the biological basis of the human physical and behavioral phenotype.
keywords: autism, behavioral phenotype, cognition, intellectual disability, Marshall–
Smith syndrome
I N T RO D U C T I O N
In studying genetic syndromes, clinicians and researchers have described difﬁculties in
examining psychological and behavioral features of the syndromes, and how they might
be causally related to underlying genetic conditions (Skuse, 2000; Cassidy & Morris,
2002). Studying syndromes that commonly occur with severe intellectual disability (ID)
is further complicated by the lack of adequate instruments to directly measure individ-
ual cognitive levels. Although correlations between biological and behavioral variables
do not necessarily imply causation, and methodological differences across studies have
often limited our ability to draw conclusions, many researchers have recognized the
importance of cross–disciplinary collaboration in studying samples of patients with
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genetic defects in an effort to improve our understanding of normal and abnormal
behaviors (Finegan, 1998). Careful clinical assessment and description are therefore cru-
cial steps in eventually determining clinical relevance.
Marshall–Smith syndrome (MSS) is an infrequently described malformation syn-
drome ﬁrst reported by Marshall et al. (1971) and characterized by ID, abnormal bone
maturation, failure to thrive, severe respiratory problems and unusual facial features. To
date, some 45 cases with this syndrome have been reported internationally in various
languages, usually as single case reports or small groups (Marshall et al., 1971; Nabrady &
Bozalyi, 1973; Tipton et al., 1973; Visveshwara et al., 1974; DeToni et al., 1976; Hassan et al.,
1976; Perrin et al., 1976; Iafusco et al., 1977; Ferran et al., 1978; Flatz & Natzschka, 1978;
LaPenna & Folger Jr, 1982; Johnson et al., 1983; Menguy et al., 1986; Roodhooft et al., 1988;
Yoder et al., 1988; Smyth et al., 1989; Charon et al., 1990; Eich et al., 1991; Pappas & Rekate,
1991; Sperli et al., 1993; Sharma et al., 1994; Endo et al., 1995; Cullen et al., 1997; Williams
et al., 1997; Antila et al., 1998; Chatel et al., 1998; Dernedde et al., 1998; Seidahmed et al.,
1999; Summers et al., 1999; Moon et al., 2002; Sumiya et al., 2002; Wang, 2002; Diab et
al., 2003; Watanabe et al., 2003; Butler, 2004; Adam et al., 2005; Deshpande et al., 2006;
Travan et al., 2008; Shaw et al., 2010).
A recent genetic study reported on mutations in transcription factor nuclear factor I
(NFIX) resulting in MSS (Malan et al., 2010). At present, the speciﬁc function of NFIX
remains unclear, but NFIX must have an important role in human brain development and
skeletogenesis.
Recently, we reviewed the physical features of a group of 19 patients and compared
these to all earlier reported cases (Shaw et al., 2010). In addition to medical assessment and
clinical examination, personal history and additional information on the patients have
been assimilated using an online Wiki. Through this resource, parents and carers had
secure access to a lay translation consisting of the general description of the syndrome and
medical complications, and could add comments on aspects of the phenotype or natural
history, based on their own experiences (Shaw et al., 2010). During the study, we noticed
unusual behavioral traits in several patients not reported before. Some behavioral features
showed resemblance to autism. Earlier reports on children with MSS had described delays
in psychomotor development (Sumiya et al., 2002; Butler, 2004; Adam et al., 2005), and
absence of speech/language development (Sperli et al., 1993), but no other behavioral
characteristics. This urged for a more detailed cognitive and behavioral assessment.
Here, we report an exploratory investigation of behavioral and psychological proﬁles
in six children with MSS. Our general aim was to describe their behavior patterns, 
development and cognitive abilities, using in–person clinical assessments and a dedicated
test battery. A speciﬁc aim was to investigate if an autism symptom proﬁle could be part
of the syndrome.
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M AT E R I A L S  A N D  M E T H O D S
Exploratory study
In accordance with the clinical impression during the study of the natural history in MSS
mentioned before (Shaw et al., 2010), we wanted to conduct an exploratory study. In this
exploratory study, we focused on autism symptomatology and distinctive behavioral fea-
tures in MSS children at different ages and developmental stages, while at the same time
systematically assessing and describing the behavior and development of the children.
Participants
The total study group of MSS patients participating in the natural history study consist-
ed of 19 children from 11 countries (Belgium, Brazil, Croatia, France, Germany, India,
Mexico, the Netherlands, Norway, UK and USA). Of these, six MSS patients could be
assessed: a personal assessment of the other children was impossible, due to a language
barrier between children, families and the examiners, death of children, or because of
the distance to their country of residence.
The six participating MSS children, three girls and three boys, were born between 1994
and 2006. Three resided in the Netherlands, two in the UK and one in France.
All parents gave written informed consent, and the Medical Review Ethics Committee
gave permission to perform the study.
A summary of the major physical characteristics of the six patients compared to those
of all known patients with MSS is provided in Table 7.1. A more detailed description of
physical manifestations can be found elsewhere (Shaw et al., 2010).
Test instruments
All children in the study were clinically examined by the same child psychiatrist (IvB) and
neuropsychologist (PJV). The child psychiatrist was trained in the Netherlands, where
she did residencies in pediatrics, genetics, psychiatry and child psychiatry. She has more
than 15 years of clinical experience and has expertise in developmental and genetic syn-
dromes. She is certiﬁed in the use of standardized assessment instruments for research
diagnosis of autism spectrum disorders (van Balkom et al., 1998, 2002, 2009).
One subject (patient 6) could not be fully assessed with the complete test battery
due to language problems and geographical distance. Only instruments valid and reli-
able in studying individuals with limited verbal abilities were chosen to assess cognitive
functioning. In–person interviews with parents were used to assess past and current
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development, and functioning on three major domains: communication (adaptive)
behavior, and social–emotional development. Through standardized questionnaires,
additional information was gathered about other symptoms and psychological func-
tions, such as aggression, attention and mood.
Assessment of intellectual capabilities
Mental and motor functioning was assessed using the Dutch version of the Bayley Scales
of Infant Development, 2nd Edition (BSID–II; Van der Meulen et al., 2002). The mental
scale consists of items assessing level of visual and auditive information processing,
hand–eye coordination, imitation, language development, memory and problem solv-
ing skills. The motor scale assesses level of ﬁne and gross motor development. The
BSID–II is considered a reliable and valid instrument (Provost et al., 2000, 2004). The raw
scores on the motor and mental scale were converted into age equivalents to determine
level of motor and mental functioning. The BSID–II was administered according to the
manual of the test.
Child psychiatric examination and Autism Diagnostic Interview
An experienced child psychiatrist (IvB) performed psychiatric examinations of each of
the children and also interviewed one or both parents of each child with the Autism
Diagnostic Interview – Revised (ADI–R) (Lord et al., 1994). The ADI–R is considered a
reliable and valid instrument (Rutter et al., 2003; Cicchetti et al., 2008; Le Couteur et al.,
2008). It is a semi–structured diagnostic interview designed to collect developmental
information, a history focused on autism–speciﬁc criteria, and information on actual
behavior as it has occurred in the child’s daily life, as a basis for a lifetime diagnosis of
pervasive developmental disorder. The ADI–R yields individual item scores (normal,
possible abnormality, deﬁnite abnormality) and domain scores in the areas of social skills
and play, communication and behavioral abnormalities. While there were concerns
about how level of ID might affect interpretation of the results, we still considered the
ADI–R an appropriate standardized instrument to collect data on development given
the lack of available measurements for individuals with severe ID (Howlin, 2000; De Bildt
et al., 2004; Bruining et al., 2010).
Adaptive functioning
To assess the degree of personal and social self–sufﬁciency, the Vineland Adaptive
Behavior Scales – Survey Form (VABS) was used (Sparrow et al., 1984). The VABS sup-
127
m ar s hall- sm ith  s y n d rome :  co g n iti o n ,  ph en ot y pe  an d  auti sm
plies measures of the level of adaptive functioning on three domains: communication,
daily living skills and socialization. These measures provide an overall adaptive compos-
ite score, allowing for a classiﬁcation in adaptive level (in ﬁve levels, high to low), and sep-
arate composite scores on the three domains. The psychometric properties of the VABS
are considered to be good (Sparrow et al., 1984). The interview was conducted by two
experienced clinicians (PJV, MF).
Behavioral characteristics
Problem behaviors and competencies of the children were assessed using the Child
Behavior Checklist (CBCL; Achenbach, 1991a,b). Kostentausta et al. have found that the
CBCL may be less reliable for those with moderate to severe ID, possibly because many
of its items may not reﬂect problem behaviors in children with ID, and may fail to reveal
all psychiatric issues (Kostentausta et al., 2004). De Ruiter et al. have studied the devel-
opmental course of psychopathology in children with and without ID using the CBCL.
They found that, while children with ID (ranging from mild to moderate levels of ID)
showed increased risk for problem behaviors across all ages when compared to typical-
ly developing children, developmental trajectories in both groups were quite similar (De
Ruiter et al., 2007). The CBCL has previously proven its usefulness in studying popula-
tions of children with severe ID, for example, Rubinstein–Taybi syndrome (Hennekam et
al., 1992), Williams syndrome (Graham et al., 2005) and Costello syndrome (Axelrad et
al., 2004).
The CBCL is completed by the parents or primary caregivers and gives insight into
problem behaviors. The questionnaire is informative on eight speciﬁc domains and
problem behaviors: aggressive behavior, mood, attention, delinquent rule–breaking
behavior, social problems, somatic complaints, thought problems and withdrawal. Total
scores for internalizing problem behavior (withdrawal, somatic complaints and anx-
ious/depressed) and externalizing problem behavior (delinquent rule–breaking behav-
ior, and aggressive behavior) are obtained as well as a total problem score by summing
all eight speciﬁc problem behaviors.
R E S U LT S
We present ﬁrst a narrative description of individual clinical assessments and behavioral
observations. Subsequently, we present measures of cognition, development, adaptive
functioning and behavior. Because patient 6 could not be assessed with the complete
test battery, his ﬁndings are included only for those items that could be studied (child
psychiatric exam; ADI–R).
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Individual child psychiatric assessments, clinical observations of interaction and
behavior
Patient 1
Patient 1 was of middle school age and had a lively, friendly demeanor. She had little
initial reserve at ﬁrst contact, showed no anxiety and immediately tried to actively and
spontaneously engage the examiner in play, by running back and forth and talking inces-
santly or by pulling hands. There was sufﬁcient eye–to–eye gaze during examination;
and although reciprocity was limited, she visibly enjoyed the interaction and play with
the other. She was able to engage in conversation, but back–and–forth interchange was
limited. For 5 to 10 min, the child’s capacity to attend to different tasks (such as toys or
objects) was observed, to conclude whether her attention span was deemed short/suf-
ﬁcient. These observations showed that she had difﬁculty completing tasks. Probably
because she did not understand some of them but also because her attention span was
short and she was easily distracted by sounds, movements and her own wishes. She
clapped her hands when she was complimented on her efforts in trying to stay on task
and during the examination she repeated this action in a ritualized manner. She made
her wishes for play clearly and insistently known; she demanded participation while
directing the actions of the other, laughing the whole time. There was little joint inter-
active or collaborative play. She walked independently at age 4, her gait broad based.
Her mood appeared happy; she often smiled without clear cause.
Patient 2
At second examination, patient 2 was of primary school age. She made a friendly,
active impression. She was diagnosed with a signiﬁcant refractive error, but only recent-
ly started training to wear glasses at school. There was some eye–to–eye gaze of brief
duration and there was little integration of gaze, facial expression, vocalization and ges-
ture. When younger she seemed interested in her surroundings, and explored her envi-
ronment primarily through turning, biting, chewing or licking objects. She had a ten-
dency of staring into lamps. Her mother mentioned that she was sensitive to noises at a
young age, she startled easily and would panic and cry loudly, but this behavior had
improved. She would usually cover her ears when her mother vacuumed. Her produc-
tion of spontaneous language and her comprehension of verbal communication are lim-
ited. She had less than 10 words but was able to vocalize sounds in differing intonations.
For 5 to 10 min, the child’s capacity to attend to different tasks (such as toys or objects)
was observed, to conclude whether her attention span was deemed short/sufﬁcient.
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These observations showed that her attention span was short; she was easily distracted
by sounds or movements. She enjoyed playing with building blocks, and she was able to
slowly stack these or hand them to her mother. Some motor milestones had not been
reached, she was not able to walk independently, but would stand and walk holding her
parent’s hand. Recently, she had started imitating her parents by drinking independent-
ly from a mug, although she would do so messily with one hand. Her mood was usually
happy; she smiled and laughed often although the cause of it was not always clear. She
sometimes smiled while looking at people, but her smiles were generally not reciprocal.
Her mother mentioned that she would have difﬁculty falling asleep, and would cry loud-
ly to be allowed out of bed.
Patient 3
Patient 3 was an alert toddler who had a friendly demeanor. He had marked vision prob-
lems and a history of recurrent ear infections. He smiled often without obvious cause
and without making eye contact with the examiner. There was little visible reaction to
his own name, nor did he respond to the examiner’s facial expression, orientation or
smiles. His eye–to–eye gaze was limited, and there was little reciprocity or spontaneous
initiation of contacting or engaging the other. His parents mentioned that he would put
up his arms to be lifted or pull their hand to get attention; he had little response to the
examiner’s attempts to draw his attention to distant objects. His mother mentioned that
he enjoyed playing ‘calling on the phone’, making prattling sounds but no words. He star-
tled easily at unexpected sounds or movements; and he would become quite upset and
start crying by more pronounced sounds as, for example, organ music in church. For 5
to 10 min, the child’s capacity to attend to different tasks (such as toys or objects) was
observed, to conclude whether his attention span was deemed short/sufﬁcient. These
observations showed that his attention span was sufﬁcient, although he showed little
interest in his surroundings beyond what was right in front of him. He had played with
one favorite musical toy for the past year and a half, enjoying its crinkly sounds. He
would sometimes reach with open hand for a favorite toy, but did not point to it to indi-
cate a desire to play with it. He could spontaneously initiate a game of peek–a–boo by
pulling a cloth over his face and waiting for his father to pull it away. Walking independ-
ently had not been achieved yet, but he started crawling at 2.5 years and could pull to
standing at 3.5 years. His mood was happy; he would laugh when physical games such as
lifting, jumping up–and–down and tickling were initiated by his parents.
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Patient 4
Patient 4 was of primary school age and seemed shy and hesitant at ﬁrst contact; she had
a friendly facial expression. At ﬁrst, eye–to–eye gaze was of brief duration, but this
improved during the examination, and there was some integration of gaze, vocalization
and gesture. It was, however, difﬁcult for the examiner to draw her attention to a distant
object through eye contact and facial orientation. She made a speciﬁc vocalization,
which according to her mother she would always use to indicate the dog. She had no
clear words, but would vocalize some sounds in differing intonations. For 5 to 10 min, the
child’s capacity to attend to different tasks (such as toys or objects) was observed, to
conclude whether her attention span was deemed short/ sufﬁcient. These observations
showed that her attention span was short; she was easily distracted by sounds or move-
ments. During the examination she was restless, active and kept moving around the
room. Her mother mentioned that she was usually ‘on–the–go’. She had difﬁculty stay-
ing on task, even when the task was very structured (such as drawing a shape) and she
tended to ﬂit from one thing to the next. She enjoyed playing with her doll, would take
it out of a toy buggy and hug it. She would recognize and point to herself in family pic-
tures when invited to do so. When looking at a photo album she was not easily distract-
ed by ringing toys, but persisted in turning the pages to continue looking at pictures. Her
mother would ﬁnd her quite active at home, often imitating play activities initiated by
her younger sister. Although she enjoyed imitating play activities she had difﬁculties ini-
tiating and organising new games herself. She was able to walk independently, her gait
was broad based and her gross motor skills were clumsy. Fine motor skills were imma-
ture. She walked around the room, pointed out the dog and walked closer to hug him.
Her mood was usually happy; she would smile frequently and sometimes put her hand
in front of her mouth to indicate surprise.
Patient 5
Patient 5 was of middle school age and had a passive and withdrawn demeanor at ﬁrst
contact; he drooled a bit. He wore a brace and was wheelchair–bound, but able to oper-
ate his wheelchair. He was diagnosed with many health problems, which included glau-
coma and severe scoliosis. He kept his head down a great deal, and although there was
some eye–to–eye gaze, there was little integration of gaze, facial expression and gesture.
He had little reciprocal response to the examiner’s facial expressions or smiles, and
there was no attempt to spontaneously engage in social interaction with the examiner
through eye gaze. He vocalized sounds, but had no words. For 5 to 10 min, the child’s
capacity to attend to different tasks (such as toys or objects) was observed. These obser-
131
m ar s hall- sm ith  s y n d rome :  co g n iti o n ,  ph en ot y pe  an d  auti sm
vations showed that his attention span was sufﬁcient. He did react to being touched by
turning his head towards the person, he would smile and laugh when he was tickled, and
clearly enjoyed physical interaction and play, inviting the other to continue by re–
extending his hands or arms after tickling. He would also extend his hand to grab and
would gesture purposively when drumming on a favorite toy drum. He drummed on the
plastic side of the toy and not on the drum itself. His mother mentioned that he only
wanted this particular toy drum of a certain style and color, and that he would accept no
other replacements. Although his motor skills were limited by his physical disabilities,
patient 5 had recently swum small distances in a pool independently from his helper, had
walked a small distance in the pool and had shown increasing conﬁdence in the water.
He would turn from a sitting position on the sofa and get down from it when verbally
requested to do so. His mood was usually happy and stable, but sometimes he would
show frustration, for example, when waiting for his food, by throwing things on the ﬂoor
to get the attention of his helpers.
Patient 6
Patient 6 was a lively, active, primary school age boy at ﬁrst contact; he was comfortable
in the presence of his mother. He wore spectacles and had hearing aids in both ears. Ini-
tially, he averted his gaze, but during the continued examination there was intermittent
eye–to–eye gaze. There was limited response to the examiner’s facial expressions or
smiles and little reciprocity in social interaction with the examiner, but he frequently
spontaneously engaged with his mother trying to get her attention to help him with
tasks and play. His spontaneous language and communication were limited, and
although he vocalized sounds there were few discernible words. Some of these were
understood by his mother, but not by many others. For 5 to 10 min, the child’s capacity
to attend to different tasks (such as toys or objects) was observed, to conclude whether
his attention span was deemed short/sufﬁcient. These observations showed that his
attention span was short: he was ﬁdgety and had difﬁculty staying on task, tending to ﬂit
from one object or activity to the other. When he was interested in the task or the
object, his perseverance improved. When interested in play he would draw his mother’s
attention primarily through sounds and by pulling her hand towards the object; his
mother mentioned that he could be very insistent when trying to have his way. Gross
motor skills were sufﬁcient; ﬁne motor skills were immature. His mother mentioned that
he was able to ride a bicycle, but was prone to fall and he would see no dangers. During
examination his mood was happy; he enjoyed trying to color a drawing. He got up just
as happily when the examination was ﬁnished and rushed to exit the room before his
mother. Often his behavior at home would be challenging, he would tend to be insistent
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and quite irritable when things would not go as he expected. When irritable he could
scream loudly; in general he demanded a lot of attention, and his mother mentioned
that it would take a lot of effort to distract and calm him. At night, he used an oxygen
mask; he would often be anxious and have difﬁculty falling asleep.
Cognitive assessment and cognitive function
Bayley Scales of Infant Development
Scores on mental age and motor development can be seen in Figure 7.1. In view of their
ID combined with the fact that chronological age of most participating children was
above that for norms of the BSID–II, we present results in Figure 7.1 as age equivalents
and omit standard scores. The graph indicates that generally a progression in mental age
and motor development can be expected with increasing age, but in a single patient
(patient 5) cognitive and motor development remains severely delayed.
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Figure 7.1  Developmental level of mental and motor functioning, measured by the Bayley Scales of 
Infant Development (BSID), compared to chronological age  
Development and autism symptomatology
Autism Diagnostic Interview – Revised
On the three domains of the ADI–R (social skills and play, communication and behav-
ioral abnormalities) all children scored above the cut–off, with the exception of patient
6, who did not score above cut–off on behavioral abnormalities (Table 7.2).
Adaptive functioning
Vineland Adaptive Behavior Scales
Patients 1 and 2 were assessed with the VABS twice during the study, with an interval of 2
years, which allowed for a limited follow–up perspective on their adaptive functioning
and development (Figure 7.2). For the other subjects, no earlier assessments were avail-
able, due either to their young age or to practical considerations, especially a geographi-
cal barrier. For these subjects, ﬁrst measurements are also shown in Figure 7.2. The fol-
lowing observations with respect to development, strengths and weaknesses can be
made on adaptive functioning based on results of the VABS. First, we see gradual
improvements on all adaptive scales of the Vineland over time, when comparing the chil-
dren with each other (with the exception of patient 5) as well as within themselves
(patient 1 and 2). Patient 2 showed progress in all domains at second measurement,
although one more gradually than the other, with scores overlapping. This seems to indi-
cate that, although children with MSS are considerably delayed on adaptive functioning,
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Table 7.2  Item scores on the three domains of the Autism Diagnostic Interview – Revised 
  Patient # 
Test domain Cut–off 1 2 3 4 5 6 
        
Social skills and play 10 14 21 16 16 11 14 
Communication (verbal & non–verbal) 8 13 NS NS NS NS 14 
Communication (non–verbal only) 7 NS 10 7 12 8 NS 
Behavioral abnormalities 3 3 4 3 4 6 2 
        
NS = no score        
 
they do have learning potential and seem to follow their own slow developmental trajec-
tory. Second, the domain of socialization appears to be somewhat better developed, with
parents reporting, for example, that their children do show affection to familiar persons,
anticipate when they are about to be picked up by their parents or caregivers and imitate
simple proceedings of adults. Third, the domain of communication seems to be a weaker
domain. Children with MSS score positive on questions like ‘understands the meaning of
at least 10 words’ or ‘listening attentively to instructions’, but they fail on questions that
imply mastering (the beginning of) expressive language like ‘has a vocabulary of at least
50 words’ or ‘uses sentences of at least 4 words’. Fourth, in most children, daily living skills
are the weakest domain. This domain contains questions regarding skills such as ‘can drink
without any help from a cup’ or ‘alerts the parent that he/she has to go to the toilet’.
Again, results for patient 5 are an exception, as is also visible in Figure 7.1 of the BSID
scales. Patient 5’s somatic condition could partly explain his scores.
Behavioral issues
Child Behavior Checklist
The subjects show hardly any externalizing problem behavior with the exception of
patient 2 (Figure 7.3), whose externalizing problems are the result of scores in the clinical
range on attention problems and scores in the borderline range on aggressive behavior.
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Figure 7.2  Developmental level on the three domains and total adaptive behavior score of the 
Vineland, compared to chronological age 
Three patients scored above the borderline or clinical range on internalizing problems:
one patient (patient 5) did so because of a high score on somatic complaints (see case
description); a second subject (patient 3) scored in the clinical range due to borderline
scores on emotionally reactive behavior and withdrawn behavior; and the third subject
(patient 2) scored in the clinical range on emotionally reactive behavior.
D I S C U S S I O N
A structured clinical and interdisciplinary approach towards syndrome characterization
and delineation includes the integration of information regarding developmental issues,
cognitive skills and behavioral characteristics. Only a limited number of studies of rare
syndromes which feature considerable ID have directly assessed cognition and behavior
by examining the child with a structured test battery. More frequently, assessment was
performed indirectly by interviewing the parents or based on observations by
researcher or clinician. In the present study, we have combined direct evaluation of the
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Figure 7.3  T–scores on internalising, externalising and total problem behavior, measured by the 
Child Behavior Checklist, in five patients with Marshall–Smith Syndrome 
 
child (BSID; psychiatric assessment), with indirect information gathered from parents
with structured interviews and questionnaires (VABS; ADI–R; CBCL).
In only a proportion of patients with MSS, a mutation involving the gene NFIX is
found, suggesting that there may be other factors involved in patients with MSS where
the mutation has not been determined. The signiﬁcance of NFIX mutations, however, is
still unclear as there is insufﬁcient information on the effects which alterations in the
gene may have. Further studies to ﬁnd other gene(s) involved in the etiology for MSS are
underway at present.
Cognitive and motor functioning in our sample of six cases with MSS is character-
ized by marked delays in individual development. The chronological age of the present
MSS children lies between 42 and 181 months, while the developmental age as assessed
by the BSID lies between 7 and 31 months on the mental scale and between 2.5 and 38
months on the motor scale respectively. When examining adaptive functioning, results
from the VABS show social functioning as a relative strength and seem to indicate that
in the presence of a slow individual development, progress in adaptive functioning,
communicative, social and motor skills could be accomplished with increasing age.
Decile scores were calculated based on the manual of the Dutch version of the VABS (De
Bildt & Kraijer, 2003). Likelihood concerning the level of cognitive functioning could not
be asserted for one participant due to young age. Within the category of severe ID, two
of the participants were categorized as profoundly intellectually disabled, while two oth-
ers were asserted as having moderate ID.
The children examined in the present study all showed signiﬁcant delays in the
development of speech and language or acquired no language at all. Language and social
cognition are closely linked in development (Tecumseh Fitch et al., 2010). Language plays
an important role in understanding social interactions, which is part of social cognition.
Social cognition in turn is necessary to acquire language. Social cognition includes the
capacity to follow the other’s gaze to objects of interest, imitate the other and under-
standing the meaning of the other (Frith & Frith, 2010; Tecumseh Fitch et al., 2010). Com-
munication between humans is determined both by speech and language abilities, and
by non–verbal expressions such as eye gaze, joint attention, facial expressions, gestures
and postures. Typically developing infants rapidly learn in their ﬁrst year of life that the
gaze and emotional expressions of others provides socially important information (Stri-
ano et al., 2006). The ability to detect emotional signals from others, interpret their
meaning and adjust behavior accordingly is an important characteristic in social interac-
tions and necessary for the development of social competence. Social competence may
be deﬁned as the ability to socially interact and understand others in an effective,
responsive and appropriate way, and this is evident in typically developing children even
before the onset of spoken language. Examples of socially competent behaviors may be
137
m ar s hall- sm ith  s y n d rome :  co g n iti o n ,  ph en ot y pe  an d  auti sm
apparent in (developmentally) young children through non–verbal social interactions
such as joint attention, smiling, approaching others, imitating another, imaginative play,
imaginative play with peers and/or group play. An inability to interact this way may indi-
cate an important deﬁcit in the social domain as can be seen in autism spectrum disor-
ders (Frith & Frith, 2008, 2010; Hoehl et al., 2009).
There were many similarities in social interactions and behavior between the chil-
dren investigated in this study. Most prominent deﬁcits in social interactions were: lim-
ited eye–to–eye gaze, lack of either initial reserve or aloofness, lack of reciprocity. Most
important behaviors were: inﬂexibility with or without temper tantrums, repetitive and
stereotypical play and limited imaginative play. In contrast to these ﬁndings is the deter-
mination that socialization may be a relative strength in MSS, as these children are able
to show affection to familiar persons, anticipate when they are about to be picked up by
their parents or caregivers and imitate simple proceedings. Scores from assessments
and interviews with parents showed that the severe delays in development of
speech/language, social skills, and levels of communicative and adaptive functioning
may be consistent with autism symptomatology, although social functioning could be
considered a relative strength in comparison with other domains of adaptive function-
ing. Differentiating between deﬁcits related to ID/developmental delay and deﬁcits
related to (subtle) autism symptomatology proved too difﬁcult to accomplish with cer-
tainty in the small sample of the present study. This is consistent with the difﬁculties
described in other published studies of genetic syndromes with signiﬁcant ID/develop-
mental delay with autism (Percy et al., 1990; Mazzocco et al., 1998; Cohen et al., 2005).
It is well possible that the autism–like behavioral features found in the present study
are inﬂuenced by the various signiﬁcant medical issues. Furthermore, we need to also
take into account the higher frequency of repetitive, stereotyped behaviors found in
individuals with severe ID reported in various studies (Bodﬁsh et al., 2000; Moss et al.,
2009). Therefore, we hesitate to draw inferences about the association of an autism
symptom proﬁle with MSS based on the ﬁndings of this ﬁrst exploratory study of behav-
ior, cognition and development in the syndrome. Continued careful case descriptions
with documentation and long–term follow–up of somatic, behavioral and cognitive phe-
notypes will eventually help determine their clinical relevance, and increase our under-
standing of diverse clinical presentations with or without autism symptomatology in this
syndrome.
Conclusion
Results from our study make it clear that the children with MSS showed moderate to
severe delays in mental age, motor development and adaptive functioning, with several
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similarities in communication, social interactions and behavior. Speech and motor mile-
stones were found to be severely delayed. Subjects mostly have a friendly or happy
demeanor and seemed to enjoy social interactions that include familiar others, and they
exhibited minimal maladaptive behaviors. Deﬁcits in communication, social interac-
tions, lack of reciprocal social communication skills appropriate for developmental level
and stereotyped, repetitive behaviors were noticeable during in–person psychiatric and
psychological assessments. There was limited imaginary play; subjects tend to play in a
repetitive, stereotypical manner with a favorite toy they are fascinated with. These char-
acteristics may ﬁt the deﬁnition of an autism spectrum disorder, but it remains unclear
how developmental progress over time might inﬂuence this determination.
By using a standardized research protocol through a dedicated test battery and re–
examining children with genetic syndromes over time, we improve our ability to detect
speciﬁc behavioral characteristics of syndromes such as autism or autism–related symp-
tomatology, and gather information on the long–term natural history. Integrating inter-
disciplinary information contributes signiﬁcantly to the development of more reﬁned,
structured measures of behavior and cognition in syndromes.
Clinical recognition of both physical and developmental and behavioral manifesta-
tions of syndromes is important for diagnosis, prognosis and counseling of the families
involved, and coupling this with molecular genetic data will increase our understanding
of the biological basis of the human physical and behavioral phenotype.
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A B S T R AC T
To study autism outside of a narrow range of settings previously studied, and in a par-
ticularly distinctive setting in the Caribbean. The aim of the Aruba Autism Project was to
determine the prevalence of autism spectrum disorders (ASDs) in birth years 1990–1999
in Aruba. A record review study was conducted; cases were ascertained from children
treated at the Child & Adolescent Psychiatry Clinic of Aruba, the ﬁrst and only child psy-
chiatry service on the island. In these 10 birth years we found a prevalence for autistic
disorder (AD) of 1.9 per 1,000 (95% CI 1.2–2.8) and for autism spectrum disorders (ASDs)
of 5.3 per 1,000 (95% CI 4.1–6.7). Comparison analysis with a cumulative incidence report
from the UK, showed a similar cumulative incidence to age ﬁve in Aruba. Prevalence of
ASDs in birth years 1990–1999 and cumulative incidence to age ﬁve in Aruba are similar
to recent reports from the United Kingdom and the United States.
keywords: autism, epidemiologic study, prevalence, cross-cultural
I N T RO D U C T I O N
Autism spectrum disorders (ASDs) are developmental disorders, characterized by
impairments in social functioning, communication and behavior. Reports of worldwide
prevalence ﬁgures since the 1990’s contributed to intensiﬁed research efforts (Fom-
bonne, 2003; Fombonne, 2009), but the descriptive epidemiology of ASDs remained
incomplete, as concern over potential environmental causes continued to increase
(Kolevzon et al., 2007).
For decades available data derived from prevalence studies in developed countries
conducted in a narrow range of settings (Fombonne, 2003). Current prevalence esti-
mates of ASDs in these settings fall in the range of 3–12 per 1,000 (Baird et al., 2006; Fom-
bonne et al., 2006; Petersen et al., 2006; Centers for Disease Control and Prevention
(CDC), 2007a, b). Autism speciﬁc epidemiologic research outside of the narrow range of
these ﬁrst world high-income countries has only recently been addressed (Ellefsen et al.,
2007; Ghanizadeh, 2008; Oliveira et al., 2007). The current project contributes to the
expansion of autism speciﬁc epidemiologic research in increasingly diverse settings.
This study is the ﬁrst attempt to study the epidemiology of ASDs in the Caribbean,
using methods that allow comparisons with other studies. Aruba is uniquely suited for
this purpose, as it has a culturally distinct, heterogeneous, multilingual and ethnically
mixed population.
Furthermore, Aruba has a well-established health care system, one centralized child
psychiatry clinic and a population registry providing both the means to identify disabled
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children, and to enumerate the island population.
Previous psychiatric epidemiologic research in rare disorders in the same region
(the Netherlands Antilles) has shown that such research is feasible (Hoek et al., 1998;
Hoek et al., 2005).
Aims of the study were to determine the prevalence for ASDs in birth years 1990–
1999 in Aruba, and to conduct a comparison analysis with a cumulative incidence report
from the UK. We performed the study because examining prevalence of autism across
diverse settings might provide clues to either genetic or environmental etiologies.
M AT E R I A L  A N D  M E T H O D S
Area and population
Aruba, a Caribbean island 17 miles off the coast of Venezuela, is a separate, autonomous
member of the Kingdom of the Netherlands. Since 1990, the population of Aruba
increased nearly 37% through immigration to 90,506 inhabitants in 2000. The population
of Aruba is predominantly of Amerindian (Arawak), Dutch, and Spanish ancestry (Toro-
Labrador et al., 2003). While there may be social distinctions based on race, these are
nowhere documented, and race is ofﬁcially considered a continuously distributed trait.
In some ways Aruban health characteristics such as life expectancy, leading causes
of death, and infant mortality are similar to those of the UK, the Netherlands, and the US
(Pan American Health Organization, 2002; United States Census Bureau, 2002; World
Health Organization, 2005).
During the 1990’s health insurance was nearly universal for legal residents, although
access to specialty services was limited. After the introduction of a mandatory universal
health insurance system in 2001 for legal residents, access to health care in Aruba
improved further. Children are entitled to health care based on legal residency of par-
ents. The insurance premium is income-dependent up to a certain maximum and paid
by employers, employees and the government.
Study population
The Aruba Autism Project was carried out at the Child and Adolescent Psychiatry (CAP)
Clinic of Aruba, an outpatient clinic established in 1997. The clinic was the ﬁrst and only
child psychiatry service on the island. Before its establishment no child psychiatry
expertise or services were locally available to the community. Children could be referred
to the service by general practitioners, pediatricians or other medical specialists. Virtu-
ally all Aruban-born children within the psychiatry service were legal residents.
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This study is based on children born in Aruba from January 1, 1990 through Decem-
ber 31, 1999 and seen at the Child and Adolescent Psychiatry Clinic between May 1, 1997
and December 31, 2003.
All clinical ﬁles for the period from the establishment of the clinic from May 1, 1997
until December 31, 2003 were reviewed for the study. In this six and a half year period the
clinic evaluated a total of 1,543 patients, including 813 Aruban children born in the tar-
geted years (see Figure 8.1).
Case ascertainment
Clinic charts of children born in the targeted birth years (N = 813) were systematically
screened, and the records of potential cases abstracted (N = 75). Study diagnoses were
assigned based on abstracted data.
Clinical records
Clinical notes and DSM-IV symptoms were recorded by the one clinic child psychiatrist
(IvB) over the entire study period. The clinic psychiatrist was trained as a child psychia-
trist in the Netherlands, where she did residencies in pediatrics, genetics, psychiatry and
child psychiatry. She has expertise in developmental and genetic syndromes (van
Balkom et al., 1992, 1998, 2002), and is certiﬁed in the use of standardized assessment
147
auti sm  spec trum  d i so rd er s  i n  aru ba
Figure 8.1  Study sampling 
 
 
instruments for research diagnosis of ASDs. Standardized forms were completed on
every child at intake. Intake included collection of medical, developmental, school and
family histories; as well as information on current clinical symptoms. Diagnostic assess-
ments were rarely concluded in one visit. Child psychiatric assessments and behavioral
observations would typically take place at second and third follow-up visits. Results of
routine psychological assessments performed at intake or during the course of treat-
ment were also recorded, as were notes from consultations with other experts.
At the clinic a ‘suspected’ ASD diagnosis was given when clinical symptoms did not
(yet) meet all the criteria necessary for a deﬁnite diagnosis of a pervasive developmen-
tal disorder. A ‘suspected’ diagnosis made support and intervention possible, while
allowing parents time to adjust, and the symptomatology to fully emerge over time
(Charman et al., 2005).
For the study the clinical cases with a ‘suspected’ ASD diagnosis were subject to
review and not automatically included in the numerator of prevalence ﬁgures. If a sus-
pected case was assigned an ASD study diagnosis— based on the presence of DSM symp-
toms in the chart notes—then he/she was included as a case in the prevalence ﬁgure.
Charts with an ASD diagnosis (Autistic Disorder, Asperger’s Disorder, Pervasive
Developmental Disorder Not Otherwise Speciﬁed, Rett’s Disorder, or Childhood Disin-
tegrative Disorder), or an ASD diagnosis “suspected” with no subsequent diagnosis 
ruling out spectrum diagnoses, were ﬂagged and abstracted by a Dutch resident of psy-
chiatry (MV).
Record review and study diagnosis
Evidence of DSM-IV symptoms was abstracted from the charts; subsequently a com-
puter algorithm was applied. The algorithm was consistent with DSM-IV symptom list
ratings for ASDs. Study inclusion was based on standardized chart abstractions; a study
diagnosis was assigned in accordance with standardized diagnostic criteria.
A study diagnosis of Autistic Disorder (AD) required chart evidence of two or more
social criteria, one or more communication criteria, and one or more behavioral criteria
for autism, totaling six or more criteria across the three symptom domains, with a delay
or abnormal functioning onset before age three in at least one of three areas—social
interaction, language used in social communication, symbolic or imaginative play. The
Asperger’s Disorder (AS) classiﬁcation required chart evidence of two or more social cri-
teria for autism, one or more behavioral criteria for autism, normal language develop-
ment (single words by 24 months, phrase speech by 36 months), and absence of mental
retardation and autistic disorder. Pervasive Developmental Disorder-Not Otherwise
Speciﬁed (PDD-NOS) classiﬁcation required one or more social criteria, and one or
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more communication criteria for autism or one or more behavioral criteria for autism in
the absence of other diagnosable autism spectrum disorders. An Autism Spectrum Dis-
order (ASD) classiﬁcation was also applied to those classiﬁed with AD, AS or PDD-NOS.
Mental retardation
Mental retardation (MR) was diagnosed based on chart records of IQ measurements.
When children were unequivocally MR (N = 15), they received a clinical diagnosis of MR
and were not tested (22%). Measurements were available in 54 of the study diagnosed
cases (78%): in 40 cases the children had a normal test-based IQ, while 14 children (20%)
had been tested as mentally retarded (IQ <70). In total 29 of the 69 cases were mentally
retarded (42%).
Validation study
To validate study classiﬁcation of ASD, the Autism Diagnostic Observation Schedule
(ADOS) was used. The ADOS is a semi-structured, standardized assessment of commu-
nication, social interaction and imaginative play for individuals suspected of having an
Autism Spectrum Disorder (Lord et al., 1989, 2000).
The subjects included 24 children with a study diagnosis of ASD, and six clinic 
children diagnosed with other disorders. Selection of non-ASD clinic children was based
on random identiﬁcation in the computerized patient list. This list was restricted to
active patients, excluding children who had previously screened positive for our study.
To prevent possible selection bias the secretary of the clinic invited parents from a list of
children with regular follow-up visits to the clinic in preceding weeks, working down the
list until six children were selected. The selected children were born 1993–1999.
Most subjects in the validation study were assessed by an independent ADOS 
certiﬁed rater from the neighboring island of Curaçao. When this rater was not available,
children were assessed by the ﬁrst author.
Conﬁdentiality
In keeping with Dutch medical ethical guidelines for the conduct of record review stud-
ies, personal information was treated conﬁdentially. Only the treating child psychiatrist
and the research psychiatrist had access to the medical charts. Data were entered into a
statistical database without identifying information.
149
auti sm  spec trum  d i so rd er s  i n  aru ba
Population data
Data on registered births and population characteristics were obtained from the Central
Bureau of Statistics, Aruba. All births to legal residents are registered. During the years
1990–1999 there were 13,109 registered births (6,755 males and 6,354 females) (Central
Bureau of Statistics (CBS), 2003).
A NA LYS I S
Main prevalence analysis
Prevalence estimates were calculated as the number of cases identiﬁed among children
born in Aruba between 1990–1999 divided by total registered live births 1990–1999. We
used the Poisson distribution to calculate 95% conﬁdence intervals (STATA, 2003).
Statistical comparison of the proportion with mental retardation among the 
diagnostic groups (AD versus PDD- NOS) was assessed with Pearson Chi Square.
Comparison analysis of cumulative incidence
The published study most similar to the Aruba study in methodology and birth years
was conducted by Powell et al. 2000 in two areas of the West Midlands, UK (Powell et
al., 2000). To compare our data to those described by Powell et al., 2000, we calculated
cumulative incidence of AD and ASDs in children with ﬁrst service contact prior to age
ﬁve, and born in the period January 1, 1996 through December 31, 1998. Children in these
birth years had access to the psychiatric service at least from ages one through 5 years.
The cumulative incidence is calculated by the number of Aruban born children 1996–
1998 with an intake prior to age ﬁve assigned a study diagnosis of ASD, divided by the
total number of children born in Aruba between 1996–1998.
R E S U LT S
Characteristics of the screened positive children
A total of 813 children born in Aruba from 1990 through 1999 were identiﬁed in the Child
and Adolescent Psychiatry Clinic records; of these 75 children screened positive.
Among the screen positive 60% of children were referred by GP’s, 30.7% were
referred by pediatricians and 9.3% by other specialists. The most common reasons for
referral were behavioral problems (61.3% of children) and speech and/or language delay
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(45.3% of children). Other reasons for referral were impaired relatedness (34.7%), 
mental retardation (4%), attentional problems, eating problems, sleeping disorder, or
anxiety. In total 54.6% of children had more than one reason for referral. 
Main prevalence ﬁndings
Sixty-nine of the screen positive children were assigned a study classiﬁcation of ASD. 25
(36.2%) were classiﬁed as AD, 2 (2.9%) were classiﬁed as AS, and 42 (60.9%) were classi-
ﬁed as PDD-NOS. No cases with regression in development, Childhood Disintegrative
Disorder or Rett’s Disorder were identiﬁed. The overall prevalence of ASDs was 5.3 (95%
CI 4.1–6.7) per 1,000 births. Details concerning prevalence are shown in Table 8.1.
Case characteristics
Clinical characteristics of the 69 cases are presented in Table 8.2. The proportion of
study-deﬁned MR in AD was 64.0%, in PDD-NOS 29.3% and overall ASDs 41.2%. The dif-
ference in percentages of children with mental retardation between AD and PDD-NOS
is signiﬁcant ( 2 =7.670; df = 1; p <.01). Boys outnumbered girls by 7.3:1 for AD, and 7.4:1
for PDD- NOS. Mean age at intake overall was 5.5 years (SD = 2.2). In children born from
1990–1994 (minimum possible intake age in the ﬁrst year the clinic was opened: 3–7
years) the mean age at intake was 7.2 years (SD = 2.1). In this group, there was no signiﬁ-
cant difference in age at intake between children classiﬁed as AD and children classiﬁed
as PDD- NOS. For children born 1995–1999 (minimum possible intake age in the ﬁrst
year the clinic was opened: 0–2 years) the mean age at intake was 4.5 years (SD = 1.5). In
this group, children classiﬁed as AD were signiﬁcantly younger than children classiﬁed
with PDD-NOS (3.9 years versus 5.1 years; t = −2.67; df = 41; p <.05). 
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Table 8.1  Prevalence per 1,000 births 
Diagnosis Male 95% CI Female 95% CI Total 95% CI 
       
AD 3.3 2.0–4.9 0.5 0.1–1.4 1.9 1.2–2.8 
PDD–NOS 5.5 3.9–7.5 0.8 0.3–1.8 3.2 2.3–4.3 
Asperger 0.1 0.0–0.8 0.2 0.0–0.9 0.2 0.0–0.6 
Total ASD 8.9 6.8–11.4 1.4 0.6–2.7 5.3 4.1–6.7 
Validation study
The subjects for the validation study included 24 children with a study diagnosis of ASD,
and six clinic children diagnosed with other disorders. The independent rater was blind-
ed to diagnostic information prior to the assessment, and assessed 17 of the 24 (70%) of
ASD study cases with the ADOS, while the remaining seven ASD subjects were exam-
ined by the ﬁrst author (IvB). All except one (95.8% of 24) of the study diagnoses of ASD
were conﬁrmed by the ADOS rating. None of the children diagnosed with other disor-
ders scored for ASD on the ADOS algorithm.
Comparison analysis of cumulative incidence
To compare our data to those described by Powell et al., 2000, we calculated the cumu-
lative incidence in children born in the period January 1, 1996 through December 31, 1998,
with intake prior to age ﬁve (Powell et al., 2000). The cumulative incidence for AD was
2.4 per 1,000 (95% CI 1.1–4.4) and for all ASDs it was 4.5 per 1,000 (95% CI 2.7–7.0). Pow-
ell reported a cumulative incidence to age ﬁve of 1.6 per 1,000 (95% CI 1.1–2.4) for AD,
and 3.4 per 1,000 (95% CI 2.5–4.4) for ASDs.
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Table 8.2  Case characteristics 
 AD (n=25) PDD–NOS (n=42) ASDs (n=69) 
    
Symptoms (range) Mean (sd) Mean (sd) Mean (sd) 
Social (0–4) 3.8 (0.5) 2.7(1.0) 3.1(1.0) 
Communication (0–3) 2.2(0.7) 1.5(0.8) 1.7(0.9) 
Repetitive behaviors (0–4) 2.2 (1.1) 0.3(0.6) 1.0(1.2) 
Total symptoms  8.2 (1.6) 4.5 (1.3) a 5.8 (2.3) 
Age at intake in years 4.6 (2.3) 6.0 (1.9) 5.5 (2.2) 
Birth cohort 1990–1999    
Mental retardation in % 64.0% 29.3% 41.2% 
    
a
 Only one case meeting study criteria of PDD–NOS had the minimum number of two 
symptoms; all other cases had three or more symptoms. 
 
D I S C U S S I O N
This is the ﬁrst report of the prevalence of autism spectrum disorders in a Caribbean
country. In the Aruba birth years 1990–1999 we found a prevalence for autistic disorder
of 1.9 per 1,000 (95% CI 1.2–2.8) and for autism spectrum disorders of 5.3 per 1,000 (95%
CI 4.1–6.7). These prevalence estimates should be considered minimum prevalence.
Centralized psychiatric services with excellent coverage and penetration, notwithstand-
ing, it is possible that ASD cases have escaped detection within the study period. Chil-
dren who have left the frame of observation may have been missed cases, but they still
were included in the denominator. Higher functioning cases and young children (i.e. year
of birth in the late nineties) may not have been referred.
The prevalence found in the present study is in the mid range of estimates report-
ed for similar birth years in studies conducted in the US and Europe, using diverse
methodologies (Baird et al., 2000, 2006; Bertrand et al., 2001; Yeargin-Allsopp et al.,
2003; Chakrabarti et al., 2005; Fombonne et al., 2006; Gillberg et al., 2006; Petersen et al.,
2006; CDC, 2007a, b). In Table 8.3 we present selected autism prevalence studies pub-
lished from 2000 reporting on children born during the same time period, but diag-
nosed using varied methodologies.
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Table 8.3  A comparison of selected descriptive epidemiology studies of autism 
 Powell et al., 
2000  
Baird et al., 
2000  
Bertrand et 
al., 2001  
Yeargin-Allsop 
et al., 2003  
Chakrabarti & 
Fombonne, 2005  
van Balkom et al., 
Present study 
       
Population 16,012
b
 16,235 8,896 289,456 10,903 13,109 
Country UK UK US US UK Aruba 
Age 1–4 years 7 years 3–10 years 3–10 years 4–6 years 4–13 years 
Diagnosis 
a
 RD DA DA RRD DA RRD 
Prevalence AD 1.6
b
 3.1 4.0 – 2.2 1.9 
Prevalence ASDs 3.4
b
 5.8 6.7 3.4 5.9 5.3 
Proportion 48% 53% 60% – 38% 36% 
AD/all ASDs (26/54) (50/94) (36/60)  (24/64) (25/69) 
Male : Female ASDs 5.7:1 7.5:1 2.8:1 4:1 6.1:1 (est) 6.7:1 
% MR: AD – 40% 58% – 67% 64% 
% MR: ASDs – 22% 49% 64% 30% 42% 
       
Legenda  
a
 DA = Direct Assessment; RD = Record Diagnosis; RRD = Record Review Diagnosis 
b
 cumulative incidence single birth year  lifetime prevalence to age 5 for birth year  
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The Aruban ﬁndings are consistent with these reports in two additional respects:
the proportion of autism spectrum cases with AD (25/69 = 36.2%), and the proportion
of cases with comorbid mental retardation (41% ASDs, 64% AD). The sex ratio (87.0%
males) is also within the range of previous reports (Fombonne, 2003, 2006; Gillberg et
al., 2006; CDC, 2007a, b). 
The validation study showed a rate of agreement between study diagnosis and
ADOS that was higher than expected at 95.8%. For example, Gray et al. showed that the
overall agreement between ADOS and clinical diagnosis was .87 (95% CI .81–.91) in a
group of young children (aged 20–55 months) (Gray et al., 2008). A possible explanation
for the higher agreement found in the present study could be the preponderance of AD
(16 of 24 subjects), and a higher age distribution; both conditions contribute to a better
performance of the ADOS (de Bildt et al., 2004; Gray et al., 2008).
A recent epidemiological study investigating children aged 3–9 years within differ-
ent health services in Venezuela (Montiel-Nava et al., 2008) yielded a treated prevalence
of 1.7 per 1,000 (95% CI 0.1–2.0) for all ASDs, and 1.1 per 1,000 (95% CI 1.0–1.4) for autism.
There could be various explanations for the markedly lower prevalence estimates in
Venezuela, especially for all ASDs, compared to our study. Aruba is distinctly different
from Venezuela, not only in terms of availability and access to health care, but also with
respect to socioeconomic and population characteristics. One explanation is a lower
degree of service coverage and penetration in the population compared to the Aruba
study, where 6% of all children born in Aruba between 1990–1999 were evaluated at the
clinic. As mentioned by the authors, a possible lack of awareness of autism and treat-
ment options in the general population could have resulted in underrecognition and
lower referral levels for higher functioning ASD cases. Of course, lower prevalence esti-
mates can also reﬂect lower prevalence in the underlying population.
Because epidemiologic ﬁndings with respect to autism spectrum disorders are par-
ticularly sensitive to study methodology, the comparison analysis was undertaken in
which we drew a direct comparison of cumulative incidence to age ﬁve of ASDs in Aruba
to that reported by a study conducted in two areas of the West Midlands, UK (Powell et
al., 2000). In this UK study case ascertainment methods are similar to the present study:
children were identiﬁed through Child Developmental Centres’ treatment records, and
similar diagnostic criteria were in use during the period of case detection. Powell report-
ed a cumulative incidence (to age ﬁve) of 1.6 per 1,000 for AD, and 3.4 per 1,000 for
ASDs. We estimated the cumulative incidence to age ﬁve of AD and ASDs to be 2.4 per
1,000, 4.5 per 1,000 respectively, at the high end of the conﬁdence intervals of the UK
study. This difference may be one of methodology.
In the UK study onset was deﬁned as the age at which a deﬁnite or probable diag-
nosis of ASD was ﬁrst communicated to the child’s family, whereas in the present study
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we used date of ﬁrst contact. However, it is uncertain whether this slightly higher cumu-
lative incidence could be accounted for by this difference.
The ideal study upon which to base comparisons in prevalence and cumulative inci-
dence across cultures would use the same rigorous methods at all research sites. How-
ever, in reality the development of comparable prevalence estimates is hampered by
methodological issues, and differences across countries and services.
It was therefore surprising that in spite of stated differences we found, using similar
methods, that the prevalence estimate for ASDs previously reported in a narrow range
of countries, also pertains in a place as distinctive as Aruba.
Strengths and limitations of the study
The strength of evidence derives from the coverage and penetration of the health care
system, the quality of diagnostic services, and the ability to accurately enumerate the
population at risk. During the 1990’s, health insurance was nearly universal for legal res-
idents, but access to specialty services was limited. From 2001 forward, access to child
psychiatry services was effectively universal; over the study period, six percent of all chil-
dren born in Aruba from 1990 to 1999 were assessed at the clinic.
The consistency and reliability of diagnosis upon which the prevalence estimates
are based also contribute to the strength of the study ﬁndings. All children were fully
assessed by the clinic psychiatrist and detailed clinical notes were systematically collect-
ed and included in charts. Study inclusion was based on standardized chart abstractions;
a study diagnosis was assigned in accordance with standardized diagnostic criteria. In an
effort to validate study classiﬁcation of ASD the ADOS was used to examine 35% (24/69)
of ASD subjects included in the study. This showed conﬁrmation of study classiﬁcation
in all cases, but one.
Finally, the population of Aruban births 1990–1999 was enumerated based on popu-
lation registry data. Because virtually all births in Aruba are attended (Pan American
Health Organization, 2002), registry data should include the births of all legal Aruban-
born children. All children identiﬁed with ASDs reported here are legal Aruban residents.
The limitations of this study are those common to record-based prevalence studies,
and fall into two principal categories: factors affecting case ascertainment and factors
affecting diagnosis. With respect to case ascertainment, a fundamental limitation of
record review methodology is that prevalence will only include children who presented
for clinical assessment, and who elicited clinical suspicion of falling within the autism
spectrum. In past studies, reliance on a single source for identifying cases has yielded
low estimates (Yeargin-Allsopp et al., 2003). In this Aruban context, diagnostic assess-
ment and treatment is centralized in the ﬁrst and only child psychiatry service on the
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island; competing diagnostic services do not exist.
Other ascertainment effects are speciﬁc to segments of the cohort, and are only rel-
evant in the context of the main prevalence analysis. Some cases among children born
in the earliest birth years and in the latest birth years may not have been referred to the
child psychiatric service. Because the clinic opened in 1997, it is possible that cases born
in the early 1990s emigrated in search of services prior to the clinic’s opening and there-
by escaped detection. It is also possible that higher functioning cases born in the late
1990s have not attained a sufﬁcient age for referral and are therefore underrepresented
in this study.
Another ascertainment issue may be relevant to both the main prevalence analysis
and the comparison analysis, that is that ascertainment of children with prominent co-
morbidities, especially mental retardation, may also have been limited. Interviews with
directors of Aruban schools and day-care programs for the disabled concerning the diag-
nostic distribution in their institutions, however, lead us to believe that few lower func-
tioning children were overlooked.
With respect to diagnosis, as in any record-based study, the ﬁndings are limited by
the absence of in-person standardized research interviews and assessments of every
study classiﬁed case. Due to restraints in time and ﬁnances only 24 of the 69 children
(almost 35%) with a study classiﬁcation of ASD were assessed with the ADOS. One study
classiﬁed ASD case was not conﬁrmed by the ADOS rating.
A potential for misdiagnosis speciﬁc to this population arises from the multilingual
environment. It is possible that some children with late language development and
behavioral disturbances (e.g., ADHD) present with ASD-like proﬁles at some point in
their development.
In conclusion, it is clear that interest in the distribution of ASDs is intensifying, as
concern over possible environmental contributions to the occurrence of these disorders
continues to grow (Kolevzon et al., 2007). Standardizing future research methodology
would permit geographic cross-cultural com- parisons. Finding areas of high and low
contrast will also motivate additional international epidemiologic investigations. In addi-
tion, each epidemiologic study will contribute to local appreciation of the magnitude of
ASDs impact on local public health resources and services.
This study shows that the prevalence of ASDs in Aruba is similar to previous preva-
lence reports from a narrow range of developed countries. We hesitate to draw infer-
ences about the causes of autism based on ﬁndings from a single setting. However, as
studies in diverse settings accumulate, we believe that the emerging picture will provide
important clues to some causes and help to rule out others. The signiﬁcance of these
ﬁndings for Aruba is clear. Aruba joins the developed world in needing to respond with
services and care for a signiﬁcant number of seriously disabled individuals.
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Signiﬁcant Outcomes:
•This ﬁrst epidemiologic study on ASD in the Caribbean shows prevalence estimates
and gender distribution similar to those reported in recent studies in the UK and US.
•Comparison analysis with a study of cumulative incidence of AD and ASD in the UK
showed a cumulative incidence rate in the youngest age group in Aruba at the high end
of the conﬁdence interval of that in the UK.
Limitations:
•Only children who presented for clinical assessment and elicited clinical suspicion of
falling within the autism spectrum are included in the prevalence estimate.
•Cases born in the early 1990s may have emigrated in search of services prior to the clin-
ic’s opening.
•Higher functioning cases born in the late 1990s may not have attained a sufﬁcient age
for referral. 
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chapter 9
Paternal age and risk 











A B S T R AC T
objective – The objective of this study was to examine paternal age in relation to risk of
autism spectrum disorders (ASDs) in a setting other than the industrialized west. 
design – a case-control study of Aruban-born children (1990-2003). Cases (N=95) were
identiﬁed at the Child and Adolescent Psychiatry Clinic, the only such clinic in Aruba;
gender and age matched controls (N=347) were gathered from public health records.
Parental age was deﬁned categorically (≤29, 30-39, 40-49, ≥50y). The analysis used con-
ditional logistic regression. 
results – Advanced paternal age was associated with increased risk of ASDs in offspring.
In comparison to the youngest paternal age group (≤29y), risk of autism increased 2.26
times for children born with fathers in their thirties, 2.70 times for fathers in their forties,
and 3.24 thereafter. 
conclusion – This study, part of the ﬁrst epidemiologic study of autism in the
Caribbean, contributes additional evidence, from a distinctive sociocultural setting, of
the risk of ASD associated with increased paternal age. 
keywords: paternal age, autism risk, case-control study
I N T RO D U C T I O N
Major studies showing that advanced paternal age elevates risk of autism in offspring
have been conducted in predominantly high-income countries (the U.S. (California),
Denmark, Israel, Western Australia, Sweden, the Netherlands, the UK) (Glasson et al.,
2004; Lauritsen et al., 2005; Reichenberg et al., 2006; Croen et al., 2007; Grether et al.,
2009; Hultman et al., 2010; Shelton et al., 2010; Buizer-Voskamp et al., 2011). 
The mechanisms underlying advanced parental age/autism risk association are not
yet fully understood. The leading hypothesis is that with advancing paternal age, de novo
genomic alterations and/or changes in gene expression regulation levels increase the
risk of autism. (Sebat et al., 2007; Alter et al., 2011). Alternatively, delayed parenthood
could reﬂect subtreshold autistic traits in individuals leading them to parent at advanced
ages (Constantino & Todd, 2005; Puelo et al., 2008). There are also suggestions that soci-
ocultural determinants of age at parenting may better explain the ﬁnding. Sociocultural
factors which inﬂuence age at parenting differ across countries and include factors such
as immigration, access to family planning services, educational attainment, and socioe-
conomic status (Bongaarts, 2003; Larsson et al., 2005; Cheslack-Postava et al., 2011;
Leonard et al., 2011). The signiﬁcance of these sociocultural factors is difﬁcult to evaluate
due to the lack of sociocultural diversity of the major studies to date. Studies of autism
161
pater nal  ag e  an d  r i sk  o f  auti sm  i n  aru ba
in a greater diversity of settings are underway or have recently been published (Sansafar
et al., 2010; Zhang et al., 2010). Among the ﬁrst of these was a prevalence study of 
treated autism spectrum disorders in Aruba (van Balkom et al., 2009). In the current
study we examined paternal age and risk for ASD.
M E T H O D S
Area and population
Aruba is a Caribbean island 17 miles off the coast of Venezuela (population 90,506 in
2000) The native-born population of Aruba is predominantly of Amerindian (Arawak),
Dutch, and Spanish ancestry (Toro-Labrador et al., 2003). In conjunction with an eco-
nomic transition in the 1990s, Aruba absorbed a large number of immigrants. Since
2000, immigrants have constituted at least 30% of the population (CBS, 2002). Although
social distinctions based on race may exist, these are nowhere documented, and race is
ofﬁcially considered a continuously distributed trait. During the 1990s health insurance
was nearly universal for legal residents; in 2001 access to health care in Aruba improved
further with the introduction of mandatory health insurance. All children of legal resi-
dents are entitled to health care (van Balkom et al., 2009). 
Study design
This study is a population-based case-control study using clinic and public health
records. Our aim was to examine the hypothesis that advanced paternal age increases
risk of autism in the non-industrial, ethnically diverse setting of Aruba. The sampling
frame includes all births in Aruba between 1990 and 2003 recorded in the Aruba public
health records. Autism in children born between 1990-1999 had previously been identi-
ﬁed in the Aruba Autism Project, a prevalence study of Autism Spectrum Disorders
(ASDs) in Aruba (van Balkom et al., 2009). This earlier prevalence study was extended to
include children born from 1990 to 2003, from clinic records of assessments recorded
until January.1, 2006. Controls were selected from the public health records (well-baby
clinics records and adolescent health preventative clinic records) matching on
date/month/year of birth and gender. 
Case identiﬁcation 
Records from the Aruba Child and Adolescent Psychiatry Clinic, the ﬁrst and only child
and adolescent psychiatry service on the island, were screened for diagnosed and sus-
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pected cases of ASD in children born in Aruba from 1990 to 2003. At the clinic a ‘sus-
pected’ ASD diagnosis was given as a working diagnosis, when clinical symptoms did not
(yet) meet all the criteria necessary for a deﬁnite diagnosis of a pervasive developmen-
tal disorder. In this way support and intervention were possible, while allowing parents
time to adjust, and ASD symptomatology to fully emerge over time (Charman, 2005).
Charts of all potential cases were abstracted; a study diagnosis was assigned based on
abstracted chart evidence of symptoms in accordance with DSM-IV symptom criteria.
Autism Spectrum Disorders were deﬁned to include Autistic Disorder, Asperger’s Dis-
order, and Pervasive Developmental Disorder Not Otherwise Speciﬁed. In total, 101
cases of ASDs were identiﬁed by these methods and included. 
Control identiﬁcation 
Data on controls were abstracted from the centralized computer records of the Aruba
public health clinics, which serve all Aruban children from infancy to age 10 to 11 years.
Public Health clinic ﬁles for selected controls were retained in one of two locations (the
centralized archive or home clinic) depending upon birth years. Clinic ﬁles include
immunization history, visit notes, and in most instances parental characteristics includ-
ing parents’ place of birth, date and/or year of birth, maternal parity, and parental occu-
pation. Parental characteristics were abstracted for each control using a standardized
abstraction form. Only anonymized data were extracted from the clinic records.
A minimum of three and a maximum of ﬁve controls, matched to each subject clas-
siﬁed with an ASD for date of birth and gender, were randomly selected from the pub-
lic health records. With these methods 469 controls were identiﬁed for the 101 ASD sub-
jects. Characteristics of the study sample are shown in Table 9.1.
Six of the cases classiﬁed as ASD for this study were excluded due to missing data
on mother and/or father’s age along with their 26 matched controls. An additional 96
controls were excluded due to missing data on mother and/or fathers age. The ﬁnal sam-
ple consisted of 95 cases and 347 controls.
Validation
The study-assigned diagnosis of 24 randomly chosen children identiﬁed as having ASD
(N=95), along with 6 clinic patients with other disorders randomly chosen from the com-
puterized clinic patient list, was validated with the Autism Diagnostic Observation Sched-
ule (ADOS) by a certiﬁed independent rater from the neighboring island of Curaçao. The
ADOS is a semi-structured, standardized assessment of communication, social interaction,
and imaginative play for individuals suspected of having an ASD (Lord et al., 1989, 2000).
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When the independent rater was not available, children were assessed by the ﬁrst
author. The independent rater was blinded for diagnostic information prior to assess-
ment and assessed 17 of 24 (70%) randomly chosen subjects with a study diagnosis of
ASD, while the remaining 7 were examined by ﬁrst author (IvB). All except one of the
study diagnosed ASD cases were conﬁrmed by the ADOS rating (95.8%). The sole
exception was a young child rediagnosed as having ADHD, two years after his initial
working diagnosis of ‘suspected’ ASD. None of the randomly selected clinic children
diagnosed with other disorders scored for ASD on the ADOS algorithm (van Balkom et
al., 2009).
Variables
Parental ages were categorized in 10 year increments: ≤29= age group 1 (reference cate-
gory), 30–39= age group 2, 40–49= age group 3, and ≥50= age group 4. 
Four potential confounders of the age-autism association under consideration were
identiﬁed a priori, and then examined in association with paternal age variable and the
outcome. These confounders were: age of other parent at birth, low birth weight,
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Table 9.1  Characteristics 
 Controls N (%) Cases N (%) 
   
Paternal Age   
 29 149 (42.9) 23 (24.2) 
30-39 159 (45.5) 55 (57.9) 
40-49 36 (10.4) 15 (15.8) 
 50 4 (1.2) 2 (2.1) 
Maternal Age   
 29 211 (60.8) 42 (44.2) 
30-39 130 (37.5) 47 (49.5) 
40-49 6 (1.7) 6 (6.3) 
Preterm birth   
Yes 29 (8.4) 10 (10.5) 
No 304 (87.6) 76 (80.0) 
Missing 14 (4.0) 9 (9.5) 
preterm birth and parental immigrant status. The ﬁrst potential confounder considered
was maternal age. Studies examining maternal age effects on risk of ASD in offspring
have reported mixed ﬁndings (Croen et al., 2007; Durkin et al., 2008; Grether et al., 2009;
Shelton et al., 2010). In this study we categorized maternal ages in 10 year increments,
resulting in the following three age groups: ≤29=age group 1 (reference category), 30–
39=age group 2, and 40–49=age group 3.
Because previous studies have suggested that low birth weight (<2500 grams)
(LBW) and preterm birth (≤ 37 weeks pregnancy) may be associated with increased risk
of autism (Larsson et al., 2005; Buchmayer et al., 2009) we addressed both these vari-
ables as potential confounders. High risk pregnancies in Aruba with risk of preterm birth
and/or low birth weight, are usually referred to the neighboring island of Curacao for
labor and delivery. These children are excluded from our sample, because they are not
Aruban born. Nonetheless, there are children of LBW in our sample (N=11) and children
born after ≤ 37 weeks pregnancy (N= 39). Finding no association with either exposure or
outcome for LBW, this confounding variable was dropped from consideration. 
In various studies parental immigrant status has been implicated in risk for ASDs in
offspring (Lauritsen et al., 2007; Hultman et al., 2010; Buizer-Voskamp et al., 2011), and as
it may impact on age at reproduction, we also addressed this as a potential confounder,
classifying parental place of birth as Aruba/ not Aruba (+/-), and four categories of com-
bined parental place of birth (AA, AᾹ, Ā A, Ā Ā). Both parents Aruban born (ᾹA) is the
referent category for combined place of birth. When adjusting for parental immigrant
status did not reveal an association with exposure or ASD we dropped this variable from
consideration also.
Analysis 
The data were analysed using STATA version 9. We used conditional logistic regression
for matched case-control groups with STATA’s “clogit” command to examine paternal
age effects of increased risk in ASDs  in offspring unadjusted, and while controlling for
maternal age effects, and while controlling for maternal age and preterm birth effects.
Conﬁdentiality
The Aruba medical ethical review committee gave permission to perform the study. All
data were entered into a statistical database without identifying information.
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R E S U LT S
Mean paternal age in cases was 33.5 (sd=6.8), and in controls, 31.1 (sd=7.1); mean mater-
nal age in cases was 30.2 (sd=5.7), and in controls, 27.6 (sd=5.6). 
Advanced paternal age was associated with increased risk of ASDs in offspring
(Table 9.2). In comparison to the youngest paternal age group (≤29), the risk of autism
increased signiﬁcantly to 2.18 times for children with fathers in their thirties, and to 2.71
in their forties. Adjusting for maternal age, paternal age effects were signiﬁcant for
fathers in their thirties, compared to younger fathers. However effects were rendered
non-signiﬁcant for other paternal age groups. When adjusting for confounding variables
maternal age and preterm birth, fathers in their thirties and forties have a signiﬁcantly
increased risk for ASDs in their offspring compared to the reference group. 
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Table 9.2  Odds ratios for paternal age adjusted for maternal age and preterm birth 
 Unadjusted 
 
OR (95% CI) 
Adjusted for maternal 
age 
OR (95% CI) 
Adjusted for maternal 
age and preterm birth 
OR (95% CI) 
    
Paternal age *    
30-39 2.18 (1.29,3.72) 1.85 (1.03,3.29) 2.16 (1.15,4.04) 
40-49 2.71 (1.27,5.78) 2.00 (0.87,4.61) 2.67 (1.07,6.68) 
 ≥50 3.22 (0.55,18.68) 2.24 (0.36,13.87) 2.38 (0.37,15.40) 
Maternal age *    
30-39  1.41 (0.83,2.40) 1.51 (0.86,2.67) 
40-49  3.39 (0.92,12.49) 3.45 (0.84,14.10) 
Preterm birth •    
< 37 weeks   1.08 (0.50,2.37) 
    
* = reference category: age group 29 years;  
• = reference category “not preterm” 
 
D I S C U S S I O N
In this case-control study in a total population Aruban birth cohort (1990-2003) we found
that advanced paternal age, in comparison to the youngest paternal age group (≤29), was
associated with increased risk of ASDs in offspring. Aruba has a multicultural, ethnically
mixed population, including a substantial proportion of at least 30% immigrants since
2000 (CBS, 2000). Its one and only centralized child psychiatry service ensured not only
a high degree of service coverage and penetration of the population, but also the cap-
ture and rigorous assessment of all cases of ASD by the same clinician (IvB).
The need to understand the distribution of autism spectrum disorders and the role
of environmental factors in the occurrence and etiology of autism spectrum disorder
remains urgent and requires studying autism in diverse environments (Kolevzon et al.,
2007). Examining the association between paternal age effects and risk of autism in pop-
ulations of different sociocultural and ethnic origin, embodying different inﬂuences on
age at parenting, will advance our understanding of the signiﬁcance of these environ-
mental effects. To date, the signiﬁcance of these factors remains difﬁcult to appreciate
due to the lack of sociocultural diversity of the major studies. 
The present study examined the paternal age contribution to risk of ASDs in off-
spring in a socioculturally diverse population. It is likely that social, cultural, and ethnic
inﬂuences on age of reproduction in this environment are affected by the transitional
economy of Aruba and the rapid inﬂux of immigrants, changing the meaning of older
ages at parenting. In our study we found that the risk of autism increased signiﬁcantly for
children with fathers in their thirties, and their forties compared to younger fathers.
After adjusting for maternal age as a confounding variable the relationship persisted
only for fathers in their thirties when compared to the reference age group. We found
that fathers in their thirties and forties have a signiﬁcantly increased risk for ASD in their
offspring when adjusting for both maternal age and preterm birth, suggesting that it is
paternal age per se that contributes to increased risk of autism in offspring. Although
certain limitations were imposed by the relatively small sample size of fathers in the
older age groups, the patterns of risk remained across paternal age categories when
adjusting for maternal age in categorical analysis. 
Our ﬁnding, in this distinct sociocultural setting, is consistent with that of previous
studies in western countries (Glasson et al., 2004; Lauritsen et al., 2005; Reichenberg et
al., 2006; Croen et al., 2007; Grether et al., 2009; Hultman et al., 2010; Shelton et al., 2010;
Buizer-Voskamp et al., 2011). It is also consistent with the ﬁndings of a recent case control
study in Iran, in which a signiﬁcant association between paternal age and an increased risk
of autism, independent of maternal age, was described (Sasanfar et al., 2010).
Other possible risk factors have been examined recently. In a study on birth spacing
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in California, Cheslack-Postava et al. (2011) suggested that children born after shorter
intervals between pregnancies had an increased risk of autism spectrum disorder, with
the highest risk found in pregnancies spaced <1 year apart. The authors suggest two rea-
sons for closely spaced births, namely unintended pregnancies and delayed childbearing
by choice (Cheslack-Postava et al., 2011). Additionally, we suggest that delayed child-
bearing may also reﬂect subtreshold autistic traits leading to childbearing at advanced
ages in both women and men. In another recent study of twins Hallmayer et al. (2011)
found a greater non-inherited contribution to risk of autism than was described in pre-
vious studies, thereby suggesting that the inﬂuence of environmental factors (whether
biological or social) may be larger than previously thought. Additional studies examining
these factors in different environment may offer clues to the etiology of ASD and eluci-
date the meaning of the paternal age/autism association. 
Strengths and limitations
Major strengths of the study include access to rigorously deﬁned cases arising in the
population of Aruban births 1990-2003, ascertainment through the only child psychiatry
clinic within a well-established universal health care system, and accurate enumeration
of the population at risk through the population registry. 
Nonetheless, the limitations of the present study also need to be considered, espe-
cially one common to record-based methodology. Findings with respect to assigning a
study diagnosis, as in any record-based study, are usually limited by the absence of in-per-
son standardized research interviews and direct clinical assessments of the study classiﬁed
cases. However, in our study we were able to validate 24% (23/95) of study classiﬁed ASD
cases. Another limitation was the fact that the sample size of oldest paternal age groups
(>40y, N=57) was relatively small, a limitation inherent to research in small populations.
Conclusion
The study contributes additional evidence, from a distinctive sociocultural setting, to
the literature on the relationship between paternal age and risk of ASDs, and it empha-
sizes the importance of replicating these ﬁndings across environments since increased
paternal age may encapsulate both biological and sociocultural risk factors for adverse
neurodevelopmental outcomes in offspring. As more studies in diverse settings, with a
focus on meaningful distinctions in the geography of autism, are carried out and ﬁndings
accumulate, it is likely that the new results will provide important clues to some causes
and help to rule out others.
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chapter 10
General discussion
I N T RO D U C T I O N
The objective of the research projects in this dissertation was to study autism as it man-
ifests itself within (ultra) rare genetic syndromes; and to examine autism within a differ-
ent sociocultural environment. In recent years the deﬁnition of autism has been hotly
debated. The criteria used to deﬁne autism as well as the theories of possible causes
have changed radically from a psychological to a biological–genetic explanation, and
from narrowly deﬁned criteria to broader criteria of atypical development and aberrant
behavior. Recognizing autism where it occurs is important; how it is deﬁned and evalu-
ated is equally important. 
The most widely used deﬁnition in clinical practice is probably the pervasive devel-
opmental disorder diagnostic algorithm presented in the Diagnostic and Statistical Man-
ual of Mental Disorders, 4th edition, text revision (DSM IV–TR). This algorithm encom-
passes twelve criteria which evaluate communication and social interaction skills as well
as behavior, and allows for classiﬁcation into one of the subcategories of the pervasive
developmental disorders group. However this algorithm is not very helpful for evaluat-
ing individuals with genetic syndromes associated with severe intellectual disability, in
which autism is probably under–recognized. Intellectual disability is a condition which is
often associated with features analogous to autism: severe language impairments, social
interaction difﬁculties, and behavioral issues. Many of these symptoms defy strict cate-
gorization; this is one of the main reasons diagnosis should be constructed upon careful
clinical observations and descriptions. In addition, clinical diagnosis should be based on
a careful evaluation of relevant symptoms and their signiﬁcance, e.g., impairment or dis-
tress, within the framework of the individual’s developmental phase, family, and other
relevant milieus, and elicited from multiple informants. 
The central topic of autism was addressed within two contexts, ﬁrst through the
study of autistic features within the context of genetic syndromes, to investigate
whether these features can be considered autism; second, through the study of autism
in a different geographic locale to investigate whether prevalence and environmental
risk factors for autism are comparable to those found elsewhere. 
Methodological challenges 
Limitations of the studies presented in this thesis have to do with the following method-
ological issues: selection method and case ascertainment, factors affecting diagnosis,
sample size, and instruments used in individual assessments. These issues are discussed
here in two parts, those pertaining to the design of the study of genetic syndromes and
those pertaining to the design of the study of autism spectrum disorder in Aruba.
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With respect to the design of the study of genetic syndromes 
Affected individuals were ﬁrst identiﬁed through their membership in a syndrome–spe-
ciﬁc Family Association and invited to participate through the Family Association. This
may have led to a disproportionate inclusion of a subgroup of (already diagnosed) indi-
viduals with more severe clinical and behavioral characteristics. Sample sizes were neces-
sarily small, but given the rarity of the syndromes studied, can be considered substantial.
A serious limitation was the lack of suitable instruments to directly measure cogni-
tive functioning in individuals with severe intellectual disability and varying chronologi-
cal ages. Proper evaluation and interpretation of the target behaviors requires standard-
ized assessments not only of cognitive levels, but also of behavior and motor skills,
adaptive functioning levels, speech and language development, and learning difﬁculties.
To avoid misattribution, social interaction, communication, social and family environ-
ment, and behaviors in different situations should also be weighed and considered at the
same time.
Measuring cognition required an a priori evaluation of approximate cognitive level
by means of a clinical psychiatric assessment. In these studies, all subjects scored within
developmental levels that could be measured by the instrument of ﬁrst choice (Bayleys).
Assessing autistic features with the ADI–R (Autism Diagnostic Interview–revised) in
individuals whose mental–age equivalent is below a developmental level of 24 months
carries the risk of over–classifying autism. There have also been several publications
showing that the use of the ADI–R at age 24 months was less successful in predicting
eventual outcome than the clinical diagnosis of an experienced clinician. In the studies
described in this thesis, the results of the ADI–R were used to add to other data collect-
ed through individual psychiatric assessments, informant reports, and individualized
standardized testing.
With respect to the design of the study of autism spectrum disorders in Aruba
Prevalence estimated by means of record review can only include children who are pre-
sented for clinical assessment and who arouse clinical suspicion of falling within the
autism spectrum. Other ascertainment difﬁculties are speciﬁc to particular segments of
the cohort. Some cases among children born in the earliest birth years and in the latest
birth years may not yet have been referred to the centralized child psychiatric service in
Aruba. Because the clinic opened in 1997 and no child psychiatric services existed before
that time, it is possible that prior to the clinic’s opening, children born in the early 1990s
emigrated in search of services and thereby escaped detection. It is also possible that
higher–functioning cases born in the late 1990s had not attained a sufﬁcient age for
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referral and are therefore underrepresented in this study. Autism in some children with
prominent comorbidities, particularly intellectual disability, may not have been recog-
nized, although interviews concerning the diagnostic distribution within the institutions
caring for the disabled indicated that few lower functioning children were overlooked.
Findings with respect to assigning a study diagnosis, as in any record-based study, are
usually limited by the absence of in-person standardized research interviews and direct
clinical assessments of the study classiﬁed cases. However, in our study we were able to
validate a proportion of the study classiﬁed ASD cases.  
Other methodological challenges
Variability of phenotypes within same genotype, variability of genotype within
same phenotype
Given the heterogeneity and pervasiveness of both intellectual disability and autism
spectrum disorder, the study of behavioral phenotypes associated with genetic syn-
dromes is challenging and complex. The phenotypic similarities between intellectual
disability and autism spectrum disorder are obvious, and affected individuals may share
many features with an early onset, such as impairments in language development, difﬁ-
culties in social interaction and communication, and stereotyped behaviors. 
Genetic syndromes associated with intellectual disability have signiﬁcant develop-
mental, cognitive, and behavioral consequences, and although these have been
described in various studies, there has been little systematic study of the psychiatric
dimension. Unfortunately, no biological or psychological markers exist for delineating
and validating psychiatric disorders and intellectual disability complicates clinical assess-
ments. This is considered a risk factor for lower levels of communicative, adaptive and
cognitive skills, and can lead to difﬁculties in social interactions within family, learning
and social environments. All these circumstances constitute the multiple genetic and
environmental interactions that both inﬂuence the architecture of the brain and are
inﬂuenced by it. Consistent with a spectrum concept, there may be many different
genetic pathways that lead to an outcome of intellectual disability and autism spectrum
disorder. Several studies have concluded that genomic abnormalities investigated were
not disease–speciﬁc, but contributed to the expression of various similar neurodevelop-
mental phenotypes. This challenges longstanding ideas of how disorders can be delin-
eated and differentiated from one another, more so in the case of psychiatric disorders,
which are deﬁned by observable behaviors. For example, it could be possible that given
the continuous nature of features and impairments, at the most disabling end of the
spectrum, autism spectrum disorder and intellectual disability co–occur.
175
g en er al  d i scu ss i o n
The inﬂuence of time and environment
Gene–behavior interactions are multidirectional, complex, and dynamic. They are
developed, shaped, and expressed over time, beginning at conception and over time
inﬂuenced by the external environment and by social information. Environmental fac-
tors may be deﬁned in many ways; for example they can be social, cultural, or biological.
To complicate matters for research, the effects of any defect on any level is inevitably
inﬂuenced by environmental and social information, which in turn may impact eventual
individual outcome and determine the need for services by the patient and family. Iden-
tifying relevant genetic and environmental factors and understanding the pathways to
expression remains challenging, and the interrelatedness of phenotypic outcomes com-
plicates clinical recognition and delineation. 
Diagnosis and classiﬁcation
In clinical practice diagnosis is inherently different from classiﬁcation. In the DSM–IV
(APA, 1994), disorders are restrictively categorized by aberrant behavior (ascribed to
individual pathology) and diagnostic thresholds are ﬁxed; signiﬁcant other factors, such
as family environment or developmental phase, may be lost. The signiﬁcance of behav-
ior, however, must always be considered within different environments, as behavior per
se does not necessarily indicate impairment. While classifying psychiatric disorder
according to the DSM–IV classiﬁcation system enables communication between clini-
cians, researchers, and policy makers, guides research, and determines access to servic-
es, it is seldom helpful in terms of determining what individual treatment interventions
are needed.
G E N E R A L  D I S C U S S I O N
There is a long tradition in medicine of observing, describing, and comparing physical
signs and symptoms. Identifying groups of similar clinical presentations (phenotypes)
for further study has offered clues to the underlying genetic causes (genotype) and
spurred advances. Examining behavioral phenotypes in genetically determined syn-
dromes provides a unique opportunity to investigate similarities and differences in
behavior as expressions of gene alterations. As in studies of physical symptoms and 
speciﬁc anomalies, these behavioral phenotypes (including autistic features or autism
spectrum disorder) in combination with certain cognitive strengths and weaknesses and
proﬁles of adaptive skills, have offered clues to the underlying genetic cause for the indi-
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vidual’s developmental and behavioral difﬁculties. In some cases, studies of behavioral
phenotypes have actually led to the delineation of a syndrome and the realization that
certain syndromes or chromosomal anomalies may be primarily characterized by spe-
ciﬁc behaviors or combination of behaviors (Mazzocco & Reiss, 1994; Flint, 1995). Con-
versely, many subsequent studies have shown that although a particular genetic varia-
tion may be the same, the behavioral outcome is not necessarily completely predictable
or unalterable. The great inter–individual outcome variability seen in clinical practice
makes it clear that behavioral characteristics in any syndrome are not solely determined
by genetics and that too strong an emphasis on biological determinants should be avoid-
ed (Harris, 2010). Behavior is also inﬂuenced by interactions with the environment and
by the reactions from that environment to a child’s temperament, external features, and
neuropsychological deﬁcits.
We would argue that deﬁning child psychiatric disorders in clinical practice as cate-
gorical entities does not do justice to the continuum of varying behavioral and cognitive
outcomes. The same argument holds true for deﬁning genetic syndromes. These are
often also regarded as ﬁxed, categorical deﬁnitions, with severe clinical cases usually ﬁrst
identiﬁed and considered prototypical, and similar outcomes of lesser severity often
subsequently described as syndrome–like phenotypes. In fact, like psychiatric disorders,
genetic syndromes usually exist along a continuum of varying physical and neurodevel-
opmental severity. Clinicians evaluating syndromes associated with intellectual disabili-
ty may be biased with respect to their expectations of a child’s developmental potential
(Sanz et al., 2010), and may make inferences of long–term behavioral outcomes without
taking changes over time into account. That said, it is likely that deﬁcits in social, com-
munication, and behavioral domains deﬁned in autism spectrum disorder exhibit higher
levels of intense, frequent, and severe presentations in intellectually disabled individuals
with co-morbid autism spectrum disorder than in intellectually disabled children with-
out autism spectrum disorder. These clinical presentations should therefore be careful-
ly considered. It is also likely that behavioral presentations with autism spectrum disor-
der change less over time than those that are primarily associated with intellectual
disability without autism. This hypothesis can only be made with follow–up, and may
shed light on developmental trajectories into adulthood.
The need to understand the distribution of autism spectrum disorders and the role
of environmental factors in the occurrence and etiology of autism spectrum disorder
remains urgent and requires studying autism within different environments (Kolevzon
et al., 2007). In contrast to the study of autism within the context of genetic syndromes,
the research focus here is on meaningful differences between different geographic loca-
tions where autism occurs rather than on similarities. As more studies in diverse settings
are carried out and ﬁndings accumulate, it is likely that the new results will provide
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important clues to some causes and help to rule out others. A recent study (Hallmayer
et al., 2011) has suggested that the inﬂuence of environmental factors (whether biologi-
cal or social) may be larger than previously thought. 
Future directions 
Longitudinal approaches and Wiki 
Evaluating syndrome–speciﬁc behavioral features at a single point in time does not pro-
vide a complete picture of developmental changes that occur from childhood to adult-
hood and it may lead to inaccurate projections of eventual outcomes. There are few lon-
gitudinal studies that examine the neuropsychological and behavioral proﬁles of
children with genetic syndromes associated with intellectual disability, but it is likely that
the impairments associated with intellectual disability and adaptive functioning persist
into adulthood. While some symptoms may diminish, others may exacerbate and
become more incapacitating as time progresses. 
Adopting a longitudinal approach in which individuals are repeatedly assessed over
time with the use of a standardized research assessment protocol would allow a more
precise description of how patterns of behavioral and cognitive deﬁcits within a genetic
syndrome change, and may reveal important syndrome–speciﬁc differences. Studying
patterns of behaviors within phenotypes associated with intellectual disability can help
determine their importance in clinical practice and in developmental trajectories which
include autism spectrum disorder. One interesting ﬁeld of study may be the study of
repetitive, stereotyped behaviors found in many individuals with severe intellectual dis-
ability, to determine how to differentiate between intellectual disability without autism
spectrum disorder and intellectual disability with co-morbid autism spectrum disorder
(Bodﬁsh et al., 2000; Moss et al., 2009; Arnott et al., 2010).
Assessments over time should help identify possible improvement or slowed
progress in performance, domains in which there may be a loss of skills, and continued
areas of developmental concern, in affected individuals.
Using an online resource such as a Wiki in research in (ultra) rare disorders has
shown itself to be very effective. It may serve two purposes: one, as a tool to gather and
collate parental information, and expertise from families which may be widely dispersed
geographically, and two, it may be useful in functioning as a virtual center of expertise
for the dissemination of information on the disorder in question (Hennekam, 2011). 
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Next–generation gene sequencing and translational genetics
The increase of genetic studies linking genes and their relevant biological (cellular/bio-
chemical) function to outcome and risk for disorder holds great promise for psychiatric
genetics. The use of next–generation sequencing technology to sequence the genes of
large patient groups with behaviorally deﬁned psychiatric disorders (phenotype) so that
those with the same gene modiﬁcations can be identiﬁed and grouped more homoge-
nously (genotype) will transform future studies, and will make it possible to better
examine similarities and differences between psychiatric disorders.
Eventually, future developments in translational genetics will involve devising
informed clinical interventions to modify genetic predispositions to pathology. 
Next–generation diagnostic criteria 
The current system for classifying psychiatric disorders is unnecessarily restrictive and
disregards clinical reality. Less reliance on narrow and rigid categorical deﬁnitions and
ﬁxed diagnostic thresholds, and more on careful lifelong evaluation of impairments and
of the signiﬁcance of symptoms will improve our understanding of the variations in nor-
mal development and the variations in clinical thresholds of speciﬁc disorders. This in
turn will lead to better diagnostic criteria and more effective clinical decisions. Hopeful-
ly the new dimensional approach of the DSM–V, which is expected to emphasize life-
time perspectives and assessment of severity and signiﬁcance of symptoms in treatment
decisions, will promote this objective (Achenbach, 2009; Rutter, 2011). 
Signiﬁcance for families
Knowledge of behavioral phenotypes and cognitive proﬁles provides the clinician with
new and additional tools for diagnosing different genetic syndromes. In addition, under-
standing the signiﬁcance and effects of these behaviors and cognitive characteristics for
each individual patient may be helpful for families. It allows parents and other caregivers
to anticipate and deal with the abnormal behaviors of the individual with the syndrome
and adjust rearing and learning environments to beneﬁt that individual’s development.
Understanding what the affected individuals are communicating, whether or not they
use language to do so, requires careful and thoughtful effort on the part of all those
involved in their lives. For parents it may be of great value to realize that certain behav-
ioral characteristics are associated with the syndrome, and that these symptoms should
not be taken personally, as a rejection. This realization may reduce feelings of stress,
guilt, incomprehension, and irritation in parents and other caregivers. Conversely, it is
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equally important that parents not accept certain behaviors associated with the syn-
drome as inevitable and unalterable. Trying to understand the meaning of certain behav-
iors and reacting appropriately to correct either adverse environmental factors or 
speciﬁc aberrant behaviors may prevent further exacerbation and stigmatization. Mean-
ingful positive experiences improve daily living skills and enhance communicative abili-
ties, regardless of impairment. From a scientiﬁc and clinical perspective, it is desirable to
determine whether psychiatric interventions may be helpful in managing behavioral
problems associated with the syndrome. From the individual’s perspective, deﬁning the
need for services at a certain point in time is necessary, but this deﬁnition should be cus-
tomized to reﬂect individual changes and development over time to enable improved
and adapted services to meet changing needs. 
Conclusion
There is a growing body of evidence to suggest that while psychiatric phenotypes in
genetic syndromes are typically diagnosed through behavioral observations, these dis-
orders are closely associated with underlying disruptions in brain development, struc-
ture, and function. Genetic syndromes associated with complex behavioral disorders
such as intellectual disability and autism spectrum disorder, for which no single
causative factor can offer a valid explanation, exemplify the interaction of multiple risk
and protective factors, whether genetic or environmental, and demonstrate how these
interactions change an individual’s development and eventual outcome. Studying phe-
notypes of rare and ultra–rare genetic syndromes associated with severe intellectual dis-
ability has made it clear that while individual outcomes may arise from genetic differ-
ences, the expression of genes affecting structure and function of the brain is also
inﬂuenced by the interplay between genes, learning, and social context. Studies investi-
gating how the interactions between genetic and environmental factors increase the
likelihood of developing the disorder seem promising, especially if these studies also
trace developmental trajectories over the lifespan to investigate changes in phenotypic
proﬁles within and across syndromes. 
Such approaches increase our understanding of how phenotypical features may be
linked to speciﬁc genetic substrates, but more importantly, reveal how genes and envi-
ronment interact in unique ways to predict outcomes. Eventually these studies may lead
to therapeutic interventions that will improve the quality of life of affected individuals
and their families.
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appendix
Summary
The objective of the research projects in this dissertation was to study autism as it man-
ifests itself within (ultra) rare genetic syndromes; and to examine autism within a differ-
ent sociocultural environment. The research projects in this thesis review, describe and
examine three sets of behaviors: intellectual disability, autism spectrum disorder, and
adaptive skills. 
Chapters 2 and 3 review the published literature regarding the phenotypes of intellectu-
al disability and behavioral abnormalities associated with genetic syndromes with a
known cause. Genetically determined syndromes may be characterized by speciﬁc dys-
morphic features and congenital anomalies, but in clinical practice, the behavioral and
cognitive patterns associated with them can be as important. Awareness of such phe-
notypes provides the clinician with additional tools for diagnosing and differentiating
these syndromes. It also allows parents and other caregivers to anticipate and deal with
abnormal behaviors. Several genetic syndromes with distinct behavioral and cognitive
phenotypes that occur frequently are reviewed in chapter 2. An example of a genetic
syndrome associated with intellectual disability that can be clinically recognized by the
unusual behavioral phenotype, is Smith–Magenis syndrome. The highly characteristic
behaviors such as self–hugging, sleep disturbances and severe self injury are reviewed in
chapter 3. The severity of the behavioral abnormalities is usually the primary reason for
referral for psychiatric evaluation.
An early clinical case description of speciﬁc behaviors and intellectual disability in an
individual suspected of having an undeﬁned genetic syndrome is presented in chapter 4.
Findings in this patient were compared to signs and symptoms found in patients with
known genetic defects described in other studies. However, these descriptions suggest-
ed the symptoms found in this patient had a different genetic origin. The marked clini-
cal similarities with two cases described by Pitt and Hopkins (1978) and one case
described by Singh (1993) led to the hypothesis of a syndrome speciﬁcally characterized
by typical facial features, severe intellectual disability, and communication problems
including a lack of expressive language, and an abnormal pattern of voluntary, episodic
overbreathing. At the time the cause of the syndrome was still unknown; discovery of
the gene involved did not take place until 2007, this disorder is now recognized as Pitt–
Hopkins syndrome. 
Pitt–Hopkins syndrome (PHS) is a rare genetic syndrome with important develop-
mental, cognitive, and behavioral consequences. Classic PHS and PH–like syndromes are
caused by genetic deletions/mutations, speciﬁcally Transcription Factor 4 (TCF4) haploin-
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sufﬁciency and NeuReXiN1 (NRXN1) and CoNTactiN Associated Protein–like 2 (CNTNAP2)
alterations. Mutations in TCF4, NRXN1, and CNTNAP2 have been implicated in intellec-
tual disability, epilepsy, autism, and schizophrenia. Assessments of behavioral, adaptive,
and psychological functioning and autism symptoms in 10 individuals with molecularly
conﬁrmed classic PHS are presented in chapter 5. Findings were compared to those
found in the literature. Participants all showed (very) profound intellectual disability, an
amiable demeanor with minimal maladaptive behaviors, severe impairments in commu-
nication and language, coupled with a failure to engage socially, and intense, frequent
motor stereotypies. The psychiatric dimension of the phenotype of the syndrome
includes autism spectrum disorder, albeit presenting in varying degrees of severity. 
Marshall–Smith syndrome (MSS) is an ultra–rare genetic syndrome, with fewer than 50
patients described in the medical literature to date. Its main clinical features are moder-
ate to severe developmental delay with absent or limited speech, unusual behavior,
abnormal bone maturation, respiratory compromise secondary to upper airway obstruc-
tion, and characteristic facial features. Hypoplasia of the corpus callosum is common.
Mortality from respiratory complications is high, but interventions to support the airway
increasingly allow survival into adulthood. A relatively large group of patients with Mar-
shall–Smith syndrome was examined and assessed through an international collaborative
effort and the use of an online Wiki to further delineate the phenotype and to gain insight
into the developmental progression of the syndrome. These ﬁndings are presented in
chapter 6. At the time of publication the etiology of the syndrome was still unknown.
Since then mutations in transcription factor Nuclear Factor I (NFIX) have been implicated
in MSS. At present the speciﬁc function of NFIX remains unclear, but it is assumed that
NFIX has an important role in human brain development and in skeletogenesis.
In the course of studying the physical features of a group of patients with Marshall–
Smith syndrome, unusual behavioral traits were observed. The study of these behavioral
traits in 6 children is described in chapter 7. Participants showed moderate to severe
intellectual disability, severe delay in the attainment of speech and motor milestones, a
friendly or happy demeanor. They enjoyed social interactions with familiar others and
exhibited minimal maladaptive behaviors. Although during clinical assessments we
observed deﬁcits in communication and social interaction, and stereotyped, repetitive
behaviors, these characteristics were ultimately not categorized as autism spectrum dis-
order because the impact of various signiﬁcant medical issues and the inﬂuence of devel-
opmental progress over time remained unclear. Interestingly, only a proportion of the
participants showed the mutation involving the gene NFIX, suggesting that there may be
as yet undeﬁned etiologic factors involved in MSS.
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Chapter 8 describes a study of autism spectrum disorders in Aruba, a context in which
autism had not previously been studied. The objective of the study was to determine the
prevalence of treated autism spectrum disorders in children born in Aruba between
1990 and 1999. All cases were ascertained from record review of children treated at the
Child & Adolescent Psychiatry Clinic of Aruba, the ﬁrst and only child psychiatry service
on the island. This ﬁrst epidemiologic study on autism spectrum disorder in the
Caribbean showed prevalence estimates and gender distribution similar to those report-
ed in recent studies in the UK and US.
Converging evidence suggests that higher paternal and maternal age elevate the risk of
autism in offspring. The ﬁndings of a case–control study in a group of Aruban–born chil-
dren (1990–2003), consisting of 95 cases and 347 controls matched for age and gender,
are presented in chapter 9. The objective of this study was to examine whether the asso-
ciation between higher paternal age and increased risk for autism spectrum disorder in
offspring could also be found in Aruba, whose population has a different sociocultural
and ethnic composition than those of western populations studied heretofore. Results
showed that higher paternal age was indeed also associated with increased risk of autism
spectrum disorder in offspring in Aruba. 
Chapter 10 offers a discussion of the ﬁndings and concluding remarks.
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Samenvatting: Fenotypes en epidemiologie van zeldzame syndromen met
ontwikkelingsproblemen 
In de onderzoeksprojecten van deze dissertatie stond onderzoek naar autisme zoals het
zich voordoet bij zeldzame genetische aandoeningen en binnen een andere sociaal-cul-
turele context centraal. 
Drie soorten gedrag werden in de literatuur bestudeerd, klinisch onderzocht en
beschreven: intellectuele beperking, autisme spectrum stoornis en aanpassings-
vermogen.
In de hoofdstukken 2 en 3 wordt de bestudeerde literatuur over verschijningsvormen
(fenotypes) van intellectuele beperking en gedragsproblemen, geassocieerd met
genetische syndromen met een bekende oorzaak, beschreven. Genetisch bepaalde syn-
dromen kunnen gekarakteriseerd worden door bijzondere uiterlijke kenmerken en
aangeboren afwijkingen, maar voor de klinische praktijk kunnen de erbij voorkomende
gedrags- en cognitieve patronen net zo belangrijk zijn. De clinicus die op de hoogte is
van dergelijke verschijningsvormen heeft extra mogelijkheden om syndromen te diag-
nosticeren en van elkaar te onderscheiden. Dergelijke kennis maakt het ook mogelijk
voor ouders en verzorgers te anticiperen op en om te gaan met afwijkend gedrag. Ver-
schillende genetische syndromen met kenmerkend gedrag en cognitief proﬁel worden
beschreven in hoofdstuk 2. Een voorbeeld van een genetisch syndroom samengaand
met intellectuele beperking, dat klinisch herkenbaar is door het bijkomende ongewone
gedrag is Smith-Magenis syndroom. De typische gedrags- en andere verschijnselen bij
dit syndroom, zoals zichzelf omhelzen, slaapstoornissen en ernstige zelfverwonding
worden beschreven in hoofdstuk 3. De ernst van de gedragsafwijkingen is vaak de belan-
grijkste reden om te verwijzen voor (kinder)psychiatrische beoordeling. 
Een vroege klinische gevalsbeschrijving van bijzonder gedrag en intellectuele beperking
bij een niet-gedeﬁnieerd genetisch syndroom wordt beschreven in hoofdstuk 4. De ver-
schijnselen werden vergeleken met klinische verschijnselen bij andere syndromen,
beschreven in de literatuur, waarvan de oorzaak wel bekend was. Bij deze vergelijkingen
werd duidelijk dat de verschijnselen in deze patiënt een andere genetische oorzaak
moesten hebben. De overeenkomsten tussen deze patiënt en twee gevallen,
beschreven door Pitt en Hopkins in 1976, en een geval beschreven door Singh in 1998 
leidde tot de hypothese van een syndroom gekenmerkt door typische gezichtsken-
merken, ernstige intellectuele beperking met ontbreken van spraak, en een abnormaal
ademhalingspatroon met vrijwillig en periodiek over-ademen. Ten tijde van de publi-
catie van deze klinische beschrijving was de oorzaak nog onbekend, het betrokken gen
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werd pas in 2007 ontdekt en deze combinatie van afwijkingen staat nu bekend als Pitt-
Hopkins syndroom. 
Pitt-Hopkins syndroom (PHS) is een zeldzaam genetisch syndroom met belangrijke
gevolgen voor de ontwikkeling, de intelligentie en het gedrag. Klassiek PHS en PH-
achtige syndromen worden veroorzaakt door genetische defecten of veranderingen in
Transcription Factor 4 (TCF4) en door veranderingen in NeuReXiN1 (NRXN1) en 
CoNTactiN Associated Protein-like 2 (CNTNAP2). Veranderingen in TCF4, NRXN1, en 
CNTNAP2 zijn betrokken bij intellectuele beperking, epilepsie, autisme en schizofrenie.
In hoofdstuk 5 worden de uitkomsten besproken van de onderzoeken naar het gedrag,
aanpassingsvermogen en psychologisch functioneren in 10 individuen, waarbij PHS mol-
eculair werd aangetoond, beschreven en vergeleken met eerdere beschrijvingen in de
literatuur. Alle deelnemers aan het onderzoek hadden een (zeer) ernstige intellectuele
beperking, een vriendelijke uitstraling met weinig gedragsproblemen, ernstige
beperkingen in communicatie en spraak, gecombineerd met problemen in de sociale
interactie en intense, vaak voorkomende motorische stereotypieën.  Geconcludeerd
werd dat bij de verschijningsvorm van dit syndroom autisme spectrum stoornis kan
voorkomen, maar dat de ernst van de autistische symptomen varieert.  
Marshall–Smith syndrome (MSS) is een ultra-zeldzaam genetisch syndroom, dat tot nu
toe bij minder dan 50 patiënten in de wereld beschreven werd. De belangrijkste klinis-
che kenmerken zijn matig tot ernstige ontwikkelingsachterstand met weinig of geen
spraak, ongewoon gedrag, abnormale botrijping, ademhalingsmoeilijkheden door
luchtwegproblemen en bijzondere gezichtskenmerken. Onderontwikkeling van het cor-
pus callosum komt vaak voor. Er is een hoge sterfte door de ademhalingsmoeilijkheden,
hoewel overleving tot in de volwassenheid steeds vaker mogelijk is wanneer door
medisch ingrijpen de luchtwegproblemen worden verminderd.
Een relatief grote groep patiënten met Marshall-Smith syndroom werd binnen een
internationaal samenwerkingsproject en met gebruik van een online Wiki lichamelijk
onderzocht. Doel was het fenotype verder af te grenzen en inzicht te krijgen in de
ontwikkelingsvoortgang van het syndroom. De uitkomsten van deze onderzoeken wor-
den beschreven in hoofdstuk 6. Ten tijde van de publicatie was de oorzaak van het syn-
droom nog onbekend. Daarna werd ontdekt dat veranderingen in transcription factor
Nuclear Factor I (NFIX) mogelijk een rol spelen. De precieze functie van NFIX is nog
steeds onduidelijk, maar aangenomen wordt dat het een belangrijke rol heeft in de
ontwikkeling van het menselijk brein en in de ontwikkeling van het skelet.
Gedurende het onderzoek naar de lichamelijke kenmerken van een groep patiënten met
Marshall-Smith syndroom werden ook enkele bijzondere gedragingen geobserveerd.
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Het onderzoek naar deze gedragingen in een groepje van 6 kinderen met Marshall-
Smith syndroom wordt beschreven in hoofdstuk 7.  De kinderen hadden matig tot ern-
stige intellectuele beperkingen, ernstige achterstand in de ontwikkeling van taal en
motoriek. Zij hadden een vriendelijk, vrolijk temperament, weinig gedragsproblemen
en ze genoten van sociale activiteiten met bekende anderen. Ondanks dat er gedurende
de onderzoeken ook tekortkomingen in het sociale contact en de communicatie werden
gezien, en stereotype motorische bewegingen, konden deze gedragskenmerken uitein-
delijk toch geen autisme spectrum stoornis genoemd worden. Vooral omdat de invloed
van ernstige lichamelijke problemen en eerdere ziekenhuisopnames onduidelijk was, en
omdat er met het voortschrijden van tijd nog steeds voortgang in de ontwikkeling van
contact, communicatie en motoriek leek te kunnen optreden.  Opvallend was dat maar
een deel van de onderzochte kinderen de verandering in het gen NFIX bleek te hebben.
Het is dus aannemelijk dat er andere, nog niet ontdekte factoren een rol spelen in het
ontstaan van MSS.
In hoofdstuk 8 wordt de studie van autisme spectrum stoornissen in Aruba beschreven,
een  context waarin nog niet eerder onderzoek naar autisme werd gedaan. Het doel van
de studie was de prevalentie te bepalen van autisme spectrum stoornissen bij in Aruba
geboren kinderen, die behandeld werden bij de Polikliniek Kinder- en Jeugdpsychiatrie
in Aruba. Alle gevallen werden gevonden door middel van een studie van de dossiers
van de Polikliniek Kinder- en Jeugdpsychiatrie, de eerste en enige kinderpsychiatrische
voorziening op het eiland. Bij deze eerste epidemiologische studie van autisme spec-
trum stoornissen in de Caribische regio werd aangetoond dat de prevalentie en ges-
lachtsverdeling van autisme spectrum stoornissen vergelijkbaar zijn met de resultaten
uit studies in de Verenigde Staten en het Verenigd Koninkrijk.  
Er zijn steeds meer aanwijzingen uit internationale onderzoeken dat het risico op
autisme van een kind toeneemt door een hogere leeftijd van vader en moeder bij de
geboorte ervan. In hoofdstuk 9 worden de bevindingen van een case-control studie in
een groep van in Aruba geboren kinderen (1990-2003), bestaande uit 95 cases en 347
controles geselecteerd op leeftijd en geslacht, beschreven. Het doel van deze studie was
te onderzoeken of de associatie tussen een hogere leeftijd van de vader en toegenomen
risico voor autisme voor het kind ook gevonden kon worden in Aruba. In Aruba heeft de
populatie een andere sociaal-culturele en etnische samenstelling dan de westerse pop-
ulaties die eerder werden onderzocht. Uit de resultaten van dit onderzoek werd
duidelijk dat ook in Aruba een hogere leeftijd van de vader samenhangt met een
toegenomen risico voor autisme in het kind.
188
In hoofdstuk 10 wordt een discussie van de bevindingen gepresenteerd met enkele 
afsluitende opmerkingen.
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